Ink applicator
The semi-permanent tattoo applicator addresses the challenge of stratum corneum barriers by providing a controlled ink dispensing system, enabling consistent and detailed tattoo application with various nib options, enhancing user experience and ink adherence.
Patent Information
- Application Number
- JP2024510357
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-08-25
- Filing Date
- 2022-08-23
- Publication Date
- 2024-11-13
AI Technical Summary
Current methods for applying semi-permanent tattoos face challenges due to the barrier properties of the stratum corneum, requiring moderate user application to ensure proper ink delivery, which can be inconsistent and difficult to control.
A semi-permanent tattoo applicator with a reservoir and nib configuration that allows for controlled dispensing of semi-permanent ink compositions, featuring a lower body with a reservoir and an upper body connected by threads, equipped with a nib to apply ink to the skin, optionally including an agitator to prevent settling and a variety of nib shapes for different effects.
Enables consistent and controlled application of semi-permanent tattoos, allowing users to create detailed designs without the need for extensive user monitoring, ensuring proper ink distribution and longevity on the skin.
Smart Images

Figure 2024541793000001_ABST
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Patent Application No. 63 / 236,968, filed August 25, 2021, the entire contents of which are incorporated by reference herein.
[0002] The present invention relates to semi-permanent tattoo ink applicators, and more particularly to semi-permanent tattoo applicators that dispense semi-permanent ink compositions. [Background technology]
[0003] Temporary or semi-permanent tattoos or body inks have been used throughout human history to decorate the body. Generally, temporary or semi-permanent tattoos are transferred to the skin by directly exposing the skin to the tattoo ink for a specified incubation period. The quality of the transferred image and its duration on the skin may depend on the ink distribution profile of the outer layer of the skin called the stratum corneum. Current manufacturing processes for pre-made tattoo designs include the use of flexographic or gravure printing, stencils, and inkjet printers. However, due to the barrier properties of the stratum corneum, many of the current methods require moderate monitoring by the end user during the tattoo application process to ensure proper ink delivery to the skin so that the tattoo ink will develop properly. Summary of the Invention
[0004] Provided herein are semi-permanent tattoos, ink applicators, and semi-permanent tattoo applicators that dispense semi-permanent ink compositions. In some embodiments, the ink applicator comprises a lower body coupled to an upper body, the upper body including a nib having a first end exterior to the upper body and a second end interior to the upper body, the nib configured to dispense the semi-permanent ink.
[0005] In some embodiments, the ink applicator comprises a lower body comprising a reservoir container housed within a cavity of the lower body, a reservoir housed within the cavity of the reservoir container, and semi-permanent ink housed in the reservoir.
[0006] In some embodiments, the ink applicator comprises a lower body comprising a reservoir contained within a cavity of the lower body and a semi-permanent ink contained in the reservoir. In some embodiments, the reservoir comprises polyethylene terephthalate. In some embodiments, the polyethylene terephthalate is saturated in the semi-permanent ink. In some embodiments, the ink applicator further comprises an agitator contained within the reservoir. In some embodiments, the agitator is made of metal.
[0007] In some embodiments, the ink applicator comprises a lower body comprising a reservoir container contained within a cavity of the lower body and semi-permanent ink contained in the reservoir.
[0008] In some embodiments, the ink applicator includes a lower body and semi-permanent ink contained within a cavity of the lower body.
[0009] In some embodiments, the lower body further comprises male threads coupleable to the upper body, In some embodiments, the upper body comprises a nib having a first end exterior to the upper body and a second end interior to the upper body, the nib configured to dispense the semi-permanent ink.
[0010] In some embodiments, the ink applicator comprises a lower body coupled to an upper body, the upper body including a nib including a first end exterior to the upper body and a second end interior to the upper body, the nib configured to dispense the semi-permanent ink. In some embodiments, the ink applicator further includes a reservoir container housed within a cavity of the lower body. In some embodiments, the ink applicator further includes a reservoir housed within a cavity of the reservoir container, the semi-permanent ink being housed within the reservoir. In some embodiments, the reservoir includes polyethylene terephthalate. In some embodiments, the polyethylene terephthalate is saturated in the semi-permanent ink.
[0011] In some embodiments, the ink applicator comprises a lower body including a reservoir container housed within a cavity of the lower body, a reservoir housed within the cavity of the reservoir container, and semi-permanent ink housed within the reservoir, and an upper body coupled to the lower body, the upper body including a nib having a first end exterior to the upper body and a second end interior to the upper body.
[0012] In some embodiments, the reservoir comprises polyethylene terephthalate. In some embodiments, the polyethylene terephthalate is saturated in the semi-permanent ink.
[0013] In some embodiments, the ink applicator comprises a lower body including a reservoir container housed within a cavity of the lower body, a reservoir housed within the cavity of the reservoir container, and semi-permanent ink housed within the reservoir, and an upper body coupled to the lower body including a nib having a first end exterior to the upper body and a second end interior to the upper body, and a transfer nib contacting the second end of the nib and the semi-permanent ink housed in the reservoir.
[0014] In some embodiments, the ink applicator further comprises an agitator housed within the reservoir. In some embodiments, the agitator is metallic. In some embodiments, the agitator is a metallic bead. In some embodiments, the nib comprises nylon brush fibers and is configured to couple to the transfer nib. In some embodiments, the nib comprises a porous, flexible tip and is configured to couple to the transfer nib. In some embodiments, the semi-permanent ink is absorbed by the transfer nib and the semi-permanent ink absorbed by the nib is transferred to a second end of the nib. In some embodiments, the ink applicator further comprises a transfer casing adjacent to a first end of the nib. In some embodiments, the transfer casing couples the transfer nib to the nib. In some embodiments, the transfer casing secures the transfer nib to the upper body. In some embodiments, the transfer casing is configured to absorb excess semi-permanent ink from the reservoir.
[0015] In some embodiments, the second end of the nib contacts the semi-permanent ink contained within the reservoir. In some embodiments, the first end of the nib is configured to deposit the semi-permanent ink composition onto a substrate. In some embodiments, the substrate is paper. In some embodiments, the substrate is animal skin. In some embodiments, the reservoir is selectively removable. In some embodiments, the lower body further comprises a transparent window. In some embodiments, the reservoir is visible through the transparent window.
[0016] In some embodiments, the ink applicator further includes male threads integrated into the lower body and female threads integrated into the upper body, the male and female threads being complementary and coupling the lower body to the upper body.
[0017] In some embodiments, the female and male threads couple the upper body to the lower body such that the cavity in the lower body is sealed. In some embodiments, the nib includes a solid round tip. In some embodiments, the nib includes a chisel tip. In some embodiments, the nib includes a fine point tip. In some embodiments, the ink applicator further comprises a lid configured to cover a first end of the nib that is exterior to the upper body. In some embodiments, the lid provides a seal between the lid and the upper body. In some embodiments, the reservoir includes a void. In some embodiments, the void is configured to contain a volume of semi-permanent ink. In some embodiments, the volume is about 0.5 mL to about 1.5 mL. In some embodiments, the volume is about 1.0 mL. In some embodiments, the ink applicator is a pen. In some embodiments, the ink applicator is a marker.
[0018] In some embodiments, the ink applicator system comprises a reservoir containing semi-permanent ink and a plurality of nibs configured to contact the semi-permanent ink in the reservoir. In some embodiments, a first nib of the plurality of nibs comprises a rigid round tip. In some embodiments, a second nib of the plurality of nibs comprises a chisel tip. In some embodiments, a third nib of the plurality of nibs comprises a fine point tip. In some embodiments, a fourth nib of the plurality of nibs comprises nylon brush fibers. In some embodiments, a fifth nib of the plurality of nibs comprises a flexible porous tip. In some embodiments, the ink applicator system further comprises a pouch of semi-permanent ink. In some embodiments, the pouch comprises a volume of about 0.5 mL to about 1.5 mL for the semi-permanent ink. In some embodiments, the pouch comprises a volume of about 1.0 mL for the semi-permanent tattoo composition. In some embodiments, the reservoir further comprises polyethylene terephthalate. In some embodiments, the polyethylene terephthalate is saturated with the semi-permanent ink. In some embodiments, the plurality of nibs correspond to a color of the semi-permanent ink.In some embodiments, the ink applicator system further comprises an ink applicator.
[0019] In some embodiments, a method for applying ink onto skin is disclosed herein, the method comprising coupling a nib to an upper body of an ink applicator containing an ink composition, and applying the ink composition of the ink applicator to a portion of skin. In some embodiments, the ink applicator is a marker. In some embodiments, the method further comprises agitating the ink applicator to initiate a flow of the ink composition from a reservoir of the ink applicator to the nib.
[0020] In some embodiments, the method further includes separating the upper body of the ink applicator from the lower body of the ink applicator, removing the reservoir from the lower body, and replacing the reservoir with a different reservoir. In some embodiments, the method further includes separating the upper body of the ink applicator from the lower body of the ink applicator, removing the reservoir from the lower body, and filling the reservoir with additional ink composition.
[0021] In some embodiments, the method further includes separating the nib from the ink applicator, coupling a different nib to the ink applicator, and applying ink to a portion of the skin via the ink applicator and the different nib.
[0022] In some embodiments, the semi-permanent ink comprises a semi-permanent colorant, the semi-permanent colorant comprising genipin, a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, a solvent, and a film forming agent.
[0023] In some embodiments, the genipin derivative is a compound of formula I,
[0024] [ka] During the ceremony: R 1 is -C(=O)OR6, C 1~6 Alkyl or C 6~10 aryl, 1~6 Alkyl and C 6~10 Aryl is 1 to 5 R 7 are optionally replaced by R 6 , H, C 1~6 Alkyl or C 6~10 aryl, 1~6 Alkyl and C 6~10 aryl is optionally substituted with 1 to 5 R7; Each R 7 is independently an electron withdrawing group or an electron donating group; R 2 H, -OR 9 , or OC(=O)R 9A and R 9 , H, C 1~6 Alkyl, C 6~10 selected from the group consisting of aryl and hydroxy protecting groups; R 9A is C 1~6 Alkyl and C 6~10 aryl; The dotted line indicates the optional presence of a double bond; If no double bond is present, R 4 and R 5 forms a 3- to 4-membered heterocyclic ring together with the carbon atom to which it is attached, and R 3 is -OH or -CHOH, or If a double bond is present, R 4 and R 5 does not exist, and R 3 -NR 7 R 8 , -CH2NR 7 R 8 , -C(=O)OR 10 , -C(=O)NR 10 R 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH2OR 10 and 1 to 5 7 phenyl substituted with R 10 , H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 phenyl substituted with R 8 is H or R 7 It is.
[0025] In some embodiments, R 1is -C(=O)OR 6 Or 1 to 5 R 7 is a phenyl substituted with R 6 , H, C 1~6 Alkyl or 1 to 5 R 7 is a phenyl substituted with R 2 H, -OR 9 , or OC(=O)R 9 and R 9 is H or C 1~6 is alkyl, If a double bond is present, R 4 and R 5 does not exist, R 3 -NR 7 R 8 , -CH2NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 , diethyl malonate and 1 to 5 R 7 phenyl substituted with R 10 , H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O) and 1 to 5 R 7 It is phenyl substituted with
[0026] In some embodiments, the hydroxy protecting group is a tri(C 1~6 In some embodiments, the hydroxy protecting group is tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), or triethylsilyl (TES). 6 is methyl. In some embodiments, R 1 is -C(=O)OR 6 and R 6 is methyl. In some embodiments, R 1 is -C(=O)OR6 and R 6 is 1 to 5 R 7 In some embodiments, R 2 is -OC(=O)CH3. In some embodiments, R 2 is -OH. In some embodiments, R 2 -OR 9 and R 9 , H, C 1~6 Alkyl, tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), triethylsilyl (TES) and C 6~10 In some embodiments, R 9 is H. In some embodiments, R 9 is tert-butyldimethylsilyl (TBS). In some embodiments, R 9 is -OH. In some embodiments, there is no double bond. In some embodiments, R 4 and R 5 forms, together with the carbon atom to which it is attached, a three-membered heterocyclic ring; R 3 is -CHOH. In some embodiments, the 3-membered heterocycle is
[0027] [ka] It is.
[0028] In some embodiments, R 4 and R 5 forms a four-membered heterocyclic ring together with the carbon atom to which it is attached, R 3 is -OH.
[0029] In some embodiments, the four-membered ring is
[0030] [ka] It is.
[0031] In some embodiments, a double bond is present. In some embodiments, R 1 1 to 3 R 7 In some embodiments, R 1 is -C(=O)OR 6 and R 6 1 to 3 R 7 In some embodiments, R 2 is -OH and R 3 is CHOH. In some embodiments, R 3 teeth, -NR 7 R 8 , -CH2NR 7 R 8 , -C(=O)OR 10 , -C(=O)NR 10 R 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH2OR 10 and phenyl substituted with 1 to 5 R7; R 1 is -C(=O)OH, R 2 is -OH, R 10 , H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 phenyl substituted with
[0032] In some embodiments, R 3 teeth, -NR 7 R 8 , -CH2-NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR10 , -C(=O)NR 10 R 10 , -CH2OR 10 and 1 to 5 R 7 phenyl substituted with R 1 is -C(=O)OH, R 2 -OR 9 and R 9 , H, C 1~6 Alkyl, tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), triethylsilyl (TES) and C 6~10 aryl.
[0033] In some embodiments, R 3 teeth, -NR 7 R 8 , -CH2-NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 , diethyl malonate and 1 to 5 R 7 phenyl substituted with R1 is -C(=O)OH; R 2 is -OH.
[0034] In some embodiments, the genipin derivative is a compound selected from the group consisting of the compounds shown in Table 1. 7 is -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -NHC(=O)R 8 , -OC(=O)R 8 , -SR 8 , -CO2 -, -SO2CF3, -NO, -NO2, -SO2R 8 , -CN, -CR 11 , -COR 11 , -CHO, -COR 8 , -C(=O)NR 8 R 8 and halides; R 8 is H, -(C 1~9 alkyl), and -(C 2~9 alkenyl), R 11 is a halide.
[0035] In some embodiments, the lawsone derivative is a compound shown in Table 4.
[0036] In some embodiments, the lawsone derivative is a compound of formula III,
[0037] [ka] R 12 is -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -NHC(=O)R 8 , -OC(=O)R 8 , -SR 8 , -CO2 - , -SO2CF3, -NO, -NO2, -SO2R 8 , -CN, -CR 11 3. -COR 11 , -CHO, -COR 8 , -C(=O)NR 8 R 8 and halides; R 8 is H, -(C 1~9 alkyl), -(C 2~9 alkenyl), R 11 is a halide.
[0038] In some embodiments, the semi-permanent coloring agent is a combination of two or more of genipin, genipin derivatives, lawsone, and lawsone derivatives. In some embodiments, the semi-permanent coloring agent includes a combination of two or more genipin derivatives. In some embodiments, the semi-permanent coloring agent includes a combination of two or more compounds as shown in Table 1. In some embodiments, the semi-permanent coloring agent includes a combination of Compound 1 and Compound 12. In some embodiments, the ratio of Compound 1 to Compound 12 is about 4:1 to about 1:4, Compound 1:Compound 12. In some embodiments, the semi-permanent coloring agent is a combination of genipin and Compound 1. In some embodiments, the ratio of genipin to Compound 1 is about 4:1 to about 1:4, Compound 1:Compound 1. In some embodiments, the ratio of genipin to Compound 1 is about 1:1, Compound 1:Compound 1. In some embodiments, the semi-permanent coloring agent includes a combination of Compound 1 and Compound 14. In some embodiments, the ratio of compound 1 to compound 14 is about 4:1 to about 1:4, compound 1:compound 14. In some embodiments, the ratio of compound 1 to compound 14 is about 1:1, compound 1:compound 14. In some embodiments, the semi-permanent colorant is a combination of genipin and compound 14. In some embodiments, the ratio of genipin to compound 14 is about 4:1 to about 1:4, compound 14. In some embodiments, the ratio of genipin to compound 14 is about 1:1, compound 14. In some embodiments, the semi-permanent colorant includes a combination of genipin, compound 1, and compound 14. In some embodiments, the ratio of genipin to compound 1 to compound 14 is about 4:1:1 to about 1:1:4, compound 14. In some embodiments, the ratio of genipin to Compound 1 to Compound 14 is about 1:1:1.
[0039] In some embodiments, the semi-permanent colorant is present in an amount of about 5% to about 15% w / w of the composition. In some embodiments, the semi-permanent colorant is present in an amount of about 9% to about 11% w / w of the composition. In some embodiments, the semi-permanent colorant is present in an amount of about 10% w / w of the composition. In some embodiments, the solvent is present in an amount of about 65% to about 85% w / w of the composition. In some embodiments, the solvent is present in an amount of about 75% to about 80% w / w of the composition. In some embodiments, the solvent is present in an amount of about 77% w / w of the composition.
[0040] In some embodiments, the solvent comprises water, methanol, ethanol, isopropanol, diethylene glycol monoethyl ether, or a combination thereof. In some embodiments, the solvent is a combination of water and ethanol. In some embodiments, the water is present in an amount of about 25% to about 35% by weight of the composition. In some embodiments, the water is present in an amount of about 30% by weight of the composition. In some embodiments, the ethanol is present in an amount of about 40% to about 55% by weight of the composition. In some embodiments, the ethanol is present in an amount of about 45% to about 50% by weight of the composition. In some embodiments, the ethanol is present in an amount of about 48% by weight of the composition. In some embodiments, the film forming agent is present in an amount of about 5% to about 10% by weight of the composition. In some embodiments, the film forming agent is present in an amount of about 6% to about 9% by weight of the composition. In some embodiments, the film forming agent is present in an amount of about 7.5% by weight of the composition.
[0041] In some embodiments, the film-forming agent comprises a volatile silicone resin, a polyvinylpyrrolidone, an acrylate, an acrylamide, a copolymer, an isododecane resin, or a combination thereof.
[0042] In some embodiments, the film former is selected from the group consisting of polymethylsilsesquioxane, trimethylsiloxysilicate, polypropylsilsesquioxane, dimethicone, cyclopentasiloxane, dimethiconol crosspolymer, polysilicone-6, polysilicone-8, polysilicone-11, polysilicone-14, acrylates copolymer, styrene / acrylates copolymer, polyvinylpyrrolidone, acrylates / C12-22 alkyl methacrylate copolymer, acrylates / polytrimethylsiloxymethacrylate copolymer, polyvinylpyrrolidone / vinyl acetate (VP / VA) copolymer, VP / Acrylates copolymer, polyvinylpyrrolidone / vinyl acetate (VP / VA) ... and combinations thereof.
[0043] In some embodiments, the film-forming agent is a combination of an acrylate copolymer, polyvinylpyrrolidone, and a styrene / acrylate copolymer. In some embodiments, the acrylate copolymer is present in an amount of about 0.1 w / w% to about 10 w / w% of the composition. In some embodiments, the acrylate copolymer is present in an amount of about 0.1 w / w% to about 1 w / w% of the composition. In some embodiments, the acrylate copolymer is present in an amount of about 0.25 w / w% of the composition. In some embodiments, the polyvinylpyrrolidone is present in an amount of about 0.1 w / w% to about 10 w / w% of the composition. In some embodiments, the polyvinylpyrrolidone is present in an amount of about 0.5 w / w% to about 1.5 w / w% of the composition. In some embodiments, the polyvinylpyrrolidone is present in an amount of about 1 w / w% of the composition. In some embodiments, the styrene / acrylate copolymer is present in an amount of about 0.1 w / w% to about 10 w / w% of the composition. In some embodiments, the styrene / acrylate copolymer is present in an amount of about 5% to about 7% w / w of the composition, hi some embodiments, the styrene / acrylate copolymer is present in an amount of about 6% w / w of the composition.
[0044] In some embodiments, the composition further comprises a humectant. In some embodiments, the humectant is present in an amount of about 0.1 w / w% to about 10 w / w% of the composition. In some embodiments, the humectant is present in an amount of about 0.5 w / w% to about 1.5 w / w% of the composition. In some embodiments, the humectant is present in an amount of about 1 w / w% of the composition.
[0045] In some embodiments, the moisturizer comprises aloe vera gel, lithium chloride, allantoin, urea, dicyanamidoglycerol, lactic acid, propylene glycol, polyethylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol, propanediol, hexylene glycol, 1,3-butylene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol, glyceryl triacetate, sorbitol, hydroxypropyl sorbitol, xylitol, maltitol, hyaluronic acid, tremella extract, sodium lactate, sodium L-pyroglutamate urea, pyrrolidone carboxylic acid, or combinations thereof. In some embodiments, the moisturizer is propanediol. In some embodiments, the composition further comprises a preservative. In some embodiments, the preservative is present in an amount of about 0.1 w / w% to about 5 w / w% of the composition. In some embodiments, the preservative is present in an amount of about 0.5 w / w% to about 1.5 w / w% of the composition. In some embodiments, the preservative is present in an amount of about 1% w / w of the composition.
[0046] In some embodiments, the preservative is ascorbic acid, ascorbate, palmitate, citric acid, benzoate, benzoic acid, propionate, propionic acid, sorbate, sorbic acid, salicylic acid, salicylates, hexa-2,4-dienoic acid, hexa-2,4-dienoate, formaldehyde, formaldehyde-releasing agents, formic acid and its salts, 3-acetyl-6-methylpyran-2,4-(3H)-dione and its salts, 3,3'-dibromo-4,4'-hexamethylenedioxydibenzamidine and its salts, thiomersal, phenylmercury salts, undec-10-enoic acid and its salts, 1,3-bis(2-ethylhexyl)hexa Hydro-5-methyl-5-pyrimidine, 5-bromo-5-nitro-1,3-dioxane, bronopol, 2,4-dichlorobenzyl alcohol, 1-(4-chlorophenyl)-3-(3,4-dichlorophenyl)urea, chlorocresol, chloroxylenol, 5-chloro-2-(2,4-dichlorophenoxy)phenol, N,N''-methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea], polyaminopropyl biguanide, methenamine, quaternium-15, climbazole, DMDM hydantoin, benzyl alcohol, 1-hydroxy-4-methyl-6-(2,4,4-Trimethylpentyl)-2-pyridone, piroctone olamine, bromochlorophene, o-cymen-5-ol, chlorophene, chloroacetamine, methylchloroisothiazolinone, methylisothiazolinone, phenoxyisopropanol, chlorhexidine, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dihydrochloride, dimethyloxazolidine, behentrimonium chloride, cetrimonium bromide, cetrimonium chloride, lautrimonium bromide, lautrimonium chloride, steartrimonium bromide, steartrimonium chloride, diazolidinyl urea, hexamidine, hexamidine diisethionate, hexamidine paraben, glutaral, 7-ethylbicyclooxazolidine, chlorphenesin, sodium hydroxymethylglycine, silver chloride, salt benzethonium chloride, benzalkonium chloride, benzalkonium bromide, benzalkonium saccharinate, benzyl hemiformal, iodopropynyl butylcarbamate, biphenyl-2-ol and its salts, zinc pyrithione, erythorbate, nitrous acid, ethylenediaminetetraacetic acid (EDTA), butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), caprylic acid, dilauryl thiodipropionate, erythorbic acid, guaiac butter, methylparaben, sulfite, bisulfite, metabisulfite, propyl galactose, propylparaben, stannous chloride, sulfur dioxide, thiodipropionic acid, isothiazolin, paraben, phenoxyethanol, ethylhexylglycerin, glycol, tocopherol, 1,2 hexanediol, or combinations thereof.
[0047] In some embodiments, the preservative comprises a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the combination of phenoxyethanol and ethylhexylglycerin is present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin. In some embodiments, the combination of phenoxyethanol and ethylhexylglycerin is present in an amount of about 0.1 w / w% to about 2 w / w% of the composition. In some embodiments, the combination of phenoxyethanol and ethylhexylglycerin is present in an amount of about 1 w / w% of the composition. In some embodiments, the preservative comprises EDTA. In some embodiments, the EDTA is present in an amount of about 0.01 w / w% to about 2 w / w% of the composition. In some embodiments, the EDTA is present in an amount of about 0.05 w / w% of the composition.
[0048] Reference to the term "about" has its ordinary meaning in the context of a composition to allow for reasonable variations in amounts that can achieve the same effect, and herein also refers to values plus or minus 10% of the provided value. For example, "about 20" means or includes an amount from 18 to 22, inclusive.
[0049] As used herein, "colorant" refers to a substance that changes the color of reflected or transmitted light as a result of wavelength-selective absorption.
[0050] As used herein, "temporary colorant" refers to a colorant that, if placed on or penetrating the skin, can diffuse off the skin or be washed away, for example, by water, soap, and / or isopropanol.
[0051] As used herein, "color" refers to wavelengths of electromagnetic radiation visible to the human eye.
[0052] As used herein, "surface active agent" or "surfactant" refers to a substance that tends to lower the surface tension of the liquid in which it is dissolved.
[0053] When the compound disclosed herein has at least one chiral center, the compound can exist as enantiomers accordingly.When the compound has two chiral centers, the compound can also exist as diastereomers.It should be understood that all such isomers and their mixtures are included within the scope of the present invention.
[0054] Unless otherwise required by context, singular terms shall include the plural and plural terms shall include the singular. As used herein, the singular forms "a," "an," and "the" include plural references unless otherwise indicated. For example, "an" excipient includes one or more excipients.
[0055] The details of one or more embodiments of the present invention are described in the accompanying drawings and the following description. Other features, objects, and advantages of the present invention will be apparent from the description and drawings, and from the claims. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present invention belongs. Methods and materials for use in the present invention are described herein, however, suitable methods and materials known in the art can also be used. The materials, methods, and examples are merely illustrative and are not intended to be limiting. All publications, patent applications, patents, sequences, database entries, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. In case of conflict, the present specification, including definitions, will control. [Brief description of the drawings]
[0056] [Figure 1] Figure 1A shows an example of an ink applicator with a cap covering the nib, and Figure 1B shows an example of an ink applicator with an exposed nib. [Diagram 2] 2 is an exploded view of a lower body of an exemplary ink applicator. [Diagram 3] 2 is an exploded view of an upper body of an exemplary ink applicator. [Figure 4] 1 illustrates a cross-sectional view of an exemplary ink applicator. [Diagram 5] 1 illustrates a cross-sectional view of an exemplary ink applicator including a transfer nib and an agitator. [Figure 6] An example of a nib with a solid rounded tip is shown. [Figure 7] 1 shows an example of a nib with a chisel tip. [Figure 8] 1 shows an example of a nib with a thin tip. [Figure 9] An example of a nib with a nylon brush tip is shown. [Figure 10] 1 shows an example of a nib with a fiber tip. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0057] A manufacturing approach utilizing inkjet printing directly onto a skin transfer substrate allows for the rapid production of custom designed semi-permanent tattoos. However, printing can impose limitations on the creativity of the tattooer. Applying freehand semi-permanent tattoos allows a user to practice their skills and / or create specialized freehand tattoos on a substrate such as human skin.
[0058] Provided herein are ink applicators (e.g., semi-permanent tattoo applicators) that allow for freehand application of tattoo designs onto a substrate. Also provided herein are compositions including such semi-permanent colorants that can be applied to the skin as semi-permanent tattoos. Such compositions can be formulated to be safe for skin contact and to maintain stability or skin transferability over the product shelf life. In some embodiments, the compositions described herein can be suitable for application to the skin using a pen-like applicator or a marker-like applicator.
[0059] As used herein, a "semi-permanent colorant" or "semi-permanent ink" refers to a colorant that penetrates one or more layers of the skin and cannot be removed from the skin without physical destruction or natural desquamation of the skin. In some embodiments, the semi-permanent colorant can include a colorant precursor, such as a molecule such as genipin, that develops color upon reaction with one or more other molecules. In some embodiments, the semi-permanent colorant can penetrate the stratum corneum and react with other molecules, such as other colorant molecules and / or other molecules present in the stratum corneum, immobilizing the semi-permanent colorant within the stratum corneum. For example, the semi-permanent colorant can crosslink with keratin found in the stratum corneum. In some embodiments, the semi-permanent colorant can react with other molecules, such as other colorant molecules and / or other molecules present in the stratum corneum, to form molecules that are too large to diffuse out of the stratum corneum. In some embodiments where the semi-permanent colorant penetrates the stratum corneum, the residence time of the colorant is determined by the natural skin desquamation process. In some examples, the natural desquamation process can be accelerated by, for example, washing, desquamation, etc. In some embodiments, the semi-permanent coloring agent cannot be washed off, for example, by water, soap, and / or isopropanol. In some embodiments, the semi-permanent coloring agent comprises a natural or synthetic pigment or dye. Non-limiting examples of semi-permanent coloring agents include genipin, genipin derivatives, lawsone, and lawsone derivatives.
[0060] As used herein, "genipin" refers to genipin extract, partially purified genipin extract, and / or purified genipin, as further described herein. Genipin is derived from an iridoid glycoside called geniposide, which is present in nearly 40 plant species. In addition, genipin is a precursor to gardenia blue pigment, which undergoes a conversion reaction upon exposure to amine groups to form a blue colorant (e.g., Touyama et al., Chem. Pharm. Bull. 42:668-673, 1994; and Touyama et al., Chem. Pharm. Bull. 42(8):1571-1578, 1994; both of which are incorporated herein by reference in their entirety). When contacted with skin, genipin can contact amines in the skin and generate polymer-based and / or oligomer-based blue colors in situ. In some embodiments, when contacted with skin, genipin reacts with primary amine functional groups within molecules in the skin.
[0061] A "genipin derivative" is a compound that has a genipin core. For example, a genipin derivative is a compound that has the following core structure:
[0062] [ka]
[0063] Reference is made to Figures 1A and 1B. Figure 1A shows an example of an ink applicator with a cap covering the nib, and Figure 1B shows an example of an ink applicator with an exposed nib. Figure 1A includes an ink applicator (e.g., semi-permanent tattoo applicator) 100, an upper body 110, a lid 114, and a lower body 116. The semi-permanent tattoo applicator 100 may be a device that contains an ink composition (e.g., semi-permanent ink) and is designed to be operated by hand to deposit the ink composition on a user's skin. For example, the semi-permanent tattoo applicator 100 may be a pen or a marker. The terms "pen" and "marker" may be used interchangeably herein to describe the semi-permanent tattoo applicator 100.
[0064] In some embodiments, the semi-permanent tattoo applicator 100 may be a pen. In some examples, the semi-permanent tattoo applicator 100 may be classified as a pen based on the desired effect of the semi-permanent tattoo applicator 100 on the user's skin. For example, the semi-permanent tattoo applicator 100 may be a pen when the desired effect is to deposit the ink composition on the user's skin in fine detail to achieve a stylistic technique (e.g., stippling) or in text form, such as numbers, letters, and / or other characters. In other examples, the semi-permanent tattoo applicator 100 may be referred to as a marker when the desired effect is to deposit ink in a thick line on the user's skin.
[0065] The ink composition can be any of the ink compositions described herein. In some embodiments, the ink composition can be a semi-permanent ink formulated to adhere to the skin of a user. For example, described herein are ink compositions including a semi-permanent colorant including a genipin derivative, lawsone, lawsone derivative, or combinations thereof, a solvent, and a semi-volatile semi-permanent colorant solubilizer. Also described herein are compositions including a semi-permanent colorant (e.g., a semi-permanent ink) including a genipin derivative, lawsone, lawsone derivative, or combinations thereof, a solvent, and a thickener. Ink compositions are described in more detail herein.
[0066] The lower body 116 can include male threads, a reservoir container, and a reservoir. In some embodiments, the male threads can couple the lower body 116 to the upper body 110. The upper body 110, the lower body 116, and the assembly are described in more detail in relation to Figures 2, 3, and 4. The length of the lower body 116 can be about 60 mm to about 110 mm. In some embodiments, the length of the lower body 116 can be about 60 mm to about 110 mm, about 65 mm to about 110 mm, about 70 mm to about 110 mm, about 75 mm to about 110 mm, about 80 mm to about 110 mm, about 85 mm to about 110 mm, about 90 mm to about 110 mm, about 95 mm to about 110 mm, about 100 mm to about 110 mm, or about 105 mm to about 110 mm. In some embodiments, the lower body 116 is about 89 mm. Further details of the lower body 116 are described in relation to FIG.
[0067] The upper body 110 can include a nib and an internal thread. In some embodiments, the internal thread can couple the upper body 110 to the lower body 116. The upper body 110, the lower body 116 and the assembly are described in more detail in relation to Figures 2, 3 and 4. The length of the upper body 110 (not including the nib) can be about 20 mm to about 50 mm. In some embodiments, the length of the upper body 110 can be about 20 mm to about 50 mm, about 25 mm to about 50 mm, about 30 mm to about 50 mm, about 35 mm to about 50 mm, about 40 mm to about 50 mm, or about 45 mm to about 50 mm. In some embodiments, the upper body 110 is about 38 mm. Further details of the upper body are described in relation to Figure 3.
[0068] FIG. 1A includes a schematic diagram of the lid 114. In some embodiments, the lid 114 connects to the upper body 110 to protect the nib and prevent excess airflow that may dry out the nib. For example, the seal may be provided by a threaded mechanism that connects the lid 114 to the upper body 110. In other examples, the seal may be provided by a snap mechanism that snaps the lid 114 over or under a lip of the upper body 110. In some embodiments, the lid 114 connects to the lower body 116 and provides a seal. For example, the seal may be provided by a threaded mechanism that connects the lid 114 to the lower body 116. In other examples, the seal may be provided by a snap mechanism that snaps the lid 114 over or under a lip of the lower body 116. The seal provided by the lid 114 can reduce drying out of the nib 112.
[0069] The length of the lid 114 may be about 30 mm to about 70 mm. In some embodiments, the length of the lid 114 is about 30 mm to about 70 mm, about 35 mm to about 70 mm, about 40 mm to about 70 mm, about 45 mm to about 70 mm, about 50 mm to about 70 mm, about 55 mm to about 70 mm, about 60 mm to about 70 mm, or about 65 mm to about 70 mm. In some embodiments, the length of the lid is about 50 mm. The lid 114 may have a diameter of about 8 mm to about 14 mm. In some embodiments, the lid 114 may have a diameter of about 8 mm to about 14 mm, about 9 mm to about 14 mm, about 10 mm to about 14 mm, about 11 mm to about 14 mm, about 12 mm to about 14 mm, or about 13 mm to about 14 mm.
[0070] Reference is now made to FIG. 1B. FIG. 1B includes an ink applicator (e.g., semi-permanent tattoo applicator) 100, a nib 112, an upper body 110, and a lower body 116. In an exemplary embodiment, the semi-permanent tattoo applicator 100 includes features similar to those described in connection with FIG. 1A. FIG. 1B includes the nib 112 and does not include the lid 114 described in connection with FIG. 1A. The nib 112 may include a variety of shapes, sizes, and materials. Nibs, such as nib 112, may be replaceable such that a user may remove an initial nib (e.g., nib 112) and replace it with a subsequent nib. Nibs may be of a variety of shapes and sizes allowing for a variety of aesthetics and techniques. Details of the various nibs 112 are described in connection with FIG. 6, FIG. 7, FIG. 8, FIG. 9, and / or FIG. 10.
[0071] The nib 112 is configured to deposit an ink composition (e.g., a semi-permanent ink composition) onto a substrate. For example, the substrate can include paper or animal skin (e.g., human skin). The ink composition is contained within a reservoir within the lower body 116. The nib 112 includes a first end that is external to the upper body 110, as shown by the nib 112 in FIG. 1B. The nib 112 includes a second end (obscured by FIG. 1B) that contacts the ink composition within the reservoir. For example, in some embodiments, the second end of the nib 112 extends a distance into the reservoir where it contacts the ink composition (discussed in more detail in connection with FIG. 4). In other embodiments, the second end of the nib 112 indirectly contacts the ink composition via a transfer nib. The transfer nib contacts the ink composition and facilitates transfer of the ink composition to the nib 112 (discussed in more detail in connection with FIG. 5). The nib 112 can be made from a variety of materials. For example, the nib can be made from polyester fibers, acrylic fibers, nylon brush fibers, and sintered polyethylene.
[0072] As referred to herein, the nib (e.g., nib 112) can be of various shapes and sizes. The nib can be about 10 mm to about 50 mm. In some embodiments, the nib (e.g., nib 112) can be about 10 mm to about 50 mm, about 15 mm to about 50 mm, about 20 mm to about 50 mm, about 25 mm to about 50 mm, about 30 mm to about 50 mm, about 35 mm to about 50 mm, about 40 mm to about 50 mm, or about 45 mm to about 50 mm. In some embodiments, the nib 112 is 15 mm. In some embodiments, the nib 112 is about 20 mm. In some embodiments, the nib 112 is about 30 mm. In some embodiments, the nib 112 is about 40 mm.
[0073] In some embodiments, the weight of the semi-permanent tattoo applicator 100 without the ink composition is between about 5 grams and about 15 grams. In some embodiments, the semi-permanent tattoo applicator 100 has a weight of about 5 grams, about 6 grams, about 7 grams, about 8 grams, about 9 grams, about 10 grams, about 11 grams, about 12 grams, about 13 grams, about 14 grams, or about 15 grams.
[0074] Reference is now made to FIG. 2, which is an exploded view of the lower body of an exemplary ink applicator. FIG. 2 includes a lower body 216, male threads 221 (a close-up of male threads 221a), a reservoir container 218 (reservoir container 218a is shown on the exterior of lower body 216), and a reservoir 220 contained within reservoir container 218 (reservoir 220a and reservoir 220b alone contained within reservoir container 218a on the exterior of lower body 216). In the exemplary embodiment shown in FIG. 2, lower body 216 includes one or more features of lower body 116 described above in connection with FIGs. 1A and 1B.
[0075] The male threads 221 / 221a can be coupled to the female threads of an upper body (e.g., the upper body 110 of FIGS. 1A and 1B). The female threads of the upper body are described in more detail in relation to FIG. 3. The male threads 221 / 221a can have a diameter of about 5 mm to about 15 mm. In some embodiments, the male threads 221 / 221a can include a diameter of about 5 mm to about 15 mm, about 7 mm to about 15 mm, about 9 mm to about 15 mm, or about 11 mm to about 15 mm. In some embodiments, the diameter of the male threads 221 / 221a is about 10 mm. In some embodiments, the diameter of the male threads is about 11 mm.
[0076] The reservoir container 218 can house a reservoir 220 within the lower body 216. The reservoir container 218a is a reservoir container 218 external to the lower body 216. In some embodiments, the reservoir container 218 is selectively removable. For example, a user can selectively remove the reservoir container 218 from the lower body 216 to facilitate replacement or refilling with a reservoir 220 containing an ink composition (e.g., a semi-permanent ink composition). The reservoir container 218 / 218a can be about 40 mm to about 120 mm in length. In some embodiments, the reservoir container 218 / 218a is about 40 mm to about 120 mm, about 45 mm to about 120 mm, about 50 mm to about 120 mm, about 55 mm to about 120 mm, about 60 mm to about 120 mm, about 65 mm to about 120 mm, about 70 mm to about 120 mm, about 75 mm to about 120 mm, about 80 mm to about 120 mm, about 85 mm to about 120 mm, about 90 mm to about 120 mm, about 95 mm to about 120 mm, about 100 mm to about 120 mm, about 105 mm to about 120 mm, about 110 mm to about 120 mm, or about 115 mm to about 120 mm.
[0077] The reservoir container 218 / 218a can include a diameter of 5 mm to about 12 mm. In some embodiments, the diameter of the reservoir container 218 / 218a is about 5 mm to about 12 mm, about 6 mm to about 12 mm, about 7 mm to about 12 mm, about 8 mm to about 12 mm, about 9 mm to about 12 mm, about 10 mm to about 12 mm, or about 11 mm to about 12 mm. In some embodiments, the reservoir container 218 is about 8 mm in diameter.
[0078] The reservoir 220 is configured to contain any of the ink compositions described herein (e.g., semi-permanent ink compositions). The reservoir 220 is contained within a reservoir container 218 within the lower body 216. Reference 220a denotes the reservoir 220 that is within the reservoir container 218 but outside of the lower body 216. Reference 220b denotes the reservoir 220 / 220a that is outside of the reservoir container 218 and lower body 216.
[0079] In some embodiments, the reservoir 220 is selectively removable. For example, the reservoir 220 can be removed from the reservoir container 218. In some embodiments, the reservoir 220 can be replaced. In some embodiments, the reservoir 220 can be refilled with any of the ink compositions described herein. For example, the reservoir 220 can contain any of the ink compositions described herein. When the reservoir 220 is empty and / or low on ink, a user can remove the reservoir 220 from the lower body 216 and replace it with another reservoir. In some embodiments, the reservoir 220 is not empty, but a user may wish to replace the initial reservoir with a different reservoir, for example of a different color. By replacing the reservoir with a different color, in some instances, the nib can be replaced as well.
[0080] For example, a particular color reservoir 220 may correspond to one or more nibs. In some embodiments, a reservoir 220 having a first color may correspond to one or more nibs, such that when a color change is desired by a user, the reservoir 220 having the first color along with its corresponding nib is replaced with a different reservoir having a second color and its respective corresponding one or more nibs.
[0081] In some embodiments, the lower body 216 can correspond to one or more nibs. In some embodiments, the lower body 216 having a first color can correspond to one or more nibs such that when a color change is desired by a user, the lower body 216 having a first color along with its corresponding nib is replaced with a different lower body having a second color and its corresponding respective one or more nibs.
[0082] In some embodiments, the reservoir 220 can be refilled with any of the ink compositions described herein. For example, a replacement ink composition can be contained in a pouch with a spout or dropper, and the ink composition can be dispensed via the pouch or dropper into the empty reservoir 220. The refilled reservoir 220 can be placed back into the reservoir container 218 for operation.
[0083] In some embodiments, the lower body 216 can include a window. In some embodiments, the lower body 216 can include a transparent window to allow the contents of the reservoir 220 to be viewed. For example, a window included in the lower body 216 can be manipulated by a user of the ink applicator to determine the properties of the ink within the reservoir 220. In some embodiments, the window can be used to determine the approximate amount of ink composition that is within the reservoir 220. In some embodiments, the window can be used to determine the color of the ink composition that is contained within the reservoir 220.
[0084] In some embodiments, in addition to or instead of the window, the lower body 216 can include graduations. In some embodiments, the lower body 216 is made from a material that is opaque or translucent such that the amount or color of the ink is visible without a window. In such embodiments, the lower body 216 can include graduations to provide a user with information regarding the amount of ink remaining and / or the color of the ink. In some embodiments, the lower body 216 can include graduations on a transparent window such that the contents of the reservoir 220 can be viewed and the amount estimated. For example, a graduated window included in the lower body 216 can be manipulated by a user of the ink applicator to determine the properties of the ink inside the reservoir 220. In some embodiments, the graduated window can be used to determine the approximate amount of ink composition that is in the reservoir 220. In some embodiments, the ink composition inside the reservoir is liquid and the amount of the liquid ink composition can be viewed through the graduated window.
[0085] The reservoir 220 and / or reservoir container 218 can include an opening to receive a nib or transfer nib. For example, the reservoir 220 and / or reservoir container 218 can include an opening that allows a portion of the nib or transfer nib to protrude into the reservoir 220 and / or reservoir container 218 so that the nib or transfer nib can contact the ink composition. The ink composition from the reservoir 220 can flow from the reservoir 220 to the nib by capillary action so that the ink composition can exit the semi-permanent tattoo applicator and be deposited on a substrate (e.g., skin).
[0086] The reservoir container 218 may be substantially hollow such that the interior of the reservoir container 218 is a substantially empty cavity. Refilling the reservoir container 218 may include introducing the liquid ink composition and filling the cavity of the reservoir container 218. In such an embodiment, the cavity may optionally include an agitator to prevent settling of the ink composition within the reservoir container 218. Such an embodiment is described in further detail in relation to FIG.
[0087] The reservoir 220 can be substantially hollow such that the interior of the reservoir 220 is a substantially empty void. Refilling the reservoir 220 can include introducing the liquid ink composition and filling the void of the reservoir 220. In such embodiments, the void can optionally include an agitator to prevent settling of the ink composition within the reservoir 220. Such embodiments are described in further detail in relation to FIG. 5. In some embodiments, the reservoir 220 contains a fibrous material saturated with any of the ink compositions described herein. In some embodiments, the fibrous material of the reservoir 220 is a polyester material (e.g., polyethylene terephthalate, polyester, and / or polypropylene). In some embodiments, the fibrous material is polyethylene terephthalate.
[0088] Reservoir 220 can be about 30 mm to about 120 mm in length. In some embodiments, reservoir 220 is about 30 mm to about 120 mm, about 35 mm to about 120 mm, about 40 mm to about 120 mm, about 45 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, about 50 mm to about 120 mm, or about 50 mm to about 120 mm.
[0089] In some embodiments, the diameter of the reservoir 220 is about 5 mm to about 12 mm. In some embodiments, the diameter of the reservoir 220 is about 5 mm to about 12 mm, about 6 mm to about 12 mm, about 7 mm to about 12 mm, about 8 mm to about 12 mm, about 9 mm to about 12 mm, about 10 mm to about 12 mm, or about 11 mm to about 12 mm. In some embodiments, the diameter of the reservoir container is about 7 mm. One skilled in the art will understand that the reservoir 220 is inserted into the reservoir container 218, and therefore the diameter of the reservoir 220 is not the same as the diameter of the reservoir container 218.
[0090] Reference is now made to FIG. 3, which is an exploded view of an exemplary ink applicator upper body. FIG. 3 includes upper body 310, internal threads 323 (close-up of internal threads 323a), and lip 325 (close-up of lip 325). In the exemplary embodiment shown in FIG. 3, upper body 310 includes one or more features of upper body 110 described above in connection with FIGs. 1A and 1B.
[0091] The female threads 323 / 323a can be coupled to the male threads of the lower body (e.g., the male threads 221 of the lower body 216 in FIG. 2). The female threads 323 / 323a can have a diameter of about 5 mm to about 15 mm. In some embodiments, the female threads 323 / 323a can include a diameter of about 5 mm to about 15 mm, about 7 mm to about 15 mm, about 9 mm to about 15 mm, or about 11 mm to about 15 mm. In some embodiments, the diameter of the female threads 323 / 323a is about 10 mm. In some embodiments, the diameter of the male threads is about 11 mm.
[0092] As referred to herein, the female threads 323 / 323a can be coupled to the male threads of the lower body (e.g., the male threads 221 of the lower body 216 in FIG. 2). When the upper body 310 and the lower body 216 in FIG. 2 are coupled together via the female threads 323 / 323a and the male threads 221 in FIG. 2, the lip 325 / 325a can contact the reservoir and / or reservoir (e.g., the reservoir 218 and / or reservoir 220 in FIG. 2) and create a seal. In such an embodiment, a nib (e.g., the nib 112 in FIG. 1) can be inserted into the upper body 310, and the lip 325 / 325a can provide a passage to the reservoir 218 and / or reservoir 220 in FIG. 2.
[0093] Reference is now made to Figure 4. Figure 4 illustrates a cross-sectional view of an exemplary ink applicator (e.g., semi-permanent tattoo applicator) 401. The semi-permanent tattoo applicator 401 includes an upper body 410 and a lower body 416, a cap 414, a nib 412, and a reservoir 420 housed within a reservoir container 418. Detail A is identified by a dashed oval and is illustrated in an enlarged view in section A identifying the second end 454a of the nib 412, the reservoir 420a, the reservoir container 418a, and the screw 421. In the exemplary embodiment illustrated in Figure 4, the semi-permanent tattoo applicator 401 includes one or more features described above in connection with Figures 1A, 1B, 2, and 3.
[0094] The nib 412 includes a first end 452 and a second end 454. The first end 452 extends outside the upper body 410, and the second end 454 extends into the lower body 416 and into the reservoir 420 and / or reservoir container 418 so that it can contact the ink composition. Detail A shows the second end 454a of the nib 412 extending into the reservoir 420a housed within the reservoir container 418a. The threads 421 are a diagram of a male thread (e.g., male threads 221 in FIG. 2) mating with a female thread (e.g., female threads 323 in FIG. 3). The threads 421 illustrate the upper body 410 coupled to the lower body 416. In some embodiments, the threads 421 are loosened so that the upper body 410 is separated from the lower body 416. Separation of the upper body 410 and the lower body 416 allows the user to replace and / or refill the reservoir 420 .
[0095] For example, in some embodiments, the upper body 410 can be separated from the lower body 416 via threads 421 to expose the reservoir container 418 and the reservoir 420. A user can, for example, remove the initial reservoir 420 and replace it with a subsequent reservoir. After replacing the reservoir 420, the user can then reconnect the upper body 410 to the lower body 416 and resume operation of the semi-permanent tattoo applicator 401 inserting the second end 454a of the nib 412 into the newly replaced reservoir 420 and / or reservoir container 418.
[0096] In some embodiments, the reservoir 420 and / or reservoir container 418 can be refilled with any of the ink compositions described herein. For example, the upper body 410 can be separated from the lower body 416 via threads 421 to expose the reservoir container 418 and the reservoir 420. A user can, for example, remove the reservoir 420 and refill it with liquid ink. After refilling the reservoir 420, the user can then recombine the upper body 410 to the lower body 416 and resume operation of the semi-permanent tattoo applicator 401 inserting the second end 454a of the nib 412 into the newly refilled reservoir 420.
[0097] In another embodiment, the user can remove the reservoir container 418 and fill or refill it with liquid ink. After the reservoir container 418 has been filled or refilled, the user can then resume operation of the semi-permanent tattoo applicator 401 by reconnecting the upper body 410 to the lower body 416 and inserting the second end 454a of the nib 412 into the newly filled or refilled reservoir container 418. The nib 412 can be replaced with a new or different nib. For example, the upper body 410 can be separated from the lower body 416 via the screws 421 to expose the reservoir container 418 and the second end 454 of the nib 412. In some embodiments, the nib 412 is replaced by pulling the nib 412 to remove it from the upper body 410. In some embodiments, the nib 412 can be removed from the upper body 410 using an instrument (e.g., forceps, tongs, or tweezers). Reference is now made to Figure 5. Figure 5 illustrates a cross-sectional view of an exemplary ink applicator (e.g., semi-permanent tattoo applicator) 502. The semi-permanent tattoo applicator 502 includes an upper body 510 and a lower body 516, a cap 514, a nib 512, a transfer nib 522, a transfer casing 526, a reservoir 520, and an agitator 524. The ink applicator 502 optionally includes a reservoir 520 and / or a reservoir container 518. In some embodiments, the reservoir 520 is optionally contained within the reservoir container 518. Detail B is identified by a dashed oval and may be shown enlarged in section B identifying a portion of the transfer nib 522a within the reservoir 520a, the reservoir container 518a, the ridge 519, and the threads 521. An embodiment illustrating a reservoir 520 without a reservoir container 518 can be held in place within the lower body 516 with a ridge 519. The ridge 519 prevents the reservoir 520a from substantially moving so that the transfer nib 522a can transfer the ink composition from the reservoir 520a to the nib 512. In the exemplary embodiment shown in FIG. 5, the semi-permanent tattoo applicator 502 includes one or more of the features described above in connection with FIGS. 1A, 1B, 2, 3, and 4.
[0098] The agitator 524 can be configured to move within the reservoir 520, the reservoir container 518, or the space in the lower body 516 optionally occupied by the reservoir 520 or the reservoir container 518. The agitator 524 can mix the liquid ink composition and prevent settling of the components of the liquid ink composition. For example, a user can shake the semi-permanent tattoo applicator 502 before using the ink applicator 502, and the agitator 524 can move within the reservoir 520, the reservoir container 518, or the space in the lower body 516 optionally occupied by the reservoir 520 or the reservoir container 518, and can mix the liquid ink. In some embodiments, the agitator is made of metal. In some embodiments, the agitator 524 is a metal ball. In some embodiments, the reservoir 520 or the reservoir container 518 contains a single agitator 524. In some embodiments, the reservoir 520 can include multiple agitators 524.
[0099] The transfer nib 522 operates to transfer the ink composition (e.g., any of the ink compositions described herein from the reservoir 520, the reservoir container 518, or a space in the lower body 516 optionally occupied by the reservoir 520 or the reservoir container 518). In some embodiments, the ink composition may be contained in a reservoir 520 housed within the reservoir container 518 within the lower body 516. In some embodiments, the transfer nib 522 contacts the ink composition within the reservoir 520 and delivers the ink composition to the nib 512. In some embodiments, the reservoir 520 contains a liquid ink composition and the transfer nib 522 absorbs and transfers the liquid ink composition to the nib 512. In some embodiments, the reservoir 520 includes fibers (e.g., polyester fibers, acrylic fibers, nylon brush fibers, and sintered polyethylene) that include the ink composition. A user can apply a first end 552 of the nib 512 to a substrate (e.g., skin). A user can replace or refill the reservoir 520 when it becomes empty. In some embodiments, the reservoir 520 can be refilled by removing the reservoir 520 from the reservoir container 518 and adding ink to the reservoir 520. In some embodiments, the reservoir 520 can be replaced by removing the reservoir 520 from the reservoir container 518, discarding it, and inserting a different (e.g., new) reservoir 520 into the reservoir container 518.
[0100] In some embodiments, the ink composition may be contained in a reservoir 520 housed within the lower body 516 (e.g., without the reservoir container 518). As shown in Detail B, a raised portion 519 may secure the reservoir 520a in place such that the transfer nib 522a contacts the ink composition housed within the reservoir 520a. In some embodiments, the transfer nib 522 contacts the ink composition inside the reservoir 520 and delivers the ink composition to the nib 512 (e.g., the second end 554 of the nib 512). In some embodiments, the reservoir 520 contains the liquid ink composition and the transfer nib 522 absorbs and transfers the liquid ink composition to the nib 512. In some embodiments, the reservoir includes fibers (e.g., polyester fibers, acrylic fibers, nylon brush fibers, and sintered polyethylene) that contain the ink composition. A user may apply the first end 552 of the nib 512 to a substrate (e.g., skin) to deposit the ink composition. A user can apply the first end 552 of the nib 512 to a substrate (e.g., skin). A user can replace or refill the reservoir 520 when it becomes empty. In some embodiments, the reservoir 520 can be refilled by removing the reservoir 520 from the lower body 516 and adding ink to the reservoir 520. In some embodiments, the reservoir 520 can be replaced by removing the reservoir 520 from the lower body 516, discarding it, and inserting a different (e.g., new) reservoir 520 into the lower body 516.
[0101] In some embodiments, the ink composition may be contained in a reservoir container 518 housed inside the lower body 516 (e.g., without the reservoir 520). In some embodiments, the transfer nib 522 contacts the ink composition inside the reservoir container 518 and delivers the ink composition to the nib 512 (e.g., the second end 554 of the nib 512). A user may apply the first end 552 of the nib 512 to a substrate (e.g., skin) and deposit the ink composition. A user may replace or refill the reservoir container 518 when the ink composition is depleted. In some embodiments, the reservoir container 518 may be refilled by removing the reservoir container 518 from the lower body 516 and adding ink to the reservoir container 518. In some embodiments, the reservoir container 518 can be replaced by removing the reservoir container 518 from the lower body 516, discarding it, and inserting a different (e.g., new) reservoir container 518 into the lower body 516.
[0102] In some embodiments, the ink composition may be contained in the lower body 516 (e.g., the space in the lower body 516 optionally occupied by the reservoir 520 or reservoir container 518). In some embodiments, the transfer nib 522 contacts the ink composition inside the lower body 516 and delivers the ink composition to the nib 512 (e.g., the second end 554 of the nib 512). A user may apply the first end 552 of the nib 512 to a substrate (e.g., skin) and deposit the ink composition. A user may replace or refill the lower body 516 (e.g., the space in the lower body 516 optionally occupied by the reservoir 520 or reservoir container 518) when the ink composition is depleted. In some embodiments, the space in the lower body 516 optionally occupied by the reservoir 520 or reservoir container 518 can be replenished by adding ink to the space in the lower body 516 optionally occupied by the reservoir 520 or reservoir container 518. In some embodiments, the lower body 516 can be replaced by separating the lower body 516 from the upper body 510, discarding it, and inserting a different (e.g., new) lower body 516.
[0103] The transfer casing 526 can be configured to connect the transfer nib 522 to the nib 512. In some embodiments, the transfer casing is made from a porous sponge material. In some embodiments, the transfer nib 522 is a slotted cylindrical attachment that functions to hold the ink composition. In some examples, the transfer nib 522 is made from a porous material and operates to transfer the ink composition from the reservoir 520 (or reservoir container 518 or lower body 516) to the second end 554 of the nib 512. The transfer nib 522 is optional for some nib 512 types. As described herein in connection with Figures 6-10, some types of nibs are configured to operate with the transfer nib 522.
[0104] In some embodiments, the ink applicator 502 includes a reservoir container 518 but does not include a reservoir 520. In such embodiments, any ink composition described herein is contained within the reservoir container 518, and the ink composition can be drawn from the reservoir container 518 to the nib 512 via the transfer nib 522.
[0105] In embodiments that do not include a reservoir container 518 or a reservoir 520, a user can add or refill the ink composition by separating the upper body 510 from the lower body 516. In other embodiments that do not include a reservoir container 518 or a reservoir 520, a user can add or refill the ink composition by separating the upper body 510 from the initial lower body 516 and reattaching the upper body 510 to a different lower body 516.
[0106] 6-10 show different types and styles of nibs. Reference is now made to FIG. 6. FIG. 6 shows an example of a nib with a stiff rounded tip. Nib 640 includes a first end 652 and a second end 654. In an exemplary embodiment, nib 640 includes one or more features of the nibs described in connection with FIGS. 1A, 1B, 2, 3, 4, and 5. Nib 640 includes a stiff rounded tip at first end 652. In some embodiments, the stiff rounded tip can provide a desired effect of ink application to a substrate such as skin.
[0107] For example, a rigid rounded tip may provide aesthetically pleasing detail and contours to a design. A user may use a rigid rounded tip nib, such as nib 640, in conjunction with a semi-permanent tattoo applicator (e.g., ink applicator 100 of FIG. 1), which allows the user creative freedom to create detailed freehand designs. Furthermore, a rigid rounded tip, such as first end 652 of nib 640, may provide precision and / or accuracy for writing text, letters, and scripts.
[0108] The second end 654 of the nib 640 can contact the ink composition. For example, the second end 654 of the nib 640 can contact the ink composition contained in a reservoir (e.g., reservoir 420a in FIG. 4). The nib 640 can have a length of about 20 mm to about 40 mm. In some embodiments, the length of the nib from the first end 652 to the second end 654 is about 20 mm to about 40 mm, about 25 mm to about 40 mm, about 30 mm to about 40 mm, or about 35 mm to about 40 mm. In some embodiments, the diameter of the top of the first end 652 is about 0.2 mm to about 1.0 mm. In some embodiments, the diameter of the first end is about 0.2 mm to about 1.0 mm, about 0.4 mm to about 1.0 mm, about 0.6 mm to about 1.0 mm, or about 0.8 mm to 1.0 mm.
[0109] Reference is now made to Figure 7. Figure 7 illustrates one example of a nib with a chisel tip. Figure 7 nib 742 includes a first end 752 and a second end 754. In an exemplary embodiment, nib 742 includes one or more features of the nibs described in connection with Figures 1A, 1B, 2, 3, 4, 5, and 6. Nib 742 includes a chisel tip at first end 752. In some embodiments, the chisel tip can provide a desired effect of ink application to a substrate such as skin.
[0110] For example, a chisel tip can provide aesthetically pleasing detail and contours for a design. Using a chisel tip nib, such as nib 742, in conjunction with a semi-permanent tattoo applicator (e.g., ink applicator 100 of FIG. 1) allows a user creative freedom to create detailed freehand designs. A chisel tip, such as first end 752 of nib 742, can provide precision and / or accuracy for writing text, letters, and scripts, such as calligraphy. A chisel tip, such as first end 752 of nib 742, can further provide precision and / or accuracy for filling larger areas of space with an ink composition. In some embodiments, ink applicator 100 of FIG. 1 is fitted with a first nib to outline the design (e.g., nib 640 of FIG. 6). First nib 640 can be removed and second nib 742 can be inserted into ink applicator 100, allowing the user to fill in the space within the outlined design.
[0111] The second end 754 of the nib 742 can contact the ink composition. For example, the second end 754 of the nib 742 can contact the ink composition contained in a reservoir (e.g., reservoir 420a in FIG. 4). The nib 742 can have a length of about 20 mm to about 40 mm. In some embodiments, the length of the nib from the first end 752 to the second end 754 is about 20 mm to about 40 mm, about 25 mm to about 40 mm, about 30 mm to about 40 mm, or about 35 mm to about 40 mm. In some embodiments, the chisel angle of the first end 752 is about 100° to about 140°. In some embodiments, the angle of the first end 754 is about 100° to about 140°, about 110° to about 140°, about 120° to about 140°, or about 130° to about 140°.
[0112] Reference is now made to FIG. 8. FIG. 8 illustrates an example of a nib with a thin tip. Nib 844 includes a first end 852 and a second end 854. In an exemplary embodiment, nib 844 includes one or more features of the nibs described in connection with FIGS. 1A, 1B, 2, 3, 4, 5, 6, and 7. Nib 844 includes a fine point tip at first end 852. In some embodiments, the fine point tip can provide a desired effect of ink application to a substrate such as skin.
[0113] For example, a fine point tip can provide aesthetically pleasing detail and contours to a design. A user can use a fine point tip nib, such as nib 844, in conjunction with a semi-permanent tattoo applicator (e.g., ink applicator 100 of FIG. 1), which allows the user creative freedom to create detailed freehand designs. Furthermore, a fine point tip, such as first end 852 of nib 844, can provide precision and / or accuracy for writing text, letters, and scripts. In another embodiment, a fine point tip, such as first end 852 of nib 844, can provide stylistic and creative detail, such as a pointillist effect.
[0114] The second end 854 of the nib 844 can contact the ink composition. For example, the second end 854 of the nib 844 can contact the ink composition contained in a reservoir (e.g., reservoir 420a in FIG. 4). The nib 844 can have a length of about 20 mm to about 60 mm. In some embodiments, the length of the nib from the first end 852 to the second end 854 is about 20 mm to about 60 mm, about 25 mm to about 60 mm, about 30 mm to about 60 mm, about 35 mm to about 60 mm, about 40 mm to about 60 mm, about 45 mm to about 60 mm, about 50 mm to about 60 mm, or about 55 mm to about 60 mm.
[0115] Reference is now made to Figure 9. Figure 9 illustrates an example of a nib with a nylon brush tip. In an exemplary embodiment, the nib 946 includes one or more features of the nibs described in connection with Figures 1A, 1B, 2, 3, 4, 5, 6, 7, and 8. The nib 946 includes nylon brush fibers at a first end 952. In some embodiments, the nylon brush fibers can provide a desired effect of ink application to a substrate, such as skin.
[0116] For example, nylon brush fibers can provide aesthetically pleasing detail and contours to a design. A user can use a nylon brush fiber tip nib, such as nib 946, in conjunction with a semi-permanent tattoo applicator (e.g., ink applicator 100 of FIG. 1), which allows the user creative freedom to create detailed freehand designs. Furthermore, a nylon brush fiber tip, such as first end 952 of nib 946, can provide precision and / or accuracy for writing text, letters, and scripts. In another embodiment, a nylon brush fiber tip, such as first end 952 of nib 946, can provide stylistic and creative detail, such as a pointillist or watercolor effect.
[0117] The nib 946 includes an opening at the second end 954. In some embodiments, the opening at the second end 954 can be used in conjunction with the transfer nib 522 of FIG. 5. The transfer nib 522 of FIG. 5 can absorb the ink composition and deliver the composition to the nylon brush fibers at the first end 952. The nib 946 can have a length from the first end 952 to the second end 954 of about 10 mm to about 25 mm. In some embodiments, the nib 946 can have a length of about 10 mm to about 25 mm, about 15 mm to about 25 mm, or about 20 mm to about 25 mm.
[0118] Reference is now made to Figure 10. Figure 10 illustrates an example of a nib with a fiber tip. In an exemplary embodiment, the nib 1048 includes one or more features of the nibs described in connection with Figures 1A, 1B, 2, 3, 4, 5, 6, 7, 8, and 9. The nib 1048 includes a porous, flexible tip at a first end 1052. In some embodiments, the porous, flexible tip can provide a desired effect of ink application to a substrate, such as skin.
[0119] For example, a porous, flexible tip can provide aesthetically pleasing detail and contours for a design. A user can use a porous, flexible tip nib, such as nib 1048, in conjunction with a semi-permanent tattoo applicator (e.g., ink applicator 100 of FIG. 1), which allows the user creative freedom to create detailed, freehand designs. Furthermore, a porous, flexible tip, such as first end 1052 of nib 1048, can provide precision and / or accuracy for writing text, letters, and scripts. In another embodiment, a porous, flexible tip, such as first end 1052 of nib 1048, can provide stylistic and creative detail, such as a pointillist or watercolor effect. In some embodiments, ink applicator 100 of FIG. 1 can be fitted with a first nib to contour a design (e.g., nib 640 of FIG. 6). The first nib 640 can be removed and the second nib 1048 can be inserted into the ink applicator 100, allowing the user to fill in the space within the outlined design using the porous, flexible tip.
[0120] The nib 1048 includes an opening at the second end 1054. In some embodiments, the opening at the second end 1054 can be used in conjunction with the transfer nib 522 of FIG. 5. The transfer nib 522 of FIG. 5 can absorb the ink composition from the reservoir 520 of FIG. 5 and deliver the composition to the nylon brush fibers at the first end 1052. The nib 1048 can have a length from the first end 1052 to the second end 1054 of about 10 mm to about 30 mm. In some embodiments, the nib 1048 can have a length of about 10 mm to about 30 mm, about 15 mm to about 30 mm, or about 20 mm to about 30 mm, or about 25 mm to about 30 mm.
[0121] In some embodiments described herein, the ink applicator (e.g., semi-permanent tattoo applicator 100) can include an upper body (e.g., upper body 110) that does not include a reservoir (e.g., reservoir 220) and / or a reservoir container (e.g., reservoir container 218). In some embodiments, the ink applicator can include a lower body (e.g., lower body 116) coupled to the upper body, the upper body including a nib (e.g., nib 112) with a first end (e.g., first end 452) that is exterior to the upper body and a second end (e.g., second end 454) that is interior to the upper body, the nib configured to dispense the semi-permanent ink. The reservoir and / or reservoir container can be added to the ink applicator by separating the upper body from the lower body and disposing the reservoir container and / or reservoir in the lower body. When the upper body is rejoined to the lower body, the second end of the nib can penetrate into the reservoir so that the ink composition inside the reservoir can be dispensed through the nib onto a substrate (e.g., paper or skin).
[0122] In some embodiments, the ink applicator can include a reservoir within the ink applicator. For example, the ink applicator can include a lower body, a reservoir container housed within a cavity of the lower body, a reservoir housed within a cavity of the reservoir container, and a semi-permanent ink housed in the reservoir. An upper body can be coupled to the lower body, and the upper body includes a nib including a first end that is exterior to the upper body and a second end that is interior to the upper body. An interior of the nib can extend into the reservoir. In some embodiments, the reservoir is a fibrous component (e.g., polyethylene terephthalate), and the fibrous component is saturated with the ink composition. In some embodiments, the reservoir does not include a fibrous component.
[0123] For example, the reservoir can contain a liquid ink composition. In some embodiments, the reservoir can be refilled with the liquid ink composition. In such embodiments, the ink applicator can include a transfer nib (e.g., transfer nib 522) that facilitates the transfer of the liquid ink composition from the reservoir to the nib. For example, the ink applicator can include a reservoir container housed within a cavity of the lower body, a reservoir housed within a cavity of the reservoir container, and semi-permanent ink housed in the reservoir. An upper body coupled to the lower body can include a nib including a first end that is external to the upper body and a second end that is internal to the upper body, and a transfer nib that contacts the second end of the nib and the semi-permanent ink housed in the reservoir. To mitigate settling of components of the liquid ink composition in the reservoir, in some embodiments, the reservoir can include an agitator. In some embodiments, the agitator is a metallic sphere.
[0124] In some examples, a user may wish to switch colors or types of ink compositions. When this occurs, embodiments described herein may include an ink applicator system having multiple nibs corresponding to reservoirs and / or refills of the ink composition. For example, the multiple nibs (e.g., nibs 640, 742, 844, 946, 1048) may correspond to a particular ink composition. In some embodiments, the first multiple nibs may correspond to a first color of the ink composition. In some embodiments, the second multiple nibs may correspond to a second color of the ink composition. In some embodiments, the third multiple nibs may correspond to a liquid ink composition (e.g., a reservoir determined to be filled with the liquid ink composition). In some embodiments, the fourth multiple nibs may correspond to a reservoir including fibers (e.g., polyester fibers, acrylic fibers, nylon brush fibers, and sintered polyethylene). In some embodiments, the ink applicator system may include nibs corresponding to multiple different metrics of the ink composition (e.g., color, liquid, refill reservoir, reservoir saturated with ink composition, ink volume, viscosity of the ink composition).
[0125] method Methods for applying an ink composition using an ink applicator are also described herein. In some embodiments, a method for applying ink onto skin includes coupling a nib (e.g., nib 640, 742, 844, 946, and / or 1048) to an upper body (e.g., upper body 110) of an ink applicator (e.g., semi-permanent tattoo applicator 100) that includes any of the ink compositions described herein, and applying the ink composition of the ink applicator to a portion of the skin.
[0126] In some embodiments, the ink applicator is a marker. In some embodiments, the ink applicator is a pen. The ink composition is, in some embodiments, a liquid. In some embodiments, an agitator is included in the ink reservoir (e.g., reservoir 220) to facilitate mixing of the ink composition. For example, the method can further include agitating the ink applicator to initiate flow of the ink composition from the reservoir of the ink applicator to the nib.
[0127] In some examples, a user may desire to switch ink composition colors, types, refill or replace the ink composition in the reservoir. For example, in some embodiments, the method can include separating an upper body of the ink applicator from a lower body of the ink applicator (e.g., lower body 116), removing the reservoir from the lower body, and replacing the reservoir with a different reservoir.
[0128] In some embodiments, the reservoir can be empty of ink refill. In such embodiments, the reservoir can be refilled. For example, the methods described herein can further include separating an upper body of the ink applicator from a lower body of the ink applicator, removing the reservoir from the lower body, and filling the reservoir with additional ink composition.
[0129] In some embodiments, a user may desire to change the nib to achieve a desired aesthetic or effect. For example, the methods disclosed herein may further include separating the nib from the ink applicator, coupling a different nib to the ink applicator, and applying ink from the ink applicator and the different nib to a portion of the skin.
[0130] composition In some embodiments, the compositions provided herein include a semi-permanent colorant (e.g., genipin, a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein), a solvent, and a humectant. In some embodiments, the compositions provided herein include a semi-permanent colorant (e.g., genipin, a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein), a solvent, and a thickener. In some embodiments, the compositions provided herein include a semi-permanent colorant, a solvent, and a humectant. In some embodiments, the compositions provided herein include a semi-permanent colorant, a solvent, a thickener, and a humectant. In some embodiments, the compositions further include a film former. In some embodiments, the compositions include a preservative. In some embodiments, the ink compositions provided herein include a semi-permanent colorant, a solvent, and a film former. In some embodiments, the ink compositions described herein may be suitable for application to skin using an ink applicator (e.g., the semi-permanent tattoo applicator 100). International Application No. PCT / CA2021 / 050790 describes genipin-based compositions that may be suitable for inkjet printing and is incorporated herein in its entirety. As used herein, a "semi-permanent colorant" refers to a colorant that penetrates one or more layers of the skin and cannot be removed from the skin without physical destruction or natural desquamation of the skin. In some embodiments, the semi-permanent colorant can include a colorant precursor, e.g., a molecule such as genipin that develops color upon reaction with one or more other molecules. In some embodiments, the semi-permanent colorant can penetrate the stratum corneum and react with other molecules, e.g., other colorant molecules and / or other molecules present in the stratum corneum, immobilizing the semi-permanent colorant within the stratum corneum. For example, the semi-permanent colorant can crosslink with collagen or keratin found in the stratum corneum. In some embodiments, the semi-permanent colorant can react with other molecules, e.g., other colorant molecules and / or other molecules present in the stratum corneum, to form molecules that are too large to diffuse out of the stratum corneum.In some embodiments, the semi-permanent coloring agent may react with other molecules, such as other coloring agent molecules and other molecules present in the stratum corneum, to form molecules that are incorporated into the structure of the stratum corneum. In some embodiments, where the semi-permanent coloring agent penetrates the stratum corneum, the residence time of the coloring agent is determined by the natural skin desquamation process. In some embodiments, the semi-permanent coloring agent cannot be washed off, for example, by water, soap, and / or isopropanol. In some embodiments, the semi-permanent coloring agent comprises a natural or synthetic pigment or dye. Non-limiting examples of semi-permanent coloring agents include genipin, genipin derivatives, lawsone, and lawsone derivatives.
[0131] As used herein, "genipin" refers to genipin extract, partially purified genipin extract, and / or purified genipin, as further described herein. Genipin is derived from an iridoid glycoside called geniposide, which is present in nearly 40 plant species. In addition, genipin is a precursor to gardenia blue pigment, which undergoes a conversion reaction upon exposure to amine groups to form a blue colorant (e.g., Touyama et al., Chem. Pharm. Bull. 42:668-673, 1994; and Touyama et al., Chem. Pharm. Bull. 42(8):1571-1578, 1994; both of which are incorporated herein by reference in their entirety). When contacted with skin, genipin can contact amines in the skin and generate polymer-based and / or oligomer-based blue colors in situ.
[0132] A "genipin derivative" is a compound that has a genipin core. For example, a genipin derivative is a compound that has the following core structure:
[0133] [ka] Non-limiting examples of genipin derivatives include those described in International Application No. PCT / US2021 / 045767, the entirety of which is incorporated herein by reference. For example, genipin derivatives include compounds of formula I:
[0134] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt), wherein: R 1 is -C(=O)OR 6 , C 1~6 Alkyl or C 6~10 aryl, 1~6 Alkyl and C 6~10 Aryl is 1 to 5 R 7 are optionally replaced by R 6 , H, C 1~6 Alkyl or C 6~10 aryl, 1~6 Alkyl and C 6~10 Aryl is 1 to 5 R 7 are optionally replaced by Each R 7 is independently an electron withdrawing group or an electron donating group; R 2 H, -OR 9 , or OC(=O)R 9A and R 9 , H, C 1~6 Alkyl, C 6~10 selected from the group consisting of aryl and hydroxy protecting groups; R 9A is C 1~6 Alkyl and C 6~10 aryl; The dotted line indicates the optional presence of a double bond; If no double bond is present, R 4 and R 5 forms a 3- to 4-membered heterocyclic ring together with the carbon atom to which it is attached, and R 3 is -OH or -CHOH, or If a double bond is present, R 4 and R 5 does not exist and R 3 But -NR 7 R 8 , -CH2NR 7 R 8 , -C(=O)OR 10 , -C(=O)NR 10 R 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH2OR 10 and 1 to 5 7 phenyl substituted with R 10 , H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 phenyl substituted with R 8 is H or R 7 It is.
[0135] In some embodiments, R 1 is -C(=O)OR 6 Or 1 to 5 R 7 is a phenyl substituted with R 6 , H, C 1~6 Alkyl or 1 to 5 R 7 is a phenyl substituted with R 2 H, -OR 9 , or OC(=O)R 9 and R 9 is H or C 1~6 is alkyl, If a double bond is present, R 4 and R 5 does not exist, R 3 -NR 7 R 8 , -CH2NR7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 , diethyl malonate and 1 to 5 R 7 phenyl substituted with R 10 , H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O) and 1 to 5 R 7 It is phenyl substituted with
[0136] In some embodiments, R 3 -NR 7 R 8 , -CH2NR 7 R 8 , -C(=O)OR 10 , -C(=O)NR 10 R 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH2OR 10 , 1 to 5 R 7 phenyl substituted with R 1 is -C(=O)OH, R 2 is -OH, R 10 , H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 phenyl substituted with
[0137] Non-limiting examples of genipin derivatives include compounds of formula I:
[0138] [ka] During the ceremony: R 1 is -C(=O)OR 6 Or 1 to 5 R 7 is a phenyl substituted with R 6 , H, C 1~6 Alkyl or 1 to 5 R 7 is a phenyl substituted with Each R 7 is independently an electron withdrawing group or an electron donating group; R 2 H, -OR 9 , or -OC(=O)R 9 and R 9 is H or C 1~6 is alkyl, The dotted line indicates the optional presence of a double bond; If no double bond is present, R 4 and R 5 forms a 3- to 4-membered heterocyclic ring together with the carbon atom to which it is attached, and R 3 is -OH or -CHOH, or If a double bond is present, R 4 and R 5 does not exist, R 3 -NR 7 R 8 , -CH2NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 , diethyl malonate and 1 to 5 R 7 phenyl substituted with In the formula, each R 10 , H, C 1~6 Alkyl, alkoxy, -OH, -CH(=O) and 1 to 5 R 7 phenyl substituted with R 8 is H or R 7It is.
[0139] In some embodiments, Formula I has the formula:
[0140] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt).
[0141] In some embodiments, Formula I has the formula:
[0142] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt).
[0143] In some embodiments, Formula I has the formula:
[0144] [ka] has.
[0145] In some embodiments, Formula I has the formula:
[0146] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt).
[0147] In some embodiments, R 6 is methyl. In some embodiments, R 1 is -C(=O)OR 6 and R 6 is methyl. In some embodiments, R 1 is -C(=O)OR 6 and R 6 is 1 to 5 R 7 It is phenyl substituted with
[0148] In some embodiments, R2 is -OC(=O)CH3. In some embodiments, R 2 is -OH.
[0149] In some embodiments, R 2 OR 9 or OC(=O)R 9A It is.
[0150] In some embodiments, R 2 OR 9 It is.
[0151] In some embodiments, R 2 is OC(=O)R 9A It is.
[0152] In some embodiments, R 9 , H, C 1~6 Alkyl and C 6~10 aryl.
[0153] In some embodiments, R 9 is a hydroxy protecting group. Suitable examples of protecting groups are described in Greene, Wuts, at al., Protective groups in organic synthesis, Fourth Edition, 2006 (ISBN: 9780471697541), and examples of such protecting groups include t-butyl, allyl, methoxymethyl (MOM), tri(C 1~6 alkyl)silyl (e.g., tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS) or triethylsilyl (TES), acyl (e.g., benzoyl, pivaloyl or acetyl), acetonide, tetrahydropyranyl (THP) and benzylidene acetal. In some embodiments, the hydroxy protecting group is a tri(C 1~6 In some embodiments, the hydroxy protecting group is tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), or triethylsilyl (TES).
[0154] In some embodiments, R 9A is C 1~6 It is an alkyl.
[0155] In some embodiments, R 9A is C 6~10 It is aryl.
[0156] In some embodiments, there are no double bonds. In some embodiments, R 4 and R 5 forms, together with the carbon atom to which it is attached, a three-membered heterocyclic ring; R 3 is -CHOH. For example, R 4 and R 5 can form, together with the carbon atom to which it is attached:
[0157] [ka]
[0158] In some embodiments, R 4 and R 5 forms a four-membered heterocyclic ring together with the carbon atom to which it is attached, R 3 is -OH. For example, R 4 and R 5 can form, together with the carbon atom to which it is attached:
[0159] [ka]
[0160] In some embodiments, a double bond is present. In some embodiments, R 1 1 to 3 R 7 In some embodiments, R 1 is -C(=O)OR 6 and R 6 1 to 3 R 7 In some embodiments, R2 is -OH and R 3 is CHOH.
[0161] In some embodiments, R 1 is C 6~10 aryl, optionally 1 to 5 R 7 is replaced by.
[0162] In some embodiments, R 6 is C 6~10 aryl, optionally 1 to 5 R 7 is replaced by.
[0163] In some embodiments, R 3 -NR 7 R 8 , -CH2-NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 , diethyl malonate and 1 to 5 R 7 phenyl substituted with R 1 is -C(=O)OH, and R 2 is -OH.
[0164] In some embodiments, R 3 is -CH2NR 7 R 8 , -C(=O)OR 10 , -C(=O)NR 10 R 10 , -CH(=O), phenyl, -CH(OH)R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH2OR 10 and 1 to 5 R 7 phenyl substituted with
[0165] In some embodiments, R 10, H, C 1~6 Alkyl, -OH, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 phenyl substituted with
[0166] In some embodiments, R 10 , H, C 1~6 Alkyl, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 phenyl substituted with
[0167] In some embodiments, R 10 , H, C 1~6 Alkyl, phenyl and 1 to 5 R 7 phenyl substituted with
[0168] In some embodiments, R 10 is H.
[0169] In some embodiments, R 10 is C 1~6 Alkyl, phenyl and 1 to 5 R 7 phenyl substituted with
[0170] In some embodiments, R 3 is -CH(OH)R 10 and R 10 is C 1~6 Alkyl, phenyl or 1 to 5 R 7 It is phenyl substituted with
[0171] In some embodiments, R 3 is -C(=O)NR 10 R 10 It is.
[0172] In some embodiments, R 3 is -CH=CHR 10 and R 10 is C 1~6Alkyl, phenyl or 1 to 5 R 7 In some embodiments, R 10 is phenyl or 1 to 5 R 7 It is phenyl substituted with
[0173] In some embodiments, R 3 is phenyl.
[0174] In some embodiments, R 3 is 1 to 5 R 7 It is phenyl substituted with
[0175] In some embodiments, R 3 is -CH=CR 10 R 10 And each R 10 are independently -CH(=O) or -C(=O)OR 6 and R 6 is C 1~6 alkyl, optionally 1 to 5 R 7 In some embodiments, R 3 is diethyl malonate.
[0176] In some embodiments, the genipin derivative is a compound selected from the group consisting of the compounds in Table 1.
[0177] [Table 1-1]
[0178] [Table 1-2]
[0179] [Table 1-3]
[0180] [Table 1-4]
[0181] [Table 1-5]
[0182] In some embodiments, R 7 The electron withdrawing or donating group of -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -NHC(=O)R 8 , -OC(=O)R 8 , -SR 8 , -CO2 - , -SO2CF3, -NO2, -SO2R 8 , -CN, -CR 9 3. -COR 9 , -CHO, -COR 8 , -C(=O)NR 8 R 8 , a halide, and —NO. In some embodiments, R 7 The electron withdrawing or donating group of -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -OC(=O)R 8 , -SR 8 , -CO2 - , -SO2CF3, -NO2, -SO2R 8 , -CN, -CR 9 3. -COR 9 , -CHO, -COR 8 , -C(=O)NR 8 R 8 and -NO.
[0183] In some embodiments, R 8 is H or R 7 In some embodiments, R 8 is H, -(C1~9 Alkyl) and -(C 2~9 alkenyl), and R9 is a halide. In some embodiments, R8 is H.
[0184] In some embodiments, the genipin derivative is a compound of formula IIa:
[0185] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt), wherein: R 9 , H, C 1~6 Alkyl, C 6~10 aryl and hydroxy protecting groups, 1~6 Alkyl and C 6~10 Each aryl is optionally represented by 1 to 5 R 7 is replaced by R 3 is -CH2NR 7 R 8 , -C(=O)OR 10 , -C(=O)NR 10 R 10 , -CH(=O), -CHR 10 R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH2OR 10 , phenyl and 1 to 5 R 7 phenyl substituted with In the formula, each R 10 , H, C 1~6 Alkyl, -OH, -CH(=O), C(=O)OR 9 , phenyl and 1 to 5 R 7 phenyl substituted with R 7 is an electron withdrawing or donating group, R 8 is H or R 7 It is.
[0186] In some embodiments, R 3 is -C(=O)OR 10 , -CH(=O), and -CHOR 10 is selected from R 10 , H, C 1~6 Alkyl, phenyl and 1 to 5 R 7 phenyl substituted with R 9 is C 1~6 Alkyl, C 6~10 aryl and hydroxy protecting groups, 1~6 Alkyl and C 6~10 Each aryl is optionally represented by 1 to 5 R 7 is replaced by.
[0187] In some embodiments, R 3 is -C(=O)OR 10 It is.
[0188] In some embodiments, R 3 is -CH(=O).
[0189] In some embodiments, R 3 -CH2OR 10 It is.
[0190] In some embodiments, R 3 is -CH=CR 10 R 10 and Each R 10 are independently CH(=O) or C(=O)OR 9 and R 9 is C 1~6 Alkyl, C 6~10 aryl and hydroxy protecting groups, 1~6 Alkyl and C 6~10 Each aryl is optionally represented by 1 to 5 R 7 is replaced by.
[0191] In some embodiments, R 3 is -CH2NR 7 R 8 , -C(=O)NR 10 R 10 , -CH(OH)R 10 , -CH=CHR 10 , phenyl and 1 to 5 R 7 phenyl substituted with Each R 10 is C 1~6 Alkyl, phenyl and 1 to 5 R 7 and wherein each of the groups is independently selected from phenyl substituted with
[0192] In some embodiments, R 9 is a hydroxy protecting group. In some embodiments, R is t-butyl, allyl, methoxymethyl, tri(C 1~6 In some embodiments, the hydroxy protecting group is selected from the group consisting of tri(C 1~6 In some embodiments, the hydroxy protecting group is tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), or triethylsilyl (TES).
[0193] In some embodiments, R 9 is C 1~6 It is an alkyl.
[0194] In some embodiments, R 9 is C 6~10 It is aryl.
[0195] In some embodiments, Formula IIa has the formula:
[0196] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt).
[0197] In some embodiments, Formula IIa has the formula:
[0198] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt).
[0199] In some embodiments, Formula IIa has the formula:
[0200] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt).
[0201] In some embodiments, Formula IIa has the formula:
[0202] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt).
[0203] In some embodiments, Formula IIa has the formula:
[0204] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt).
[0205] In some embodiments, Formula IIa has the formula:
[0206] [ka] or a salt thereof (e.g., a pharma- ceutically acceptable salt).
[0207] In some embodiments, the genipin derivative is a compound of formula IIa:
[0208] [ka] During the ceremony: R 9 , H, C 1~6 Alkyl, C 6~10 aryl and hydroxy protecting groups, 1~6 Alkyl and C 6~10 Each aryl is optionally represented by 1 to 5 R 7 is replaced by R 3 is -C(=O)OR 10 , -CH(=O), -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 , -C(=O)NR 10 R 10 , phenyl and 1 to 5 R 7 phenyl substituted with In the formula, each R 10 is H, -OH, -CH(=O), diethyl malonate, phenyl, and 1 to 5 R 7 phenyl substituted with R 7 is an electron withdrawing or electron donating group, such as, for example, any of the electron withdrawing or electron donating groups described herein.
[0209] In some embodiments, R 9 is tert-butyldimethylsilyl (TBS). In some embodiments, R 3 is -C(=O)OR 10 , -CH(=O), -CH=CHR 10 , -CH2OR 10 and -C(=O)NR 10 R 10 In some embodiments, each R 10 , H, C 1~6 Alkyl, -CH(=O), -phenyl and 1 to 5 R 7In some embodiments, R 10 is phenyl substituted with -NO. In some embodiments, R 3 is -C(=O)OR 10 and R 10 is H. In some embodiments, R 3 is -CH=CHR 10 and R 10 is H, CH(=O), phenyl and 1 to 5 R 7 In some embodiments, R 3 is -CH=CHR 10 and R 10 is phenyl substituted with -NO. In some embodiments, R 3 -CH2OR 10 and R 10 is H or phenyl. In some embodiments, R 3 is C(=O)NR 10 R 10 and R 10 is C 1~6 In some embodiments, R 3 is C(=O)NR 10 R 10 and R 10 is ethyl.
[0210] In some embodiments, R 9 is -OH. In some embodiments, R 3 is -C(=O)OR 10 , -CH(=O), -CH=CHR 10 , -CH2OR 10 and -C(=O)NR 10 R 10 In some embodiments, each R 10 , H, C 1~6 Alkyl, -CH(=O), -phenyl and 1 to 5 R 7 In some embodiments, R 10is phenyl substituted with -NO. In some embodiments, R 3 is -C(=O)OR 10 and R 10 is H. In some embodiments, R 3 is -CH=CHR 10 and R 10 is H, CH(=O), phenyl and 1 to 5 R 7 In some embodiments, R 3 is -CH=CHR 10 and R 10 is phenyl substituted with -NO. In some embodiments, R 3 -CH2OR 10 and R 10 is H or phenyl. In some embodiments, R 3 is C(=O)NR 10 R 10 and R 10 is C 1~6 In some embodiments, R 3 is C(=O)NR 10 R 10 and R 10 is ethyl.
[0211] In some embodiments, the genipin derivative is a compound shown in Table 2.
[0212] [Table 2-1]
[0213] [Table 2-2]
[0214] [Table 2-3]
[0215] In some embodiments, the compound has formula IIb:
[0216] [ka] or a pharma- ceutically acceptable salt thereof.
[0217] In some embodiments, R 3 is -CH2NR 7 R 8 , -C(=O)OR 10 , -CH(=O), -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 and 1 to 5 R 7 phenyl substituted with Each R 10 is H, -OH, -CH(=O) and 1 to 5 R 7 and wherein each of the groups is independently selected from phenyl substituted with
[0218] In some embodiments, the genipin derivative is a compound of formula IIb:
[0219] [ka] During the ceremony: R 3 is -CH2NR 7 R 8 , -C(=O)OR 10 , -CH(=O), -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 and 1 to 5 R 7 phenyl substituted with In the formula, each R 10 is H, -OH, -CH(=O) and 1 to 5 R 7 phenyl substituted with R 7 is an electron withdrawing or electron donating group, such as, for example, any of the electron withdrawing or electron donating groups described herein.
[0220] In some embodiments, R 3 is -C(=O)OR 10 , -CH(=O), -CH=CHR 10 , -CH2OR 10 and -C(=O)NR 10 R 10 is selected from the group consisting of:
[0221] In some embodiments, each R 10 , H, C 1~6 Alkyl, -CH(=O), -phenyl and 1 to 5 R 7 In some embodiments, R 10 is phenyl substituted with -NO2.
[0222] In some embodiments, R 3 is -C(=O)OR 10 and R 10 is H.
[0223] In some embodiments, R 3 is -CH=CHR 10 and R 10 is H, CH(=O), phenyl, 1-5 R 7 In some embodiments, R 3 is -CH=CHR 10 and R 10 is phenyl substituted with -NO2.
[0224] In some embodiments, R 3 -CH2OR 10 and R 10 is H or phenyl.
[0225] In some embodiments, R 3 is C(=O)NR 10 R 10 and R 10 is C 1~6 It is an alkyl.
[0226] In some embodiments, R 3 is C(=O)NR 10 R 10 and R 10 is ethyl.
[0227] In some embodiments, the genipin derivative is a compound shown in Table 3.
[0228] [Table 3-1]
[0229] [Table 3-2]
[0230] [Table 3-3]
[0231] In some embodiments, R 7 is -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -NHC(=O)R 8 , -OC(=O)R 8 , -SR 8 , -CO2 - , -SO2CF3, -NO2, -SO2R 8 , -CN, -CR 9 3. -COR 9 , -CHO, -COR 8 , -C(=O)NR 8 R 8 , a halide, and -NO; R 8 is H, -(C 1~9 alkyl), -(C 2~9 alkenyl), unsubstituted -(C 2~9 alkynyl), R9 is a halide. In some embodiments, R 7 is -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -OC(=O)R 8 , -SR 8 , -CO2 - , -SO2CF3, -NO2, -SO2R 8 , -CN, -CR 9 3. -COR 9 , -CHO, -COR 8 , -C(=O)NR 8 R 8 and -NO.
[0232] In some embodiments, the chiral carbon atom of formula IIb has the same configuration (R or S) as in formula IIa.
[0233] Without being bound by any theory, it is believed that the penetration profile of genipin or genipin derivatives can determine the color density profile of the stratum corneum because polymer-based and / or oligomer-based colorants are too large to penetrate the skin at relevant concentrations. For example, the average molecular weight of polymer-based and / or oligomer-based blue colorants from genipin has been reported to be 8900±600 Daltons, and the polymer-based and / or oligomer-based blue colorants contain 40-44 monomer units (see, e.g., Touyama et al., Chem..Pharm.Bull.42:668-673,1994). In some embodiments, the average molecular weight of monomeric genipin, polymerized genipin and / or oligomerized genipin or genipin derivatives present in the compositions described herein can range from about 200 Daltons to about 15,000 Daltons. In some embodiments, the average molecular weight of the polymerized genipin and / or oligomerized genipin or genipin derivatives present in the compositions described herein can range from about 500 Daltons to about 15,000 Daltons. In some embodiments, genipin or genipin derivatives of multiple different molecular weights can be used. For example, in some embodiments, the compositions described herein can include genipin having an average molecular weight of about 200 Daltons to about 15,000 Daltons. In some embodiments, the compositions described herein can include genipin or genipin derivatives having a molecular weight of about 200 to about 1000 Daltons, about 500 to about 1500 Daltons, about 1000 to about 2000 Daltons, about 1500 to about 2500 Daltons, about 2000 to about 3500 Daltons, 3500 to about 5000 Daltons, 5000 to about 6500 Daltons, 6000 to about 8300 Daltons, about 8300 to about 9500 Daltons, and combinations thereof.
[0234] As used herein, "lawsone" refers to 2-hydroxy-1,4-naphthoquinone, also known as henna tannic acid. Lawsone is a red-orange dye present in the leaves of the henna plant (Lawsonia inermis) and the flowers of the water hyacinth (Eichhornia crassipes). Lawsone reacts with proteins such as keratin in skin and hair, and the semi-permanent color lasts until the skin or hair is bleached.
[0235] As used herein, "lawsone derivatives" refers to compounds that have a lawsone core. For example, lawsone derivatives are compounds that have the following core structure:
[0236] [ka]
[0237] Non-limiting examples of lawsone derivatives are the compounds shown in Table 4.
[0238] [Table 4]
[0239] Further non-limiting examples of lawsone derivatives include compounds of formula III:
[0240] [ka] In the formula, R 7 is -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -NHC(=O)R 8 , -OC(=O)R 8 , -SR 8 , -CO2 - , -SO2CF3, -NO2, -SO2R 8 , -CN, -CR 9 3. -COR 9 , -CHO, -COR8 , -C(=O)NR 8 R 8 , halogen and -NO; R 8 But, H, -(C 1~9 alkyl), -(C 2~9 alkenyl), R 9 is a halide.
[0241] In some embodiments, R 7 The electron withdrawing or donating group of -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -OC(=O)R 8 , -SR 8 , -CO2 - , -SO2CF3, -NO2, -SO2R 8 , -CN, -CR 9 3. -COR 9 , -CHO, -COR 8 , -C(=O)NR 8 R 8 and -NO.
[0242] In some embodiments, the semi-permanent colorant (e.g., genipin, genipin derivatives, lawsone, lawsone derivatives, or combinations thereof) is purified. Amines, such as amines present endogenously in plant extracts or amines exogenously introduced into the genipin or other semi-permanent colorant solution, can shorten the lifespan of the semi-permanent colorant solution. For example, over time, reactive precursors can stain into polymer-based and / or oligomer-based colorants prior to application to the skin, limiting the penetration of the semi-permanent colorant into the stratum corneum. Penetration of genipin or other semi-permanent colorants into deeper layers of the stratum corneum can allow for subsequent staining and retention of the semi-permanent colorant (e.g., polymer-based and / or oligomer-based semi-permanent colorant) in the skin, leading to increased longevity of the semi-permanent tattoo. The longevity of the semi-permanent tattoo or the residence time of the semi-permanent colorant in the skin can be limited by natural skin desquamation processes. In some embodiments, the purified semi-permanent colorant has a purity of greater than about 85 w / w%. For example, a purified semi-permanent colorant has a purity of greater than about 86 w / w%, about 88 w / w%, about 90 w / w%, about 92 w / w%, about 94 w / w%, about 96 w / w%, about 98 w / w%, about 99 w / w%, or about 99.5 w / w% of the semi-permanent colorant solution.
[0243] In some embodiments, the salts of any of the compounds described herein are formed between an acidic group of the compound, such as an amino functional group, and a basic group, or between a basic group of the compound, such as a carboxy functional group, and an acidic group. According to another embodiment, the compound is a pharma- ceutically acceptable acid addition salt.
[0244] In some embodiments, acids commonly utilized to form pharma- ceutically acceptable salts of compounds of the present disclosure include inorganic acids such as hydrogen bisulfide, hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, and phosphoric acid, and organic acids such as para-toluenesulfonic acid, salicylic acid, tartaric acid, bitartaric acid, ascorbic acid, maleic acid, besylic acid, fumaric acid, gluconic acid, glucuronic acid, formic acid, glutamic acid, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, lactic acid, oxalic acid, para-bromophenylsulfonic acid, carbonic acid, succinic acid, citric acid, benzoic acid, and acetic acid, and related inorganic and organic acids. Accordingly, such pharma- ceutically acceptable salts include, but are not limited to, sulfate, pyrosulfate, bisulfate, sulfite, bisulfite, phosphate, monohydrogen phosphate, dihydrogen phosphate, metaphosphate, pyrophosphate, chloride, bromide, iodide, acetate, propionate, decanoate, caprylate, acrylate, formate, isobutyrate, caprate, heptanoate, propiolate, oxalate, malonate, succinate, suberate, sebacate, fumarate, maleate, butyne-1,4-dioate, hexyne-1,6-dioate, hexyne-2,6 ... These include dioate, benzoate, chlorobenzoate, methyl benzoate, dinitrobenzoate, hydroxybenzoate, methoxybenzoate, phthalate, terephthalate, sulfonate, xylenesulfonate, phenylacetate, phenylpropionate, phenylbutyrate, citrate, lactate, β-hydroxybutyrate, glycolate, maleate, tartrate, methanesulfonate, propanesulfonate, naphthalene-1-sulfonate, naphthalene-2-sulfonate, mandelate and other salts. In one embodiment, pharma- ceutically acceptable acid addition salts include those formed with mineral acids such as hydrochloric acid, hydrobromic acid, and especially those formed with organic acids such as maleic acid.
[0245] In some embodiments, bases commonly utilized to form pharma- ceutically acceptable salts of compounds of the present disclosure include hydroxides of alkali metals including sodium, potassium, and lithium, hydroxides of alkaline earth metals such as calcium and magnesium, hydroxides of other metals such as aluminum and zinc, ammonia, unsubstituted or hydroxy-substituted mono-, di-, or tri-alkylamines, organic amines such as dicyclohexylamine, tributylamine, pyridine, N-methyl, N-ethylamine, diethylamine, triethylamine, mono-, bis-, or tris-(2-OH-(C1-C6)-alkylamines) such as N,N-dimethyl-N-(2-hydroxyethyl)amine or tri-(2-hydroxyethyl)amine, N-methyl-D-glucamine, morpholine, thiomorpholine, piperidine, pyrrolidine, and amino acids such as arginine, lysine, etc.
[0246] In some embodiments, the semi-permanent coloring agent is a combination of two or more semi-permanent coloring agents (e.g., a combination of two or more of genipin, genipin derivatives, lawsone, and lawsone derivatives). The combination of two or more semi-permanent coloring agents can include, for example, a combination of two or more genipin derivatives, a combination of one or more genipin derivatives and lawsone, a combination of one or more genipin derivatives and one or more lawsone derivatives, a combination of lawsone and one or more lawsone derivatives, and a combination of one or more genipin derivatives, lawsone, and one or more lawsone derivatives. In some embodiments, the semi-permanent coloring agent includes a combination of two or more of the compounds of formula I, formula IIa, formula IIb, and formula III.
[0247] In some embodiments, the semi-permanent colorant comprises two semi-permanent colorants, such as a first semi-permanent colorant and a second semi-permanent colorant. For example, the semi-permanent colorant can comprise genipin and a genipin derivative, or the semi-permanent colorant can comprise two different genipin derivatives (e.g., any two of the genipin derivatives described herein). In some embodiments, the first semi-permanent colorant is genipin and the second semi-permanent colorant is Compound 1. In some embodiments, the first semi-permanent colorant is genipin and the second semi-permanent colorant is Compound 12. In some embodiments, the first semi-permanent colorant is Compound 1 and the second semi-permanent colorant is Compound 12. In some embodiments, the first semi-permanent colorant is genipin and the second semi-permanent colorant is Compound 14. In some embodiments, the first semi-permanent colorant is Compound 1 and the second semi-permanent colorant is Compound 14. In some embodiments, the first semi-permanent colorant is Compound 7 and the second semi-permanent colorant is Compound 9. In some embodiments, the first semi-permanent colorant is Compound 7 and the second semi-permanent colorant is Compound 16. In some embodiments, the first semi-permanent colorant is Compound 9 and the second semi-permanent colorant is Compound 16.
[0248] In some embodiments, the first semi-permanent colorant and the second semi-permanent colorant are present in a ratio of about 10:1 to about 1:10 of the first semi-permanent colorant:second semi-permanent colorant, such as about 1:10 to 10:1, about 2:10 to 10:2, about 3:10 to 10:3, about 4:10 to 10:4, about 6:10 to 10:6, about 7:10 to 10:7, about 8:10 to 10:8, or about 9:10 to 10:9, such as about 1:8 to 8:1, about 3:8 to 8:3, about 5:8 to 8:5, or about 7:8 to 8:7. For example, the ratio of the first semi-permanent colorant to the second semi-permanent colorant is about 1:4 to about 1:3, about 1:4 to about 1:2, about 1:4 to about 1:1, about 1:4 to about 2:1, about 1:4 to about 3:1, about 3:1 to about 4:1, about 3:4 to about 4:3, about 2:1 to about 4:1, about 1:1 to about 4:1, about 1:2 to about 4:1, or about 1:3 to about 4:1. In some embodiments, the first semi-permanent colorant and the second semi-permanent colorant are present in a ratio of about 1:4, about 1:3, about 1:2, about 1:1, about 2:1, about 1:1, about 2:1, about 3:1, or about 4:1 of the first semi-permanent colorant:second semi-permanent colorant. In some embodiments, the first semi-permanent colorant and the second semi-permanent colorant are present in a ratio of about 1:1 first semi-permanent colorant:second semi-permanent colorant.
[0249] In some embodiments, the semi-permanent coloring agent comprises three semi-permanent coloring agents, such as a first semi-permanent coloring agent, a second semi-permanent coloring agent, and a third semi-permanent coloring agent. For example, the semi-permanent coloring agent can comprise genipin and two different genipin derivatives, or the semi-permanent coloring agent can comprise three different genipin derivatives (e.g., any three of the genipin derivatives described herein). In some embodiments, the first semi-permanent coloring agent is genipin, the second semi-permanent coloring agent is compound 1, and the third semi-permanent coloring agent is compound 12. In some embodiments, the first semi-permanent coloring agent is genipin, the second semi-permanent coloring agent is compound 1, and the third semi-permanent coloring agent is compound 14. In some embodiments, the first semi-permanent coloring agent is compound 7, the second semi-permanent coloring agent is compound 9, and the third semi-permanent coloring agent is compound 16.
[0250] In some embodiments, the first semi-permanent colorant, the second semi-permanent colorant, and the third semi-permanent colorant are present in a ratio of about 1:4:1 to about 4:1:1 of the first semi-permanent colorant:the second semi-permanent colorant:the third semi-permanent colorant. For example, the ratio of the first semi-permanent colorant:the second semi-permanent colorant:the third semi-permanent colorant is about 1:4:1 to about 1:3:1, about 1:4:1 to about 1:2:1, about 1:4:1 to about 1:1:1, about 1:4:1 to about 2:1:1, about 1:4:1 to about 3:1:1, about 3:1:1 to about 4:1:1, about 2:1:1 to about 4:1:1, about 1:1:1 to about 4:1:1, about 1:2:1 to about 4:1:1, or about 1:3:1 to about 4:1:1. In some embodiments, the first semi-permanent colorant, the second semi-permanent colorant, and the third semi-permanent colorant are present in a ratio of about 1:4:1, about 1:3:1, about 1:2:1, about 1:1:1, about 2:1:1, about 1:1:1, about 2:1:1, about 3:1:1, or about 4:1:1 of the first semi-permanent colorant:second semi-permanent colorant:third semi-permanent colorant. In some embodiments, the first semi-permanent colorant, the second semi-permanent colorant, and the third semi-permanent colorant are present in a ratio of about 1:1:1 of the first semi-permanent colorant:second semi-permanent colorant:third semi-permanent colorant.
[0251] In some embodiments, the semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) is present in an amount of about 0.1 w / w% to about 25 w / w% of the composition. For example, about 0.1 w / w% to about 24 w / w%, about 0.1 w / w% to about 22 w / w%, about 0.1 w / w% to about 20 w / w%, about 0.1 w / w% to about 18 w / w%, about 0.1 w / w% to about 16 w / w%, about 0.1 w / w% to about 14 w / w%, about 0.1 w / w% to about 12 w / w%, about 0.1 w / w% to about 10 w / w%, about 0.1 w / w% to about 8 w / w%, about 0.1 w / w% to about 6 w / w%, about 0.1 w / w% to about 4 w / w%, about 0.1 w / w% about 2 w / w%, about 24 w / w% to about 25 w / w%, about 22 w / w% to about 25 w / w%, about 20 w / w% to about 25 w / w%, about 18 w / w% to about 25 w / w%, about 16 w / w% to about 25 w / w%, about 14 w / w% to about 25 w / w%, about 12 w / w% to about 25 w / w%, about 10 w / w% to about 25 w / w%, about 8 w / w% to about 25 w / w%, about 6 w / w% to about 25 w / w%, about 4 w / w% to about 25 w / w%, or about 2 w / w% to about 25 w / w%. In some embodiments, the semi-permanent colorant is present in an amount of about 0.1 w / w% to about 3 w / w%, about 0.1 w / w% to about 1 w / w%, about 0.5 w / w% to about 1 w / w%, about 0.5 w / w% to about 1.5 w / w%, or about 0.5 w / w% to about 3 w / w% of the composition. In some embodiments, the semi-permanent colorant is present in an amount of about 0.5 w / w% to about 1.5 w / w% of the composition. In some embodiments, the semi-permanent colorant is present in an amount of about 5 w / w% to about 15 w / w%, about 10 w / w% to about 15 w / w%, about 10 w / w% to about 20 w / w%, about 15 w / w% to about 20 w / w%, about 8 w / w% to about 12 w / w%, about 10 w / w% to about 14 w / w%, about 12 w / w% to about 16 w / w%, about 14 w / w% to about 18 w / w%, or about 16 w / w% to about 20 w / w% of the composition. In some embodiments, the semi-permanent colorant is present in an amount of about 12 w / w% to about 16 w / w% of the composition. In some embodiments, the semi-permanent colorant is present in an amount of about 9 w / w% to about 11 w / w% of the composition.In some embodiments, the semi-permanent colorant is about 0.5 w / w%, about 0.9 w / w%, about 1 w / w%, about 2 w / w%, about 3 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w%, about 7 w / w%, about 7.5 w / w%, about 8 w / w%, about 8.5 w / w%, about 9 w / w%, about 9.5 w / w%, about 10 w / w%, The semi-permanent coloring agent is present in an amount of about 10.5 w / w%, about 11 w / w%, about 11.5 w / w%, about 12 w / w%, about 12.5 w / w%, about 13 w / w%, about 13.5 w / w%, about 14 w / w%, about 15 w / w%, about 16 w / w%, about 17 w / w%, about 18 w / w%, about 19 w / w%, about 20 w / w%, about 21 w / w%, about 22 w / w%, about 23 w / w%, about 24 w / w%, or about 25 w / w%. In some embodiments, the semi-permanent coloring agent is present in an amount of about 14 w / w% of the composition. In some embodiments, the semi-permanent coloring agent is present in an amount of about 10 w / w% of the composition. In some embodiments, the semi-permanent coloring agent comprises a genipin derivative, a lawsone, and a lawsone derivative, or a combination thereof.
[0252] Non-limiting examples of solvents include water, methanol, ethanol, isopropanol, and diethylene glycol monoethyl ether. In some embodiments, the solvent is a volatile solvent, e.g., the solvent can evaporate or vaporize at room temperature. Non-limiting examples of volatile solvents include water, methanol, ethanol, and isopropanol. In some embodiments, the solvent is selected to have a low toxicity profile when used as described herein. For example, the solvent can be selected such that the amount of any residual solvent remaining after the composition (e.g., the composition described herein) dries on the applicator is not a toxic amount for contact with a human skin surface.
[0253] In some embodiments, the solvent (e.g., any of the solvents described herein) is present in an amount of about 1 w / w% to about 95 w / w% of the composition, e.g., about 10 w / w% to about 95 w / w%, about 20 w / w% to about 95 w / w%, about 30 w / w% to about 95 w / w%, about 40 w / w% to about 95 w / w%, about 50 w / w% to about 95 w / w%, about 60 w / w% to about 95 w / w%, about 70 w / w% to about 95 w / w%, about 80 w / w% to about 95 w / w%, or about 100 w / w% to about 95 w / w% of the composition. 5 w / w%, about 1 w / w% to about 20 w / w%, about 1 w / w% to about 30 w / w%, about 1 w / w% to about 40 w / w%, about 1 w / w% to about 50 w / w%, about 1 w / w% to about 60 w / w%, about 1 w / w% to about 70 w / w%, about 1 w / w% to about 80 w / w%, or about 1 w / w% to about 90 w / w%. In some embodiments, the solvent is present in an amount of about 50 w / w% to about 75 w / w%, about 55 w / w% to about 80 w / w%, about 60 w / w% to about 85 w / w%, about 65 w / w% to about 90 w / w%, about 55 w / w% to about 75 w / w%, about 60 w / w% to about 80 w / w%, about 65 w / w% to about 85 w / w%, about 70 w / w% to about 90 w / w%, about 75 w / w% to about 95 w / w%, about 60 w / w% to about 70 w / w%, about 65 w / w% to about 75 w / w%, about 70 w / w% to about 80 w / w%, or about 75 w / w% to about 85 w / w% of the composition. For example, about 60 w / w% to about 65 w / w%, about 62 w / w% to about 67 w / w%, about 65 w / w% to about 70 w / w%, about 68 w / w% to about 72 w / w%, about 70 w / w% to about 75 w / w%, about 72 w / w% to about 76 w / w%, about 75 w / w% to about 80 w / w%, about 77 w / w% to about 82 w / w%, about 80 w / w% to about 85 w / w%, about 82 w / w% to about 87 w / w%, about 85 w / w% to about 90 w / w%, about 87 w / w% to about 92 w / w%, or about 90 w / w% to about 95 w / w% of the composition. In some embodiments, the solvent is present in an amount of about 80 w / w% to about 90 w / w% of the composition. In some embodiments, the solvent is present in an amount of about 76 w / w% to about 79 w / w% of the composition. In some embodiments, the solvent is present in an amount of about 77 w / w% to about 78 w / w% of the composition. In some embodiments, the solvent is present in an amount of about 72 w / w% to about 76 w / w% of the composition. In some embodiments, the solvent is present in an amount of about 69 w / w% to about 71 w / w% of the composition.In some embodiments, the solvent is present in an amount of about 70% to about 71% w / w of the composition. In some embodiments, the solvent is present in an amount of about 50%, about 55%, about 60%, about 65%, about 66%, about 67%, about 68%, about 69%, about 70%, about 71%, about 72%, about 73%, about 74%, about 75%, about 76%, about 78%, about 79%, about 80%, about 81%, about 82%, about 83%, about 84%, about 85%, about 86%, about 87%, about 88%, about 89%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, about 100%, about 101%, about 102%, about 103%, about 104%, about 105%, about 106%, about 107%, about 108%, about 109%, about 110%, about 111%, about 112%, about 113%, about 114%, about 115%, about 116%, about 117%, about 118%, about 119%, about 120%, about 121%, about 122%, about 123%, about 124%, about 125%, about 126%, about 127%, about 128%, about 129%, about 130%, about 131%, about 132%, about 133%, about 134%, about 135%, about 136%, about 137%, about 138%, about 139%, about 140%, about 141%, about 142%, about 143%, about 144%, about 145%, about 146%, about 6 w / w%, about 77 w / w%, about 78 w / w%, about 79 w / w%, about 80 w / w%, about 81 w / w%, about 82 w / w%, about 83 w / w%, about 84 w / w%, about 85 w / w%, about 86 w / w%, about 87 w / w%, about 88 w / w%, about 89 w / w%, about 90 w / w% or about 95 w / w%. In some embodiments, the solvent is present in an amount of about 74 w / w% of the composition. In some embodiments, the solvent is present in an amount of about 77 w / w% of the composition. In some embodiments, the solvent is present in an amount of about 71 w / w% of the composition. In some embodiments, the solvent is present in an amount of about 86 w / w% of the composition.
[0254] In some embodiments, the solvent is a combination of two or more solvents, such as two or more of water, methanol, ethanol, isopropanol, and diethylene glycol monoethyl ether, in some embodiments, each solvent is independently present in an amount of about 5% to about 80% by weight of the composition. For example, each solvent can be independently present in an amount of about 5 w / w% to about 10 w / w%, about 5 w / w% to about 20 w / w%, about 5 w / w% to about 30 w / w%, about 5 w / w% to about 40 w / w%, about 5 w / w% to about 50 w / w%, about 5 w / w% to about 60 w / w%, about 5 w / w% to about 70 w / w%, about 70 w / w% to about 80 w / w%, about 60 w / w% to about 80 w / w%, about 50 w / w% to about 80 w / w%, about 40 w / w% to about 80 w / w%, about 30 w / w% to about 80 w / w%, about 20 w / w% to about 80 w / w%, or about 10 w / w% to about 80 w / w% of the composition. In some embodiments, the solvent is independently present in an amount of from 10 w / w% to about 20 w / w%, from about 15 w / w% to about 25 w / w%, from about 20 w / w% to about 30 w / w%, from about 25 w / w% to about 35 w / w%, from about 30 w / w% to about 40 w / w%, from about 35 w / w% to about 45 w / w%, from about 40 w / w% to about 50 w / w%, from about 45 w / w% to about 50 w / w%, from about 50 w / w% to about 60 w / w%, or from about 65 w / w% to about 75 w / w% of the composition. For example, each solvent may be present in an amount of about 13 w / w%, about 14 w / w%, about 15 w / w%, about 16 w / w%, about 17 w / w%, about 18 w / w%, about 19 w / w%, about 20 w / w%, about 21 w / w%, about 22 w / w%, about 23 w / w%, about 24 w / w%, about 25 w / w%, about 26 w / w%, about 27 w / w%, about 28 w / w%, about 29 w / w%, about 30 w / w%, about 31 w / w%, about 32 w / w%, about 33 w / w%, about 34 w / w%, about 35 w / w%, about 36 w / w%, about 37 w / w%, about 38 w / w%, about 39 w / w%, about 40 w / w%, about 41 w / w%, about 42 w / w%, about 43 w / w%, about 44 w / w%, about 45 w / w%, about 46 w / w%, about 47 w / w%, about 48 w / w%, about 49 w / w%, about 50 w / w%, about 51 w / w%, about 52 w / w%, about 53 w / w%, about 54 w / w%, about 55 w / w%, about 56 w / w%, about 57 w / w%, about 58 w / w%, about 59 w / w%, about 60 w / w%, about 61 w / w%, about 62 w / w%, about 63 w / w%, about 64 w / w%, about 65 w / w%, about 66 w / w%, about 67 w / w%, about 68 w / w%, about 69 w / w%, about 70 w / w%, about 71 w / w%, about 72 w / w%, about 73 w / w%, about 74 w / w%, about 7 %, about 37 w / w%, about 38 w / w%, about 39 w / w%, about 40 w / w%, about 41 w / w%, about 42 w / w%, about 43 w / w%, about 44 w / w%, about 45 w / w%, about 46 w / w%, about 47 w / w%, about 48 w / w%, about 49 w / w%, about 50 w / w%, about 51 w / w%, about 52 w / w%, about 53 w / w%, about 54 w / w%, about 55 w / w%, about 60 w / w%, about 65 w / w%, about 70 w / w% or about 72 w / w%.
[0255] In some embodiments, the solvent is a combination of water and ethanol, hi some embodiments, the water is present in an amount of about 15% to about 40% w / w of the composition, and the ethanol is present in an amount of about 30% to about 55% w / w of the composition. For example, water is present in an amount of about 20 w / w% to about 30 w / w%, about 25 w / w% to about 35 w / w%, about 25 w / w% to about 30 w / w%, or about 28 w / w% to about 32 w / w% of the composition, and ethanol is present in an amount of about 35 w / w% to about 45 w / w%, about 40 w / w% to about 50 w / w%, about 40 w / w% to about 55 w / w%, about 45 w / w% to about 55 w / w%, about 45 w / w% to about 50 w / w%, about 40 w / w% to about 45 w / w%, about 42 w / w% to about 47 w / w%, or about 45 w / w% to about 50 w / w% of the composition. In some embodiments, water is present in an amount of about 25 w / w% to about 30 w / w% of the composition, and ethanol is present in an amount of about 40 w / w% to about 50 w / w% of the composition. In some embodiments, water is present in an amount of about 28 w / w% to about 32 w / w% of the composition, and ethanol is present in an amount of about 45 w / w% to about 50 w / w% of the composition. In some embodiments, water is present in an amount of about 15 w / w% to about 25 w / w%, about 18 w / w% to about 22 w / w%, or about 19 w / w% to about 21 w / w% of the composition, and ethanol is present in an amount of about 45 w / w% to about 55 w / w%, about 48 w / w% to about 52 w / w%, or about 49 w / w% to about 51 w / w% of the composition. In some embodiments, water is about 15 w / w%, about 16 w / w%, about 17 w / w%, about 18 w / w%, about 19 w / w%, about 20 w / w%, about 21 w / w%, about 22 w / w%, about 23 w / w%, about 24 w / w%, about 25 w / w%, about 26 w / w%, about 27 w / w%, about 28 w / w%, about 29 w / w%, about 30 w / w%, about 31 w / w%, about 32 w / w%, about 33 w / w%, about 34 w / w%, about 35 w / w%, about 36 w / w%, about 37 w / w%, about 38 w / w%, about 39 w / w%, about 40 w / w%, about 41 w / w%, about 42 w / w%, about 43 w / w%, about 44 w / w%, about 45 w / w%, about 46 w / w%, about 47 w / w%, about 48 w / w%, about 49 w / w%, about 50 w / w%, about 51 w / w%, about 52 w / w%, about 53 w / w%, about 54 w / w%, about 55 w / w%, about 56 w / w%, about 57 w / w%, about 58 w / w%, about 59 w / w%, about 60 w / w%, about 61 w / w%, about 62 w / w%, about 63 w / w%, about 64 w / w%, about 65 w / w%, about 66 w / w%, about 67 w / w%, about 68 w / w%, about 69 w / w%, about 70 w / w%, about 71 w / w%, about 72 w / w%, about 73 w / w%, about 74 w / w%, about 75 w / w%, about 76 w / w%, about 77 w / w%, about The ethanol is present in an amount of about 40 w / w%, about 41 w / w%, about 42 w / w%, about 43 w / w%, about 44 w / w%, about 45 w / w%, about 46 w / w%, about 47 w / w%, about 48 w / w%, about 49 w / w%, about 50 w / w%, about 51 w / w%, about 52 w / w%, about 53 w / w%, about 54 w / w%, or about 55 w / w% of the composition.In some embodiments, the water is present in an amount of about 28% w / w of the composition and the ethanol is present in an amount of about 46% w / w of the composition.
[0256] In some embodiments, water is present in an amount of about 65 w / w% to about 75 w / w% of the composition, and ethanol is present in an amount of about 10 w / w% to about 20 w / w% of the composition. In some embodiments, water is present in an amount of about 72 w / w% of the composition, and ethanol is present in an amount of about 14 w / w% of the composition. In some embodiments, water is present in an amount of about 30 w / w% of the composition, and ethanol is present in an amount of about 48 w / w% of the composition. In some embodiments, water is present in an amount of about 21 w / w% of the composition, and ethanol is present in an amount of about 50 w / w% of the composition.
[0257] As used herein, "thickening agent" refers to an agent that increases the viscosity of a liquid. In some embodiments, the thickening agent increases the viscosity of a liquid without substantially changing other properties of the liquid. Non-limiting examples of thickening agents include starches, gums (e.g., natural and synthetic gums), cellulose, and arabinogalactans. Non-limiting examples of starches include aluminum starch octenyl succinate. Non-limiting examples of gums include xanthan gum, sclerotium gum, tragacanth gum, pectin, karaya gum, arabic gum, agar, guar gum, carrageenan, locust bean gum, alginate, arginine, gelatin, tara gum, ghatti gum, gellan gum, konjac gum, cassia gum, spruce gum, chicle gum, dammar, curdlan gum, and pullulan. Non-limiting examples of cellulosics include hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, ethyl cellulose, soybean hemicellulose, and sodium carboxymethylcellulose.
[0258] In some embodiments, the thickener is present in an amount of about 0.1 w / w% to about 10 w / w% of the composition, such as about 0.1 w / w% to about 8 w / w%, about 0.1 w / w% to about 6 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 4 w / w%, about 0.1 w / w% to about 3 w / w%, about 0.1 w / w% to about 2 w / w%, about 0.1 w / w% to about 1 w / w%, about 8 w / w% to about 10 w / w%, about 6 w / w% to about 10 w / w%, about 4 w / w% to about 10 w / w%, about 3 w / w% to about 10 w / w%, about 2 w / w% to about 10 w / w%, or about 1 w / w% to about 10 w / w% of the composition. In some embodiments, the thickening agent is present in an amount of about 1 w / w% to about 5 w / w% of the composition. In some embodiments, the thickening agent is present in an amount of about 0.25 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 7 w / w%, about 8 w / w%, about 9 w / w%, or about 10 w / w% of the composition. In some embodiments, the thickening agent is present in an amount of about 4 w / w% of the composition.
[0259] In some embodiments, the thickener is present in an amount of about 0.01 w / w% to about 1 w / w% of the composition, for example, about 0.01 w / w% to about 0.05 w / w%, about 0.01 w / w% to about 0.1 w / w%, about 0.01 w / w% to about 0.15 w / w%, about 0.01 w / w% to about 0.2 w / w%, about 0.01 w / w% to about 0.3 w / w%, about 0.01 w / w% to about 0.4 w / w%, about 0.01 w / w% to about 0.5 w / w%, about 0.01 w / w% to about 0.6 w / w%, about 0.01 w / w% to about 0.7 w / w%, about 0.01 w / w% to about 0.8 w / w%, about 0.01 w / w% to about 0.9 w / w%, about 0.9 w / w% to about 1 w / w%, about 0.8 w / w% to about 1 w / w%, about 0.7 w / w% to about 1 w / w%, about 0.6 w / w% to about 1 w / w%, about 0.5 w / w% to about 1 w / w%, about 0.4 w / w% to about 1 w / w%, about 0.3 w / w% to about 1 w / w%, about 0.2 w / w% to about 1 w / w%, about 0.15 w / w% to about 1 w / w%, about 0.1 w / w% to about 1 w / w%, or about 0.05 w / w% to about 1 w / w%. In some embodiments, the thickening agent is present in an amount of about 0.05 w / w% to about 0.25 w / w%, about 0.05 w / w% to about 0.2 w / w%, about 0.1 w / w% to about 0.2 w / w%, or about 0.1 w / w% to about 0.15 w / w% of the composition. In some embodiments, the thickening agent is present in an amount of about 0.05 w / w% to about 0.2 w / w% of the composition. In some embodiments, the thickening agent is about 0.01 w / w%, about 0.05 w / w%, 0.06 w / w%, about 0.07 w / w%, about 0.08 w / w%, about 0.09 w / w%, about 0.10 w / w%, about 0.11 w / w%, about 0.12 w / w%, about 0.13 w / w%, about 0.14 w / w%, about 0.15 w / w%, about 0.16 w / w% of the composition. , about 0.17 w / w%, about 0.18 w / w%, about 0.19 w / w%, about 0.2 w / w%, about 0.22 w / w%, about 0.24 w / w%, about 0.26 w / w%, about 0.28 w / w%, about 0.3 w / w%, about 0.4 w / w%, about 0.5 w / w%, about 0.6 w / w%, about 0.8 w / w%, about 0.9 w / w%, or about 1 w / w%. In some embodiments, the thickening agent is present in an amount of about 0.12 w / w% of the composition.
[0260] In some embodiments, the thickening agent is xanthan gum, hi some embodiments, the xanthan gum is present in an amount of about 0.1% to about 10% w / w of the composition. For example, about 0.1 w / w% to about 8 w / w%, about 0.1 w / w% to about 6 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 4 w / w%, about 0.1 w / w% to about 3 w / w%, about 0.1 w / w% to about 2 w / w%, about 0.1 w / w% to about 1 w / w%, about 8 w / w% to about 10 w / w%, about 6 w / w% to about 10 w / w%, about 4 w / w% to about 10 w / w%, about 3 w / w% to about 10 w / w%, about 2 w / w% to about 10 w / w%, or about 1 w / w% to about 10 w / w% of the composition. In some embodiments, xanthan gum is present in an amount of about 1 w / w% to about 5 w / w% of the composition. In some embodiments, the xanthan gum is present in an amount of about 0.25 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 7 w / w%, about 8 w / w%, about 9 w / w%, or about 10 w / w% of the composition. In some embodiments, the xanthan gum is present in an amount of about 4 w / w% of the composition.
[0261] In some embodiments, the thickening agent is a combination of two or more thickening agents, such as arabinogalactan, aluminum starch octenyl succinate, xanthan gum, sclerotium gum, tragacanth gum, pectin, karaya gum, arabic gum, agar, guar gum, carrageenan, locust bean gum, alginate, arginine, gelatin, tara gum, ghatti gum, gellan gum, konjac gum, cassia gum, spruce gum, chicle gum, dammar, curdlan gum, pullulan, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, ethylcellulose, soybean hemicellulose, and sodium carboxymethylcellulose. In some embodiments, each thickening agent is independently present in an amount of about 0.01 w / w% to about 0.5 w / w% of the composition. For example, each thickening agent may be present in an amount of about 0.01 w / w% to about 0.05 w / w%, about 0.01 w / w% to about 0.1 w / w%, about 0.01 w / w% to about 0.15 w / w%, about 0.01 w / w% to about 0.2 w / w%, about 0.01 w / w% to about 0.25 w / w%, about 0.01 w / w% to about 0.3 w / w%, about 0.01 w / w% to about 0.35 w / w%, about 0.01 w / w% to about 0.4 w / w%, about 0.01 w / w% to about 0.
[0043] The present invention may be independently present in an amount of about 45 w / w%, about 0.45 w / w% to about 0.5 w / w%, about 0.4 w / w% to about 0.5 w / w%, about 0.35 w / w% to about 0.5 w / w%, about 0.3 w / w% to about 0.5 w / w%, about 0.25 w / w% to about 0.5 w / w%, about 0.2 w / w% to about 0.5 w / w%, about 0.15 w / w% to about 0.5 w / w%, about 0.1 w / w% to about 0.15 w / w%, or about 0.05 w / w% to about 0.15 w / w%. In some embodiments, each thickening agent is independently present in an amount of about 0.01 w / w% to about 0.04 w / w%, about 0.02 w / w% to about 0.06 w / w%, about 0.03 w / w% to about 0.07 w / w%, 0.04 w / w% to about 0.08 w / w%, about 0.06 w / w% to about 0.1 w / w%, or about 0.08 w / w% to about 0.12 w / w%, or about 0.1 w / w% to about 0.14 w / w% of the composition.For example, each thickening agent may be present in an amount of about 0.01 w / w%, about 0.02 w / w%, about 0.03 w / w%, about 0.04 w / w%, about 0.05 w / w%, about 0.06 w / w%, about 0.07 w / w%, about 0.08 w / w%, about 0.09 w / w%, about 0.1 w / w%, about 0.11 w / w%, about 0.12 w / w%, about 0.13 w / w%, about 0.14 w / w%, about 0.15 w / w%, about 0.16 w / w%, about 0.17 w / w%, about 0.18 w / w%, about 0.19 w / w%, about 0.20 w / w%, about 0.21 w / w%, about 0.22 w / w%, about 0.23 w / w%, about 0.24 w / w%, about 0.25 w / w%, about 0.26 w / w%, about 0.27 w / w%, about 0.28 w / w%, about 0.29 w / w%, about 0.30 w / w%, about 0.31 w / w%, about 0.32 w / w%, about 0.33 w / w%, about 0.34 w / w%, about 0.35 w / w%, about 0.36 w / w%, about 0.37 w / w%, about 0.38 w / w%, about 0.39 w / w%, about 0.40 w / w%, about 0.41 w / w%, about 0.42 w / w%, about 0.43 w / w%, about 0.44 w / w%, about 0.45 w / w%, about 0.46 w / w%, about 0.47 w / w%, about 0.48 w / w%, about 0.49 w / w%, about 0.50 w / It may be independently present in an amount of about 0.16 w / w%, about 0.17 w / w%, about 0.18 w / w%, about 0.19 w / w%, about 0.2 w / w%, about 0.22 w / w%, about 0.24 w / w%, about 0.26 w / w%, about 0.28 w / w%, about 0.3 w / w%, about 0.4 w / w%, about 0.5 w / w%, about 0.6 w / w%, about 0.8 w / w%, about 0.9 w / w%, or about 1 w / w%.
[0262] In some embodiments, the thickening agent is a combination of hydroxyethyl cellulose and xanthan gum. In some embodiments, the hydroxyethyl cellulose is present in an amount of about 0.01 w / w% to about 0.5 w / w% of the composition, and the xanthan gum is present in an amount of about 0.01 w / w% to about 0.5 w / w% of the composition. In some embodiments, the hydroxyethyl cellulose is present in an amount of about 0.01 w / w% to about 0.04 w / w%, about 0.02 w / w% to about 0.06 w / w%, about 0.03 w / w% to about 0.07 w / w%, about 0.04 w / w% to about 0.08 w / w%, about 0.06 w / w% to about 0.1 w / w%, about 0.08 w / w% to about 0.12 w / w%, about 0.1 w / w% to about 0.14 w / w% of the composition. %, and the xanthan gum is present in an amount of about 0.01 w / w% to about 0.04 w / w%, about 0.02 w / w% to about 0.06 w / w%, about 0.03 w / w% to about 0.07 w / w%, 0.04 w / w% to about 0.08 w / w%, about 0.06 w / w% to about 0.1 w / w%, about 0.08 w / w% to about 0.12 w / w%, or about 0.1 w / w% to about 0.14 w / w% of the composition. In some embodiments, the hydroxyethyl cellulose is present in an amount of about 0.04 w / w% to about 0.08 w / w% of the composition, and the xanthan gum is present in an amount of about 0.04 w / w% to about 0.08 w / w% of the composition.In some embodiments, hydroxyethylcellulose is about 0.01 w / w%, about 0.02 w / w%, about 0.03 w / w%, about 0.04 w / w%, about 0.05 w / w%, about 0.06 w / w%, about 0.07 w / w%, about 0.08 w / w%, about 0.09 w / w%, about 0.1 w / w%, about 0.11 w / w%, about 0.12 w / w%, about 0.13 w / w%, about 0.14 w / w%, about 0.15 w / w%, about 0.16 w / w%, about 0.17 w / w%, about 0.18 w / w%, about 0.19 w / w%, or about 0.18 w / w% of the composition. The xanthan gum is present in an amount of about 0.01%, about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09%, about 0.1%, about 0.11%, about 0.12%, about 0.13%, about 0.14%, about 0.15%, about 0.16%, about 0.17%, about 0.18%, about 0.19%, or about 0.2% by weight of the composition. In some embodiments, the hydroxyethyl cellulose is present in an amount of about 0.06% w / w of the composition and the xanthan gum is present in an amount of about 0.06% w / w of the composition.
[0263] As used herein, "humectant" refers to a substance that attracts water. For example, a humectant can attract water and provide moisture to skin. Non-limiting examples of humectants include polyhydric alcohols, such as polyalkylene glycols (e.g., alkylene polyols and their derivatives), alpha hydroxy acids, sugars, aloe vera gel, vegetable oils, lithium chloride, allantoin, urea, and dicyanamide. Non-limiting examples of polyhydric alcohols include glycerol, lactic acid, propylene glycol, propanediol, polyethylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and its derivatives, hexylene glycol, 1,3-butylene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol, glyceryl triacetate, sorbitol, hydroxypropyl sorbitol, xylitol, maltitol, hyaluronic acid, tremella extract, sodium lactate, sodium L-pyroglutamate urea, and pyrrolidone carboxylic acid.
[0264] In some embodiments, the humectant is present in an amount of about 0.1 w / w% to about 20 w / w% of the composition, such as about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 10 w / w%, about 0.1 w / w% to about 15 w / w%, about 15 w / w% to about 20 w / w%, about 10 w / w% to about 20 w / w%, about 5 w / w% to about 20 w / w%, or about 1 w / w% to about 20 w / w% of the composition. In some embodiments, the humectant is present in an amount of about 0.5 w / w% to about 2 w / w%, about 0.5 w / w% to about 5%, about 1% to about 10 w / w%, about 1% to about 5%, about 2 w / w% to about 7 w / w%, about 5% to about 10 w / w%, about 7 w / w% to about 12%, or about 10 w / w% to about 15 w / w% of the composition. In some embodiments, the humectant is present in an amount of about 0.5 w / w% to about 1.5 w / w% of the composition. In some embodiments, the humectant is present in an amount of about 2 w / w% to about 6 w / w% of the composition. In some embodiments, the humectant comprises about 0.1 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w%, about 7 w / w% of the composition. %, about 7.5 w / w%, about 8 w / w%, about 8.5 w / w%, about 9 w / w%, about 9.5 w / w%, about 10 w / w%, about 11 w / w%, about 12 w / w%, about 13 w / w%, about 14 w / w%, about 15 w / w%, about 16 w / w%, about 17 w / w%, about 18 w / w%, about 19 w / w%, or about 20 w / w%. In some embodiments, the humectant is present in an amount of about 4 w / w% of the composition. In some embodiments, the humectant is present in an amount of about 1 w / w% of the composition.
[0265] In some embodiments, the humectant is propanediol. In some embodiments, the propanediol is present in an amount of about 0.1 w / w% to about 20 w / w% of the composition. For example, about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 10 w / w%, about 0.1 w / w% to about 15 w / w%, about 15 w / w% to about 20 w / w%, about 10 w / w% to about 20 w / w%, about 5 w / w% to about 20 w / w%, or about 1 w / w% to about 20 w / w% of the composition. In some embodiments, the propanediol is present in an amount of about 0.5 w / w% to about 2 w / w%, about 0.5 w / w% to about 5%, about 1% to about 10 w / w%, about 1% to about 5%, about 2 w / w% to about 7 w / w%, about 5% to about 10 w / w%, about 7 w / w% to about 12%, or about 10 w / w% to about 15 w / w% of the composition. In some embodiments, the propanediol is present in an amount of about 0.5 w / w% to about 1.5 w / w% of the composition. In some embodiments, the propanediol is present in an amount of about 2 w / w% to about 6 w / w% of the composition. In some embodiments, propanediol is about 0.1 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w%, about 7 w / w%, about 8 w / w%, about 9 w / w%, about 10 w / w%, about 11 w / w%, about 12 w / w%, about 13 w / w%, about 14 w / w%, about 15 w / w%, about 16 w / w%, about 17 w / w%, about 18 w / w%, about 19 w / w%, about 20 w / w%, about 21 w / w%, about 22 w / w%, about 23 w / w%, about 24 w / w%, about 25 w / w%, about 26 w / w%, about 27 w / w%, about 28 w / w%, about 29 w / w%, about 30 w / w%, about 31 w / w%, about 32 w / w%, about 33 w / w%, about 34 w / w%, about 35 w / w%, about 36 w / w%, about 37 w / w%, about 38 w / w%, about 39 w / w%, about 40 ... In some embodiments, the propanediol is present in an amount of about 4 w / w% of the composition. In some embodiments, the propanediol is present in an amount of about 1 w / w% of the composition. In some embodiments, the propanediol is present in an amount of about 1 w / w% of the composition. In some embodiments, the propanediol is present in an amount of about 2 w / w% of the composition. In some embodiments, the propanediol is present in an amount of about 3 w / w% of the composition. In some embodiments, the propanediol is present in an amount of about 4 w / w% of the composition. In some embodiments, the propanediol is present in an amount of about 1 w / w% of the composition.
[0266] In some embodiments, the humectant is glycerin. In some embodiments, the glycerin is present in an amount of about 0.1 w / w% to about 20 w / w% of the composition. For example, about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 10 w / w%, about 0.1 w / w% to about 15 w / w%, about 15 w / w% to about 20 w / w%, about 10 w / w% to about 20 w / w%, about 5 w / w% to about 20 w / w%, or about 1 w / w% to about 20 w / w% of the composition. In some embodiments, glycerin is present in an amount of about 1% to about 10%, about 1% to about 5%, about 2% to about 7%, about 5% to about 10%, about 7% to about 12%, or about 10% to about 15% by weight of the composition. In some embodiments, glycerol is present in an amount of about 2% to about 6% by weight of the composition. In some embodiments, glycerol is present in an amount of about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w%, about 7 w / w%, about 7.5 w / w%, about 8 w / w%, about 8.5 w / w%, about 9 w / w%, about 9.5 w / w%, about 10 w / w%, about 11 w / w%, about 12 w / w%, about 13 w / w%, about 14 w / w%, about 15 w / w%, about 16 w / w%, about 17 w / w%, about 18 w / w%, about 19 w / w%, or about 20 w / w% of the composition. In some embodiments, glycerol is present in an amount of about 4% w / w of the composition.
[0267] In some embodiments, the humectant is a vegetable oil. In some embodiments, the vegetable oil is present in an amount of about 0.1 w / w% to about 20 w / w% of the composition. For example, about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 10 w / w%, about 0.1 w / w% to about 15 w / w%, about 15 w / w% to about 20 w / w%, about 10 w / w% to about 20 w / w%, about 5 w / w% to about 20 w / w%, or about 1 w / w% to about 20 w / w% of the composition. In some embodiments, the vegetable oil is present in an amount of about 1 w / w% to about 10 w / w%, about 1 w / w% to about 5 w / w%, about 2 w / w% to about 7 w / w%, about 5 w / w% to about 10 w / w%, about 7 w / w% to about 12 w / w%, or about 10 w / w% to about 15 w / w% of the composition. In some embodiments, the vegetable oil is present in an amount of about 7 w / w% to about 11 w / w% of the composition. In some embodiments, the vegetable oil is present in an amount of about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w%, about 7 w / w%, about 7.5 w / w%, about 8 w / w%, about 8.5 w / w%, about 9 w / w%, about 9.5 w / w%, about 10 w / w%, about 11 w / w%, about 12 w / w%, about 13 w / w%, about 14 w / w%, about 15 w / w%, about 16 w / w%, about 17 w / w%, about 18 w / w%, about 19 w / w%, or about 20 w / w% of the composition. In some embodiments, the vegetable oil is present in an amount of about 9% w / w of the composition.
[0268] In some embodiments, the composition further comprises a film former. As used herein, "film former" refers to a compound that can form a continuous film on the skin. In some embodiments, the film former is a compound that forms a continuous film on the skin when dry. Non-limiting examples of film formers include volatile silicone resins, polyvinylpyrrolidone, acrylates, acrylamides, copolymers, and isododecane resins. Non-limiting examples of volatile silicone resins include polymethylsilsesquioxane, trimethylsiloxysilicate, polypropylsilsesquioxane, dimethicone, cyclopentasiloxane, dimethiconol crosspolymer, polysilicone-6, polysilicone-8, polysilicone-11, and polysilicone-14. Non-limiting examples of copolymers include acrylate copolymers, styrene / acrylate copolymers, acrylates / C12-22 alkyl methacrylate copolymers, acrylates / polytrimethylsiloxymethacrylate copolymers, polyvinylpyrrolidone / vinyl acetate (VP / VA) copolymers, VP / dimethiconyl acrylate / polycarbamyl / polyglycol esters, VP / dimethylaminoethyl methacrylate copolymers, VP / dimethylaminoethyl methacrylate / polycarbamyl polyglycol esters, VP / eicosene copolymers, VP / hexadecene copolymers, VP / methacrylamide / vinylimidazole copolymers, VP / polycarbamyl polyglycol esters, VP / VA copolymers, polyester-1, polyester-2, polyester-3, polyester-4, polyester-5, polyester-7, polyester-8, and polyester-10.
[0269] In some embodiments, the film-forming agent is present in an amount of about 0.1 w / w% to about 20 w / w% of the composition, e.g., about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 10 w / w%, about 0.1 w / w% to about 15 w / w%, about 15 w / w% to about 20 w / w%, about 10 w / w% to about 20 w / w%, about 5 w / w% to about 20 w / w%, or about 1 w / w% to about 20 w / w% of the composition. In some embodiments, the film forming agent is present in an amount of about 1 w / w% to about 10%, about 1 w / w% to about 5 w / w%, about 2 w / w% to about 7 w / w%, about 5% to about 10 w / w%, about 7 w / w% to about 12%, or about 10 w / w% to about 15 w / w% of the composition. In some embodiments, the film forming agent is present in an amount of about 4 w / w% to about 6 w / w% of the composition. In some embodiments, the film forming agent is present in an amount of about 6 w / w% to about 9 w / w% of the composition. In some embodiments, the film forming agent is present in an amount of about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w%, about 7 w / w%, about 7.5 w / w%, about 8 w / w%, about 8.5 w / w%, about 9 w / w%, about 9.5 w / w%, about 10 w / w%, about 11 w / w%, about 12 w / w%, about 13 w / w%, about 14 w / w%, about 15 w / w%, about 16 w / w%, about 17 w / w%, about 18 w / w%, about 19 w / w%, or about 20 w / w% of the composition. In some embodiments, the film forming agent is present in an amount of about 5% w / w of the composition. In some embodiments, the film forming agent is present in an amount of about 7.5% w / w of the composition.
[0270] In some embodiments, the film former is a combination of two or more film formers, such as polymethylsilsesquioxane, trimethylsiloxysilicate, polypropylsilsesquioxane, dimethicone, cyclopentasiloxane, dimethiconol crosspolymer, polysilicone-6, polysilicone-8, polysilicone-11, polysilicone-14, acrylates copolymer, styrene / acrylates copolymer, polyvinylpyrrolidone, acrylates / C12-22 alkyl methacrylate copolymer, acrylates / polytrimethylsiloxymethacrylate copolymer, polyvinylpyrrolidone / vinyl acetate (VP / VA) copolymer, VP / acrylates copolymer, polyvinylpyrrolidone / vinyl acetate (VP / VA) ... Two or more of methiconyl / polycarbamyl / polyglycol ester, VP / dimethylaminoethyl methacrylate copolymer, VP / dimethylaminoethyl methacrylate / polycarbamyl polyglycol ester, VP / eicosene copolymer, VP / hexadecene copolymer, VP / methacrylamide / vinylimidazole copolymer, VP / polycarbamyl polyglycol ester, VP / VA copolymer, polyester-1, polyester-2, polyester-3, polyester-4, polyester-5, polyester-7, polyester-8, polyester-10. In some embodiments, each film former is independently present in an amount of about 0.1 w / w% to about 15 w / w% of the composition. For example, about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 10 w / w%, about 10 w / w% to about 15 w / w%, about 5 w / w% to about 15 w / w%, or about 1 w / w% to about 15 w / w% of the composition. In some embodiments, each film-forming agent is present in an amount of about 0.1 w / w% to about 2 w / w%, about 0.5 w / w% to about 2%, about 1% to about 10 w / w%, about 1% to about 5%, about 2 w / w% to about 7 w / w%, about 5% to about 10 w / w%, about 7 w / w% to about 12%, or about 10 w / w% to about 15 w / w% of the composition. In some embodiments, the film forming agent is present in an amount of about 1 w / w% to about 10%, about 1 w / w% to about 5 w / w%, about 2 w / w% to about 7 w / w%, about 5% to about 10 w / w%, about 7 w / w% to about 12%, or about 10 w / w% to about 15 w / w% of the composition.For example, about 0.1 w / w%, about 0.25 w / w%, about 0.5 w / w%, about 0.75 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w% of the composition. , about 7 w / w%, about 7.5 w / w%, about 8 w / w%, about 8.5 w / w%, about 9 w / w%, about 9.5 w / w%, about 10 w / w%, about 11 w / w%, about 12 w / w%, about 13 w / w%, about 14 w / w%, about 15 w / w%, about 16 w / w%, about 17 w / w%, about 18 w / w%, about 19 w / w%, or about 20 w / w%.
[0271] In some embodiments, the film former is a combination of polymethylsilsesquioxane and acrylates / C12-22 alkyl methacrylate copolymer. In some embodiments, the polymethylsilsesquioxane is present in an amount of about 0.5 w / w% to about 10 w / w% of the composition, and the acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 0.5 w / w% to about 10 w / w% of the composition. For example, the polymethylsilsesquioxane is present in an amount of about 0.05 w / w% to about 1 w / w%, about 0.05 w / w% to about 5 w / w%, about 0.05 w / w% to about 8 w / w%, about 8 w / w% to about 10 w / w%, about 5 w / w% to about 10 w / w%, about 1 w / w% to about 10 w / w%, or about 1 w / w% to about 5 w / w% of the composition, and the acrylates The acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 0.05 w / w% to about 1 w / w%, about 0.05 w / w% to about 5 w / w%, about 0.05 w / w% to about 8 w / w%, about 8 w / w% to about 10 w / w%, about 5 w / w% to about 10 w / w%, about 1 w / w% to about 10 w / w%, or about 1 w / w% to about 5 w / w% of the composition. In some embodiments, the polymethylsilsesquioxane is present in an amount of about 1 w / w% to about 5 w / w% of the composition and the acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 1 w / w% to about 5 w / w% of the composition. In some embodiments, the polymethylsilsesquioxane is present in an amount of about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w%, about 7 w / w%, about 7.5 w / w%, about 8 w / w%, about 8.5 w / w%, about 9 w / w%, about 9.5 w / w%, or about 10 w / w% of the composition; The acrylate / C12-22 alkyl methacrylate copolymer is present in an amount of about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w%, about 7 w / w%, about 7.5 w / w%, about 8 w / w%, about 8.5 w / w%, about 9 w / w%, about 9.5 w / w%, or about 10 w / w% of the composition.In some embodiments, the polymethylsilsesquioxane is present in an amount of about 2 w / w% of the composition and the acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 3 w / w% of the composition.
[0272] In some embodiments, the film former is a combination of an acrylate copolymer, polyvinylpyrrolidone, and a styrene / acrylate copolymer, in some embodiments, the acrylate copolymer is present in an amount of about 0.1% to about 10% by weight of the composition, the polyvinylpyrrolidone is present in an amount of about 0.1% to about 10% by weight of the composition, and the styrene / acrylate copolymer is present in an amount of about 0.1% to about 10% by weight of the composition. In some embodiments, the acrylates copolymer is present in an amount of about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 8 w / w%, about 8 w / w% to about 10 w / w%, about 5 w / w% to about 10 w / w%, or about 1 w / w% to about 10 w / w% of the composition; and the polyvinylpyrrolidone is present in an amount of about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 10 w / w% of the composition. % to about 8 w / w%, about 8 w / w% to about 10 w / w%, about 5 w / w% to about 10 w / w%, or about 1 w / w% to about 10 w / w%, and the styrene / acrylate copolymer is present in an amount of about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 8 w / w%, about 8 w / w% to about 10 w / w%, about 5 w / w% to about 10 w / w%, or about 1 w / w% to about 10 w / w% of the composition. In some embodiments, the acrylate copolymer is present in an amount of about 0.1 w / w% to about 1 w / w% of the composition, the polyvinylpyrrolidone is present in an amount of about 0.5 w / w% to about 1.5 w / w% of the composition, and the styrene / acrylate copolymer is present in an amount of about 5 w / w% to about 7 w / w% of the composition.In some embodiments, the acrylate copolymer is present in an amount of about 0.1 w / w%, about 0.25 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, or about 5 w / w% of the composition and the polyvinylpyrrolidone is present in an amount of about 0.25 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, or about 5 w / w% of the composition. %, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w% or about 6 w / w% and the styrene / acrylate copolymer is present in an amount of about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, about 6 w / w%, about 6.5 w / w%, about 7 w / w%, about 7.5 w / w%, about 8 w / w%, about 8.5 w / w%, about 9 w / w%, about 9.5 w / w% or about 10 w / w% of the composition. In some embodiments, the acrylate copolymer is present in an amount of about 0.25 w / w% of the composition, the polyvinylpyrrolidone is present in an amount of about 1 w / w% of the composition, and the styrene / acrylate copolymer is present in an amount of about 6 w / w% of the composition.
[0273] In some embodiments, the composition can further comprise an amine, non-limiting examples of which include arginine, alanine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, propyne, serine, threonine, tryptophan, tyrosine, valine, δ-aminolevulinic acid, 4-aminobenzoic acid, and γ-aminobutyric acid.
[0274] In some embodiments, the amine is present in an amount of about 0.01 w / w% to about 1 w / w% of the composition, e.g., about 0.01 w / w% to about 0.05 w / w%, about 0.01 w / w% to about 0.1 w / w%, about 0.01 w / w% to about 0.5 w / w%, about 0.5 w / w% to about 1 w / w%, about 0.1 w / w% to about 1 w / w%, about 0.05 w / w% to about 1 w / w%, or about 0.1 w / w% to about 1 w / w% of the composition. In some embodiments, the amine is present in an amount of about 0.02 w / w% of the composition.
[0275] In some embodiments, the composition can further include a temporary coloring agent. In some embodiments, the temporary coloring agent can be used to indicate what a semi-permanent tattoo will look like, to outline the placement of the semi-permanent tattoo by the applicator, and to provide a logo, e.g., a brand logo, that does not transfer to the skin, or that transfers but exists for a short period of time compared to the duration of the semi-permanent tattoo. In some embodiments, the temporary coloring agent can be used to provide a semi-permanent tattoo that changes appearance over time, e.g., the duration of the semi-permanent coloring agent and the duration of the temporary coloring agent.Non-limiting examples of temporary colorants include iron oxide black (Fe3O4), iron oxide (FeO), carbon, logwood, ochre, cinnabar (HgS), cadmium red (CdSe), iron(III) oxide (Fe2O3), naphthol-AS pigment, disazodiarylide, disazopyrazolone, cadmium selenosulfide, cadmium yellow (CdS, CdZnS), curcuma yellow, chrome yellow (PbCrO4), disazodiarylide, chromium oxide (Cr2O3), malachite [Cu2(CO3)(OH)2], fluoride, fluorite ... Ferrocyanide, Ferricyanide, Lead chromate, Monoazo pigments, Cu / Al phthalocyanine, Cu phthalocyanine, Azure blue, Cobalt blue, Cu-phthalocyanine, Manganese violet (manganese ammonium pyrophosphate), Aluminum salts, Quinacridone, Dioxazine / Carbazole, Lead white (lead carbonate), Titanium dioxide (TiO2), Barium sulfate (BaSO4), Zinc oxide, Anthraquinone dyes and derivatives, Annatto, Caramel, β-carotene, Bismuth citrate, Copper disodium EDTA Thorium, sodium copper chlorophyllin potassium, dihydroxyacetone, bismuth oxychloride, guaiazulene, henna, ferric ammonium ferrocyanide, ferric ferrocyanide, chromium hydroxide green, chromium oxide green, guanine, lead acetate, pyrophyllite, mica, silver, titanium dioxide, aluminum powder, bronze powder, copper powder, ultramarine, manganese violet, zinc oxide, luminescent zinc sulfide, D&C Black No. 2 and No. 3, FD&C Blue No. 1 (e.g., Acid Blue 9), D D&C Blue No. 4, D&C Brown No. 1, FD&C Green No. 3, D&C Green No. 5, 6 and 8, D&C Orange No. 4, 5, 10 and 11, FD&C Red No. 4, D&C Red No. 6, 7, 17, 21, 22, 27, 28, 30, 32, 33, 34, 36 and 40, D&C Violet No. 2, Ext. D&C Violet No. 2, FD&C Yellow No. 5 and 6, D&C Yellow No. 7, 8, 10 and 11, and Ext. D&C Yellow No. 7. In some embodiments, the temporary colorant does not contain an amine group. In some embodiments, the temporary colorant is ultramarine blue.
[0276] In some embodiments, the temporary colorant is present in an amount of about 0.01 w / w% of the composition, hi some embodiments, the temporary colorant is present in an amount of about 0.001 w / w% to about 0.01 w / w% of the composition.
[0277] In some embodiments, the composition may further comprise a preservative. As used herein, "preservative" refers to an agent that protects against decay, discoloration, and / or spoilage. Non-limiting examples of preservatives include ascorbic acid, ascorbate, palmitate, citric acid, benzoate, benzoic acid, propionate, propionic acid, sorbate, sorbic acid, salicylic acid, salicylates, hexa-2,4-dienoic acid, hexa-2,4-dienoate, formaldehyde, formaldehyde-releasing agents, formic acid and its salts, 3-acetyl-6-methylpyran-2,4-(3H)-dione and its salts, 3,3'-dibromo-4,4'-hexamethylenedioxydibenzamidine and its salts, thiomersal, phenylmercury salts, undec-10-enoic acid and its salts, 1,3-bis(2-ethylhexyl)hexahydrazine ... 5-bromo-5-nitro-1,3-dioxane, bronopol, 2,4-dichlorobenzyl alcohol, 1-(4-chlorophenyl)-3-(3,4-dichlorophenyl)urea, chlorocresol, chloroxylenol, 5-chloro-2-(2,4-dichlorophenoxy)phenol, N,N''-methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea], polyaminopropyl biguanide, methenamine, quaternium-15, climbazole, DMDM hydantoin, benzyl alcohol, 1-hydroxy-4-methyl-6-(2,4,4-Trimethylpentyl)-2-pyridone, piroctone olamine, bromochlorophene, o-cymen-5-ol, chlorophene, chloroacetamine, methylchloroisothiazolinone, methylisothiazolinone, phenoxyisopropanol, chlorhexidine, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dihydrochloride, dimethyloxazolidine, behentrimonium chloride, cetrimonium bromide, cetrimonium chloride, lautrimonium bromide, lautrimonium chloride, steartrimonium bromide, steartrimonium chloride, diazolidinyl urea, hexamidine, hexamidine diisethionate, hexamidine paraben, glutaral, 7-ethylbicyclooxazolidine, chlorphenesin, sodium hydroxymethylglycine, silver chloride , benzethonium chloride, benzalkonium chloride, benzalkonium bromide, benzalkonium saccharinate, benzyl hemiformal, iodopropynyl butylcarbamate, biphenyl-2-ol and its salts, zinc pyrithione, erythorbate, nitrous acid, ethylenediaminetetraacetic acid (EDTA), sodium lignosulfonate, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), caprylic acid, dilauryl thiodipropionate, erythorbic acid, guaiac butter, methylparaben, sulfite, bisulfite, metabisulfite, propyl galactose, propylparaben, stannous chloride, sulfur dioxide, thiodipropionic acid, isothiazolin, paraben, phenoxyethanol, ethylhexylglycerin, glycol, and tocopherol.
[0278] In some embodiments, the preservative is present in an amount of about 0.05 w / w% to about 10 w / w% of the composition, for example, about 0.05 w / w% to about 0.1 w / w%, about 0.05 w / w% to about 0.5 w / w%, about 0.05 w / w% to about 1 w / w%, about 0.05 w / w% to about 2 w / w%, about 0.05 w / w% to about 3 w / w%, about 0.05 w / w% to about 4 w / w%, about 0.05 w / w% to about 5 w / w%, about 0.05 w / w% to about 6 w / w%, about 0.05 w / w% to about 7 w / w%, about 0.05 w / w% to about 8 w / w%, about 0.0 5 w / w% to about 9 w / w%, about 9 w / w% to about 10 w / w%, about 8 w / w% to about 10 w / w%, about 7 w / w% to about 10 w / w%, about 6 w / w% to about 10 w / w%, about 5 w / w% to about 10 w / w%, about 4 w / w% to about 10 w / w%, about 3 w / w% to about 10 w / w%, about 2 w / w% to about 10 w / w%, about 1 w / w% to about 10 w / w%, about 0.5 w / w% to about 10 w / w%, or about 0.1 w / w% to about 10 w / w%. In some embodiments, the preservative is present in an amount of about 1 w / w% to about 5 w / w% of the composition. In some embodiments, the preservative is present in an amount of from about 0.1 w / w% to about 2 w / w%, 0.5 w / w% to about 2.5 w / w%, from about 1 w / w% to about 3 w / w%, from about 1.5 w / w% to about 3.5 w / w%, from about 2 w / w% to about 4 w / w%, from about 2.5 w / w% to about 4.5 w / w%, or from about 3 w / w% to about 5 w / w% of the composition. In some embodiments, the preservative is present in an amount of from about 0.5 w / w% to about 1.5 w / w%, from about 0.5 w / w% to about 1.0 w / w%, from about 1.5 w / w% to about 2 w / w%, from about 1 w / w% to about 2 w / w%, from about 0.5 w / w% to about 2 w / w%, or from about 0.8 w / w% to about 2 w / w% of the composition. For example, about 0.05 w / w% to about 0.4 w / w%, about 0.05 w / w% to about 0.2 w / w%, about 0.2 w / w% to about 0.5 w / w%, about 0.15 w / w% to about 0.25 w / w%, or about 0.1 w / w% to about 0.3 w / w% of the composition. In some embodiments, the preservative is present in an amount of about 0.01 w / w%, about 0.05 w / w%, about 0.1 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, or about 6 w / w% of the composition.In some embodiments, the preservative is present in an amount of about 3% w / w of the composition. In some embodiments, the preservative is present in an amount of about 1% w / w of the composition.
[0279] In some embodiments, the preservative is a combination of two or more preservatives, such as two or more of ascorbic acid, ascorbate, palmitate, citric acid, benzoate, benzoic acid, propionate, propionic acid, sorbate, sorbic acid, salicylic acid, salicylates, hexa-2,4-dienoic acid, hexa-2,4-dienoate, formaldehyde, formaldehyde-releasing agents, formic acid and its salts, 3-acetyl-6-methylpyran-2,4-(3H)-dione and its salts, 3,3'-dibromo-4,4'-hexamethylenedioxydibenzamidine and its salts, thiomersal, phenylmercury salts, undecane, methylmercury salts ... Carboxylic acid and its salts, 1,3-bis(2-ethylhexyl)hexahydro-5-methyl-5-pyrimidine, 5-bromo-5-nitro-1,3-dioxane, bronopol, 2,4-dichlorobenzyl alcohol, 1-(4-chlorophenyl)-3-(3,4-dichlorophenyl)urea, chlorocresol, chloroxylenol, 5-chloro-2-(2,4-dichlorophenoxy)phenol, N,N''-methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea], polyamino Propyl biguanide, methenamine, quaternium-15, climbazole, DMDM hydantoin, benzyl alcohol, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-pyridone, piroctone olamine, bromochlorophene, o-cymen-5-ol, chlorophene, chloroacetamine, methylchloroisothiazolinone, methylisothiazolinone, phenoxyisopropanol, chlorhexidine, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dichloride Benzyl alcohol, dimethyl oxazolidine, behentrimonium chloride, cetrimonium bromide, cetrimonium chloride, lautrimonium bromide, lautrimonium chloride, steartrimonium bromide, steartrimonium chloride, diazolidinyl urea, hexamidine, hexamidine diisethionate, hexamidine paraben, glutaral, 7-ethylbicyclooxazolidine, chlorphenesin, sodium hydroxymethylglycine, silver chloride, benzethonium chloride, benzalkonium chloride, benzalkonium bromide, benzalkonium saccharinate,benzyl hemiformal, iodopropynyl butylcarbamate, biphenyl-2-ol and its salts, zinc pyrithione, erythorbate, nitrous acid, ethylenediaminetetraacetic acid (EDTA), sodium lignosulfonate, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), caprylic acid, dilauryl thiodipropionate, erythorbic acid, guaiac acid, methylparaben, sulfite, bisulfite, metabisulfite, propyl galactose, propylparaben, stannous chloride, sulfur dioxide, thiodipropionic acid, isothiazolin, paraben, phenoxyethanol, ethylhexylglycerin, glycol, and tocopherol. In some embodiments, each preservative is independently present in an amount of about 0.01% to about 8% by weight of the composition. For example, about 0.01 w / w% to about 0.05 w / w%, about 0.01 w / w% to about 0.1 w / w%, about 0.01 w / w% to about 0.5 w / w%, about 0.01 w / w% to about 1 w / w%, about 0.01 w / w% to about 2 w / w%, about 0.01 w / w% to about 3 w / w%, about 0.01 w / w% to about 4 w / w%, about 0.01 w / w% to about 5 w / w%, about 0.01 w / w% about 6 w / w%, about 0.01 w / w% to about 7 w / w%, about 7 w / w% to about 8 w / w%, about 6 w / w% to about 8 w / w%, about 5 w / w% to about 8 w / w%, about 4 w / w% to about 8 w / w%, about 3 w / w% to about 8 w / w%, about 2 w / w% to about 8 w / w%, about 1 w / w% to about 8 w / w%, about 0.5 w / w% to about 8 w / w%, or about 0.1 w / w% to about 8 w / w%. In some embodiments, each preservative is independently present in an amount of about 0.05 w / w% to about 8 w / w% of the composition. For example, about 0.05 w / w% to about 0.1 w / w%, about 0.05 w / w% to about 0.5 w / w%, about 0.05 w / w% to about 1 w / w%, about 0.05 w / w% to about 2 w / w%, about 0.05 w / w% to about 3 w / w%, about 0.05 w / w% to about 4 w / w%, about 0.05 w / w% to about 5 w / w%, About 0.05 w / w% to about 6 w / w%, about 0.05 w / w% to about 7 w / w%, about 7 w / w% to about 8 w / w%, about 6 w / w% to about 8 w / w%, about 5 w / w% to about 8 w / w%, about 4 w / w% to about 8 w / w%, about 3 w / w% to about 8 w / w%, about 2 w / w% to about 8 w / w%, about 1 w / w% to about 8 w / w%,about 0.5 w / w% to about 8 w / w%, about 0.1 w / w% to about 8 w / w%. In some embodiments, each preservative is independently present in an amount of about 1 w / w% to about 5 w / w% of the composition. In some embodiments, each preservative is independently present in an amount of about 0.025 w / w% to about 0.1 w / w%, about 0.1 w / w% to about 2 w / w%, 0.5 w / w% to about 2.5 w / w%, about 1 w / w% to about 3 w / w%, about 1.5 w / w% to about 3.5 w / w%, about 2 w / w% to about 4 w / w%, about 2.5 w / w% to about 4.5 w / w%, or about 3 w / w% to about 5 w / w% of the composition. In some embodiments, each preservative is independently present in an amount of about 0.5 w / w% to about 1.5 w / w%, about 0.5 w / w% to about 1.0 w / w%, about 1.5 w / w% to about 2 w / w%, about 1 w / w% to about 2 w / w%, about 0.5 w / w% to about 2 w / w%, or about 0.8 w / w% to about 2 w / w% of the composition. In some embodiments, each preservative is independently present in an amount of about 0.01 w / w%, about 0.05 w / w%, about 0.1 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w%, or about 6 w / w% of the composition.
[0280] In some embodiments, the preservative includes a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the preservative further comprises 1,2-hexanediol (e.g., the preservative is a combination of phenoxyethanol, ethylhexylglycerin, and 1,2-hexanediol). In some embodiments, the preservative further comprises EDTA (e.g., the preservative is a combination of phenoxyethanol, ethylhexylglycerin, and EDTA). In some embodiments, the phenoxyethanol is present in an amount between about 0.1 w / w% and about 5 w / w% of the composition, the ethylhexylglycerin is present in an amount between about 0.01 w / w% and about 3 w / w% of the composition, and the 1,2-hexanediol is present in an amount between about 0.1 w / w% and about 5 w / w% of the composition.In some embodiments, phenoxyethanol is from about 0.1 w / w% to about 0.5 w / w%, from about 0.1 w / w% to about 1 w / w%, from about 0.1 w / w% to about 2 w / w%, from about 0.1 w / w% to about 3 w / w%, from about 0.1 w / w% to about 4 w / w%, from about 4 w / w% to about 5 w / w%, from about 3 w / w% to about 5 w / w%, from about 2 w / w% to about 5 w / w%, from about 1 w / w% to about 5 w / w%, from about 0.5 w / w% to about 5 w / w%, from about 0.5 w / w% to about 1 w / w%, or about 0.5 w / w% to about 0.5 w / w% ethylhexylglycerin is present in an amount of about 0.01 w / w% to about 0.1 w / w%, about 0.01 w / w% to about 0.5 w / w%, 0.01 w / w% to about 1 w / w%, about 0.01 w / w% to about 2 w / w%, about 2 w / w% to about 3 w / w%, about 1 w / w% to about 3 w / w%, about 0. the 1,2-hexanediol is present in an amount of from about 0.1 w / w% to about 1 w / w%, from about 0.05 w / w% to about 3 w / w%, from about 0.05 w / w% to about 0.15 w / w%, from about 0.05 w / w% to about 1 w / w%, from 0.5 w / w% to about 2.5 w / w%, from about 1 w / w% to about 3 w / w%, from about 1.5 w / w% to about 3.5 w / w%, from about 2 w / w% to about 4 w / w%, from about 2.5 w / w% to about 4.5 w / w%, or from about 3 w / w% to about 5 w / w%, the 1,2-hexanediol being present in an amount of from about 0.1 w / w% to about 1 w / w%, It is present in an amount of about 0.1 w / w% to about 2 w / w%, about 0.1 w / w% to about 3 w / w%, about 0.1 w / w% to about 4 w / w%, about 4 w / w% to about 5 w / w%, about 3 w / w% to about 5 w / w%, about 2 w / w% to about 5 w / w%, about 1 w / w% to about 5 w / w%, 0.5 w / w% to about 2.5%, about 1 w / w% to about 3 w / w%, about 1.5 w / w% to about 3.5 w / w%, about 2 w / w% to about 4 w / w%, about 2.5 w / w% to about 4.5 w / w%, or about 3 w / w% to about 5 w / w%.In some embodiments, phenoxyethanol is present in an amount of about 0.5 w / w%, about 0.6 w / w%, about 0.7 w / w%, about 0.8 w / w%, about 0.9 w / w%, about 1 w / w%, about 1.1 w / w%, about 1.2 w / w%, about 1.3 w / w%, about 1.4 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, or about 4.5 w / w% of the composition and ethylhexylglycerin is present in an amount of about 0.01 w / w%, about 0.05 w / w%, about 0.06 w / w%, about 0.07 w / w%, about 0.08 w / w%, about 1.1 w / w%, about 1.2 w / w%, about 1.3 w / w%, about 1.4 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, or about 4.5 w / w% of the composition. w / w%, about 0.09 w / w%, about 0.1 w / w%, about 0.12 w / w%, about 0.13 w / w%, about 0.14 w / w%, about 0.15 w / w%, about 0.25 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w% or about 2.5 w / w% and 1,2-hexanediol is present in an amount of about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, about 4.5 w / w%, about 5 w / w%, about 5.5 w / w% or about 6 w / w% of the composition.
[0281] In some embodiments, the preservative further comprises EDTA (e.g., the preservative is a combination of phenoxyethanol, ethylhexylglycerin, and EDTA). In some embodiments, the phenoxyethanol is present in an amount between about 0.1% and about 5% w / w of the composition, the ethylhexylglycerin is present in an amount between about 0.01% and about 3% w / w of the composition, and the EDTA is present in an amount between about 0.01% and about 2% w / w of the composition. In some embodiments, phenoxyethanol is from about 0.1 w / w% to about 0.5 w / w%, from about 0.1 w / w% to about 1 w / w%, from about 0.1 w / w% to about 2 w / w%, from about 0.1 w / w% to about 3 w / w%, from about 0.1 w / w% to about 4 w / w%, from about 4 w / w% to about 5 w / w%, from about 3 w / w% to about 5 w / w%, from about 2 w / w% to about 5 w / w%, from about 1 w / w% to about 5 w / w%, from about 0.5 w / w% to about 5 w / w%, or about 0.5 w / w% and ethylhexylglycerin is present in an amount of about 0.01 w / w% to about 0.1 w / w%, about 0.01 w / w% to about 0.5 w / w%, about 1 w / w% to about 2.5 w / w%, about 1 w / w% to about 3 w / w%, about 1.5 w / w% to about 3.5 w / w%, about 2 w / w% to about 4 w / w%, or about 2.5 w / w% to about 4.5 w / w% of the composition. % to about 3 w / w%, about 1 w / w% to about 3 w / w%, about 0.1 w / w% to about 3 w / w%, about 0.05 w / w% to about 3 w / w%, about 0.05 w / w% to about 0.15 w / w%, about 0.05 w / w% to about 1 w / w%, 0.5 w / w% to about 2.5 w / w%, about 1 w / w% to about 3 w / w%, about 1.5 w / w% to about 3.5 w / w%, about 2 w / w% to about 4 w / w%, about 2.5 w / w% to about 4.5 w / w%, or about 3 w / w% to about 5 w / w% and EDTA is present in an amount of about 0.01 w / w% to about 0.05 w / w%, about 0.01 w / w% to about 0.1 w / w%, about 0.01 w / w% to about 0.5 w / w%, about 0.01 w / w% to about 1 w / w%, about 0.1 w / w% to about 1.5 w / w%, about 1.5 w / w% to about 2 w / w%, about 1 w / w% to about 2 w / w%, about 0.5 w / w% to about 2 w / w%, about 0.1 w / w% to about 2%, or about 0.05 w / w% to about 2 w / w% of the composition.In some embodiments, phenoxyethanol is present in an amount of about 0.5 w / w%, about 0.6 w / w%, about 0.7 w / w%, about 0.8 w / w%, about 0.9 w / w%, about 1 w / w%, about 1.1 w / w%, about 1.2 w / w%, about 1.3 w / w%, about 1.4 w / w%, about 1.5 w / w%, about 2 w / w%, about 2.5 w / w%, about 3 w / w%, about 3.5 w / w%, about 4 w / w%, or about 4.5 w / w% of the composition and ethylhexylglycerin is present in an amount of about 0.01 w / w%, about 0.05 w / w%, about 0.0 6 w / w%, about 0.07 w / w%, about 0.08 w / w%, about 0.09 w / w%, about 0.1 w / w%, about 0.12 w / w%, about 0.13 w / w%, about 0.14 w / w%, about 0.15 w / w%, about 0.25 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w%, about 2 w / w% or about 2.5 w / w% and EDTA is present in an amount of about 0.01 w / w%, about 0.05 w / w%, about 0.1 w / w%, about 0.5 w / w%, about 1 w / w%, about 1.5 w / w% or about 2 w / w% of the composition.
[0282] In some embodiments, the phenoxyethanol and ethylhexylglycerin are present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin (eg, EUXYL® PE9010).
[0283] In some embodiments, the EDTA is disodium EDTA.
[0284] In some embodiments, the preservative further comprises sodium lignosulfonate.
[0285] In some embodiments, the ink composition may further include one or more temporary colorants. In some embodiments, the one or more temporary colorants are present in an amount of about 0.1 w / w% to about 10 w / w% of the composition. For example, about 0.1 w / w% to about 1 w / w%, about 0.1 w / w% to about 5 w / w%, about 0.1 w / w% to about 8 w / w%, about 8 w / w% to about 10 w / w%, about 5 w / w% to about 10 w / w%, or about 1 w / w% to about 10 w / w% of the composition. In some embodiments, the one or more temporary colorants are present in an amount of about 2 w / w% to about 3 w / w% of the composition. In some embodiments, the one or more temporary colorants are present in an amount of about 2.5 w / w% of the composition.In some embodiments, the one or more temporary colorants are iron oxide black (Fe3O4), iron oxide (FeO), carbon, logwood, ochre, cinnabar (HgS), cadmium red (CdSe), iron(III) oxide (Fe2O3), naphthol-AS pigment, disazodiarylide, disazopyrazolone, cadmium selenosulfide, cadmium yellow (CdS, CdZnS), curcuma yellow, chrome yellow (PbCrO4), disazodiarylide, chromium oxide (Cr2O3), malachite [Cu2(CO3)(OH) 2], Ferrocyanide, Ferricyanide, Lead chromate, Monoazo pigments, Cu / Al phthalocyanine, Cu phthalocyanine, Azure blue, Cobalt blue, Cu-phthalocyanine, Manganese violet (manganese ammonium pyrophosphate), Aluminum salts, Quinacridone, Dioxazine / Carbazole, Lead white (lead carbonate), Titanium dioxide (TiO2), Barium sulfate (BaSO4), Zinc oxide, Anthraquinone dyes and derivatives, Annatto, Caramel, β-carotene, Bismuth citrate, Copper disodium EDTA Thorium, Sodium Copper Chlorophyllin Potassium, Dihydroxyacetone, Bismuth Oxychloride, Guaiazulene, Henna, Ferric Ammonium Ferrocyanide, Ferric Ferrocyanide, Chromium Hydroxide Green, Chromium Oxide Green, Guanine, Lead Acetate, Pyrophyllite, Mica, Silver, Titanium Dioxide, Aluminum Powder, Bronze Powder, Copper Powder, Ultramarine, Manganese Violet, Zinc Oxide, Luminescent Zinc Sulfide, D&C Black No. 2 and No. 3, FD&C Blue No. 1 (e.g., Acid Blue 9), D&C Blue No. 2, D&C Blue No. 3, D&C Blue No. 4, D&C Blue No. 5, D&C Blue No. 6, D&C Blue No. 7, D&C Blue No. 8, D&C Blue No. 9, D&C Blue No. 10, D&C Blue No. 11, D&C Blue No. 12, D&C Blue No. 13, D&C Blue No. 14, D&C Blue No. 15, D&C Blue No. 16, D&C Blue No. 17, D&C Blue No. 18, D&C Blue No. 19, D&C Blue No. 21, D&C Blue No. 22, D&C Blue No. 23, D&C Blue No. 24, D&C Blue No. 25, D&C Blue No. 26, D&C Blue No. 27, D&C Blue No. 28, D&C Blue No. 29, D&C Blue No. 31, D&C Blue No. 32, D&C Blue No. 33, D&C Blue No. 34, D&C Blue No. 35, D&C Blue No. 36, D&C Blue No. 37, D&C Blue No. 3 D&C Blue No. 4, D&C Brown No. 1, FD&C Green No. 3, D&C Green No. 5, 6 and 8, D&C Orange No. 4, 5, 10 and 11, FD&C Red No. 4, D&C Red No. 6, 7, 17, 21, 22, 27, 28, 30, 32, 33, 34, 36 and 40, D&C Violet No. 2, Ext. D&C Violet No. 2, FD&C Yellow No. 5 and 6, D&C Yellow No. 7, 8, 10 and 11, and Ext. D&C Yellow No. 7. In some embodiments, the temporary colorant does not contain an amine group. In some embodiments, the temporary colorant is D&C Black No. 2.
[0286] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 10% to about 20% w / w of the composition; a solvent present in an amount of about 65 w / w% to about 80 w / w% of the composition; and a thickening agent present in an amount of about 0.01 w / w% to about 0.3 w / w% of the composition. In some embodiments, the solvent is a combination of water and ethanol. In some such embodiments, the water is present in an amount of about 25 w / w% to about 30 w / w% of the composition, and the ethanol is present in an amount of about 40 w / w% to about 50 w / w% of the composition. In some embodiments, the thickening agent is a combination of hydroxyethyl cellulose and xanthan gum. In some such embodiments, the hydroxyethyl cellulose is present in an amount of about 0.01 w / w% to about 0.1 w / w% of the composition, and the xanthan gum is present in an amount of about 0.01 w / w% to about 0.1 w / w% of the composition.
[0287] In some embodiments, the composition further comprises a humectant present in an amount of about 1% to about 10% w / w of the composition, hi some embodiments, the humectant is glycerol.
[0288] In some embodiments, the composition further comprises a film former present in an amount of about 0.1% to about 10% by weight of the composition. In some embodiments, the film former is a combination of polymethylsilsesquioxane and acrylates / C12-22 alkyl methacrylate copolymer. In some such embodiments, the polymethylsilsesquioxane is present in an amount of about 1% to about 5% by weight of the composition, and the acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 1% to about 5% by weight of the composition.
[0289] In some embodiments, the composition further comprises a preservative present in an amount of about 0.1 w / w% to about 5 w / w% of the composition. In some embodiments, the preservative includes a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the preservative includes a combination of phenoxyethanol, ethylhexylglycerin, and 1,2-hexanediol. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present together in the composition in an amount of about 0.1 w / w% to about 2 w / w% of the composition. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin. In some such embodiments, the 1,2-hexanediol is present in an amount of about 1 w / w% to about 3 w / w% of the composition.
[0290] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 10% to about 20% w / w of the composition; a solvent present in an amount of about 65 w / w% to about 80 w / w% of the composition; and a humectant present in an amount of about 1 w / w% to about 10 w / w% of the composition. In some embodiments, the solvent is a combination of water and ethanol. In some embodiments, water is present in an amount of about 25 w / w% to about 30 w / w% of the composition. In some such embodiments, ethanol is present in an amount of about 40 w / w% to about 50 w / w% of the composition. In some embodiments, the humectant is glycerol.
[0291] In some embodiments, the composition further comprises a thickening agent present in an amount of about 0.01% to about 0.3% w / w of the composition. In some embodiments, the thickening agent is a combination of hydroxyethyl cellulose and xanthan gum. In some such embodiments, the hydroxyethyl cellulose is present in an amount of about 0.01% to about 0.1% w / w of the composition, and the xanthan gum is present in an amount of about 0.01% to about 0.1% w / w of the composition.
[0292] In some embodiments, the composition further comprises a film-forming agent present in an amount of about 0.1% to about 10% by weight of the composition. In some embodiments, the film-forming agent is a combination of polymethylsilsesquioxane and acrylates / C12-22 alkyl methacrylate copolymer. In some such embodiments, the polymethylsilsesquioxane is present in an amount of about 1% to about 5% by weight of the composition, and the acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 1% to about 5% by weight of the composition. In some embodiments, the composition further comprises a humectant present in an amount of about 1% to about 10% by weight of the composition. In some embodiments, the humectant is glycerol.
[0293] In some embodiments, the composition further comprises a preservative present in an amount of about 0.1 w / w% to about 5 w / w% of the composition. In some embodiments, the preservative includes a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the preservative includes a combination of phenoxyethanol, ethylhexylglycerin, and 1,2-hexanediol. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present together in the composition in an amount of about 0.1 w / w% to about 2 w / w% of the composition. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin. In some such embodiments, the 1,2-hexanediol is present in an amount of about 1 w / w% to about 3 w / w% of the composition.
[0294] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 12% to about 16% by weight of the composition; a solvent present in an amount of about 72 w / w% to about 76 w / w% of the composition; and a thickening agent present in an amount of about 0.05 w / w% to about 0.20 w / w% of the composition. In some embodiments, the solvent is a combination of water and ethanol. In some such embodiments, the water is present in an amount of about 25 w / w% to about 30 w / w% of the composition, and the ethanol is present in an amount of about 45 w / w% to about 47 w / w% of the composition. In some embodiments, the thickening agent is a combination of hydroxyethyl cellulose and xanthan gum. In some such embodiments, the hydroxyethyl cellulose is present in an amount of about 0.04 w / w% to about 0.08 w / w% of the composition, and the xanthan gum is present in an amount of about 0.04 w / w% to about 0.08 w / w% of the composition.
[0295] In some embodiments, the composition further comprises a film former present in an amount of about 4% to about 6% w / w of the composition. In some embodiments, the film former is a combination of polymethylsilsesquioxane and acrylates / C12-22 alkyl methacrylate copolymer. In some such embodiments, the polymethylsilsesquioxane is present in an amount of about 1% to about 5% w / w of the composition, and the acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 1% to about 5% w / w of the composition.
[0296] In some embodiments, the composition further comprises a humectant present in an amount of about 2% to about 6% w / w of the composition, hi some embodiments, the humectant is glycerol.
[0297] In some embodiments, the composition further comprises a preservative present in an amount of 2% to about 4% w / w of the composition. In some embodiments, the preservative includes a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the preservative includes a combination of phenoxyethanol, ethylhexylglycerin, and 1,2-hexanediol. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present together in the composition in an amount of about 0.1% to about 2% w / w of the composition. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin. In some such embodiments, the 1,2-hexanediol is present in an amount of about 1% to about 3% w / w of the composition.
[0298] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 12% to about 16% by weight of the composition; a solvent present in an amount of about 72 w / w% to about 76 w / w% of the composition; and a humectant present in an amount of about 2 w / w% to about 6 w / w% of the composition. In some embodiments, the solvent is a combination of water and ethanol. In some such embodiments, the water is present in an amount of about 25 w / w% to about 30 w / w% of the composition, and the ethanol is present in an amount of about 45 w / w% to about 47 w / w% of the composition. In some embodiments, the humectant is glycerol.
[0299] In some embodiments, the composition further comprises a thickening agent present in an amount of about 0.05% to about 0.20% w / w of the composition. In some embodiments, the thickening agent is a combination of hydroxyethyl cellulose and xanthan gum. In some such embodiments, the hydroxyethyl cellulose is present in an amount of about 0.04% to about 0.08% w / w of the composition, and the xanthan gum is present in an amount of about 0.04% to about 0.08% w / w of the composition.
[0300] In some embodiments, the composition further comprises a film former present in an amount of about 4% to about 6% w / w of the composition. In some embodiments, the film former is a combination of polymethylsilsesquioxane and acrylates / C12-22 alkyl methacrylate copolymer. In some such embodiments, the polymethylsilsesquioxane is present in an amount of about 1% to about 5% w / w of the composition, and the acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 1% to about 5% w / w of the composition.
[0301] In some embodiments, the composition further comprises a preservative present in an amount of 2% to about 4% w / w of the composition. In some embodiments, the preservative includes a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the preservative includes a combination of phenoxyethanol, ethylhexylglycerin, and 1,2-hexanediol. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present together in the composition in an amount of about 0.1% to about 2% w / w of the composition. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin. In some such embodiments, the 1,2-hexanediol is present in an amount of about 1% to about 3% w / w of the composition.
[0302] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 14% w / w of the composition; A solvent present in an amount of about 74 w / w% of the composition; and a thickening agent present in an amount of about 0.12 w / w% of the composition. In some embodiments, the solvent is a combination of water and ethanol. In some such embodiments, the water is present in an amount of about 28 w / w% of the composition and the ethanol is present in an amount of about 46 w / w% of the composition. In some embodiments, the thickening agent is a combination of hydroxyethyl cellulose and xanthan gum. In some embodiments, the hydroxyethyl cellulose is present in an amount of about 0.06 w / w% of the composition and the xanthan gum is present in an amount of about 0.06 w / w% of the composition.
[0303] In some embodiments, the composition further comprises a film-forming agent present in an amount of about 5 w / w% of the composition. In some embodiments, the film-forming agent is a combination of polymethylsilsesquioxane and acrylates / C12-22 alkyl methacrylate copolymer. In some such embodiments, the polymethylsilsesquioxane is present in an amount of about 2 w / w% of the composition and the acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 3 w / w% of the composition. In some embodiments, the composition further comprises a humectant present in an amount of about 4 w / w% of the composition. In some embodiments, the humectant is glycerol.
[0304] In some embodiments, the composition further comprises a preservative present in an amount of 3 w / w% of the composition. In some embodiments, the preservative comprises a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the preservative comprises a combination of phenoxyethanol, ethylhexylglycerin, and 1,2-hexanediol. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present together in the composition in an amount of about 1 w / w% of the composition. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin. In some such embodiments, the 1,2-hexanediol is present in an amount of about 2 w / w% of the composition.
[0305] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 14% w / w of the composition; A solvent present in an amount of about 74 w / w% of the composition; and a humectant present in an amount of about 4 w / w% of the composition. In some embodiments, the solvent is a combination of water and ethanol. In some such embodiments, the water is present in an amount of about 28 w / w% of the composition, and the ethanol is present in an amount of about 46 w / w% of the composition. In some embodiments, the humectant is glycerol.
[0306] In some embodiments, the composition further comprises a thickening agent present in an amount of about 0.12 w / w% of the composition. In some embodiments, the thickening agent is a combination of hydroxyethyl cellulose and xanthan gum. In some such embodiments, the hydroxyethyl cellulose is present in an amount of about 0.06 w / w% of the composition, and the xanthan gum is present in an amount of about 0.06 w / w% of the composition.
[0307] In some embodiments, the composition further comprises a film former present in an amount of about 5 w / w% of the composition. In some embodiments, the film former is a combination of polymethylsilsesquioxane and acrylates / C12-22 alkyl methacrylate copolymer. In some such embodiments, the polymethylsilsesquioxane is present in an amount of about 2 w / w% of the composition and the acrylates / C12-22 alkyl methacrylate copolymer is present in an amount of about 3 w / w% of the composition.
[0308] In some embodiments, the composition further comprises a preservative present in an amount of 3 w / w% of the composition. In some embodiments, the preservative comprises a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the preservative comprises a combination of phenoxyethanol, ethylhexylglycerin, and 1,2-hexanediol. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present together in the composition in an amount of about 1 w / w% of the composition. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin. In some such embodiments, the 1,2-hexanediol is present in an amount of about 2 w / w% of the composition.
[0309] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 5% to about 15% w / w of the composition; a solvent present in an amount of about 65 w / w% to about 85 w / w% of the composition; and a film forming agent present in an amount of about 5 w / w% to about 10 w / w% of the composition.
[0310] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 9% to about 11% w / w of the composition; a solvent present in an amount of about 75 w / w% to about 80 w / w% of the composition; and a film forming agent present in an amount of about 6 w / w% to about 9 w / w% of the composition.
[0311] In some embodiments, the solvent is a combination of water and ethanol. In some such embodiments, the water is present in an amount of about 25% to about 35% w / w of the composition and the ethanol is present in an amount of about 45% to about 50% w / w of the composition. In some embodiments, the film former is a combination of an acrylate copolymer, polyvinylpyrrolidone, and a styrene / acrylate copolymer.
[0312] In some embodiments, the composition further comprises a humectant present in an amount of about 0.5% to about 1.5% w / w of the composition, hi some embodiments, the humectant is propanediol.
[0313] In some embodiments, the composition further comprises a preservative present in an amount of 0.5% to about 1.5% w / w of the composition. In some embodiments, the preservative includes a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the preservative includes a combination of phenoxyethanol, ethylhexylglycerin, and EDTA. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present together in the composition in an amount of about 0.1% to about 2% w / w of the composition. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin. In some such embodiments, the EDTA is present in an amount of about 0.05% w / w of the composition.
[0314] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 10 w / w% of the composition; A solvent present in an amount of about 77 w / w% of the composition; and a film forming agent present in an amount of about 7.5 w / w% of the composition.
[0315] In some embodiments, the solvent is a combination of water and ethanol. In some such embodiments, the water is present in an amount of about 30% by weight of the composition and the ethanol is present in an amount of about 48% by weight of the composition. In some embodiments, the film former is a combination of an acrylate copolymer, polyvinylpyrrolidone, and a styrene / acrylate copolymer.
[0316] In some embodiments, the composition further comprises a humectant present in an amount of about 1% w / w of the composition, hi some embodiments, the humectant is propanediol.
[0317] In some embodiments, the composition further comprises a preservative present in an amount of about 1.05 w / w% of the composition. In some embodiments, the preservative includes a combination of phenoxyethanol and ethylhexylglycerin. In some embodiments, the preservative includes a combination of phenoxyethanol, ethylhexylglycerin, and EDTA. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present together in the composition in an amount of about 1 w / w% of the composition. In some such embodiments, the phenoxyethanol and ethylhexylglycerin are present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin. In some such embodiments, the EDTA is present in an amount of about 0.05 w / w% of the composition.
[0318] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 0.1 w / w% to about 1.5 w / w% of the composition; a solvent present in an amount of about 80 w / w% to about 90 w / w% of the composition; and a humectant present in an amount of about 10 w / w% to about 15 w / w% of the composition.
[0319] In some embodiments, the solvent is a combination of water and ethanol. In some such embodiments, the water is present in an amount of about 65% to about 75% w / w of the composition, and the ethanol is present in an amount of about 10% to about 20% w / w of the composition. In some embodiments, the humectant is a vegetable oil.
[0320] In some embodiments, the composition further comprises a thickening agent present in an amount of about 1% to about 10% w / w of the composition. In some embodiments, the thickening agent is xanthan gum. In some embodiments, the composition further comprises a temporary colorant present in an amount of less than about 0.1% w / w of the composition. In some embodiments, the composition further comprises an amine present in an amount of about 0.01% to about 1% w / w of the composition.
[0321] In some embodiments, the compositions provided herein comprise: a semi-permanent coloring agent (e.g., a genipin derivative, lawsone, a lawsone derivative, or a combination thereof, e.g., any of the combinations described herein) present in an amount of about 0.9 w / w% of the composition; A solvent present in an amount of about 86 w / w% of the composition; and a moisturizing agent present in an amount of about 9 w / w% of the composition. In some embodiments, the solvent is a combination of water and ethanol. In some such embodiments, the water is present in an amount of about 71 w / w% of the composition, and the ethanol is present in an amount of about 14 w / w% of the composition. In some embodiments, the moisturizing agent is a vegetable oil.
[0322] In some embodiments, the composition further comprises a thickening agent present in an amount of about 4 w / w% of the composition. In some embodiments, the thickening agent is xanthan gum. In some embodiments, the composition further comprises a temporary colorant present in an amount of less than about 0.1 w / w% of the composition. In some embodiments, the composition further comprises an amine present in an amount of about 0.02 w / w% of the composition.
[0323] Other embodiments A first embodiment is an ink applicator, A lower body, a reservoir container housed within a cavity of the lower body; a reservoir contained within a cavity of the reservoir container; and a lower body containing a semi-permanent ink contained within a reservoir.
[0324] A second embodiment is an ink applicator comprising: A lower body, a reservoir contained within a cavity in the lower body; and a lower body containing a semi-permanent ink contained within a reservoir.
[0325] Embodiment 3 is the ink applicator of embodiment 1 or embodiment 2, wherein the reservoir comprises polyethylene terephthalate.
[0326] Embodiment 4 is the ink applicator of embodiment 3, wherein the polyethylene terephthalate is saturated with a semi-permanent ink.
[0327] Embodiment 5 is the ink applicator according to any one of embodiments 1 to 4, further comprising an agitator housed within the reservoir.
[0328] Embodiment 6 is the ink applicator of embodiment 5, wherein the stirrer is made of metal.
[0329] A seventh embodiment is an ink applicator comprising: A lower body, a reservoir container housed within a cavity of the lower body; and a lower body containing a semi-permanent ink contained within a reservoir.
[0330] An eighth embodiment is an ink applicator comprising: An ink applicator includes a lower body containing semi-permanent ink contained within a cavity of the lower body.
[0331] Example 9 is the ink applicator of any one of Examples 1 to 8, wherein the lower body further includes male threads coupleable to the upper body.
[0332] Embodiment 10 is the ink composition of embodiment 9, wherein the upper body includes a nib including a first end exterior to the upper body and a second end interior to the upper body, the nib configured to dispense a semi-permanent ink.
[0333] An eleventh embodiment is an ink applicator comprising: A lower body coupled to an upper body, the upper body comprising: An ink applicator comprising a lower body coupled to the upper body, the lower body including a nib having a first end exterior to the upper body and a second end interior to the upper body, the nib being configured to dispense semi-permanent ink.
[0334] Example 12 is the ink applicator of example 11, further comprising a reservoir container housed within the cavity of the lower body.
[0335] Example 13 is the ink applicator of example 12, further comprising a reservoir contained within the cavity of the reservoir container, the semi-permanent ink being contained within the reservoir.
[0336] Embodiment 14 is the ink applicator of embodiment 12 or embodiment 13, wherein the reservoir comprises polyethylene terephthalate.
[0337] Embodiment 15 is the ink applicator of embodiment 14, wherein the polyethylene terephthalate is saturated with the semi-permanent ink.
[0338] Embodiment 16 is an ink applicator comprising: A lower body, a reservoir container housed within a cavity of the lower body; a reservoir contained within a cavity of the reservoir container; a lower body including a semi-permanent ink contained within a reservoir; an upper body coupled to a lower body, the upper body comprising: The ink applicator includes a nib having a first end exterior to the upper body and a second end interior to the upper body.
[0339] Embodiment 17 is the ink applicator of embodiment 16, wherein the reservoir comprises polyethylene terephthalate.
[0340] Embodiment 18 is the ink applicator of embodiment 17, wherein the polyethylene terephthalate is saturated with the semi-permanent ink.
[0341] Embodiment 19 is an ink applicator comprising: A lower body, a reservoir container housed within a cavity of the lower body; a reservoir contained within a cavity of the reservoir container; a lower body including a semi-permanent ink contained within a reservoir; an upper body coupled to a lower body, the upper body comprising: a nib including a first end exterior to the upper body and a second end interior to the upper body; and an upper body including a nib second end and a transfer nib in contact with the semi-permanent ink contained in the reservoir.
[0342] Embodiment 20 is the ink applicator of embodiment 19, further comprising an agitator contained within the reservoir.
[0343] Embodiment 21 is the ink applicator of embodiment 20, wherein the agitator is made of metal.
[0344] Embodiment 22 is the ink applicator of embodiment 20 or embodiment 21, wherein the agitator is a metallic bead.
[0345] Example 23 is the ink applicator of any one of Examples 19-22, wherein the nib comprises nylon brush fibers and is configured to couple to the transfer nib.
[0346] Example 24 is the ink applicator of any one of examples 19-22, wherein the nib includes a porous, flexible tip and is configured to couple to the transfer nib.
[0347] Embodiment 25 is an ink applicator described in any one of embodiments 19 to 24, wherein the semi-permanent ink is absorbed by the transfer nib and the semi-permanent ink absorbed by the nib is transferred to a second end of the nib.
[0348] Embodiment 26 is the ink applicator of any one of embodiments 19-25, further comprising a transfer casing adjacent the first end of the nib.
[0349] Embodiment 27 is the ink applicator of embodiment 26, wherein a transfer casing connects the transfer nib to the nib.
[0350] Embodiment 28 is the ink applicator of embodiment 27 or embodiment 26, wherein a transfer casing secures the transfer nib to the upper body.
[0351] Example 29 is the ink applicator of any one of Examples 26-28, wherein the transfer casing is configured to absorb excess semi-permanent ink from the reservoir.
[0352] Embodiment 30 is the ink applicator of any one of embodiments 16-29, wherein the second end of the nib contacts the semi-permanent ink contained within the reservoir.
[0353] Embodiment 31 is the ink applicator of any one of embodiments 16-29, wherein the first end of the nib is configured to deposit a semi-permanent ink composition onto a substrate.
[0354] Embodiment 32 is the ink applicator of embodiment 31, wherein the substrate is paper.
[0355] Embodiment 33 is the ink applicator of embodiment 31, wherein the substrate is animal skin.
[0356] Embodiment 34 is the ink applicator of any one of embodiments 16-33, wherein the reservoir is selectively removable.
[0357] Embodiment 35 is the ink applicator of any one of embodiments 16 to 34, wherein the lower body further comprises a transparent window.
[0358] Embodiment 36 is the ink applicator of embodiment 35, wherein the reservoir is visible through a transparent window.
[0359] Embodiment 37 is A male thread integrated into the lower body; and a female thread integral with the upper body; 37. The ink applicator of any one of embodiments 11-36, wherein the male and female threads are complementary and connect the lower body to the upper body.
[0360] Example 38 is the ink applicator of example 37, wherein the female and male threads couple the upper body to the lower body such that the cavity in the lower body is sealed.
[0361] Embodiment 39 is the ink applicator of any one of embodiments 11 to 38, wherein the nib includes a stiff rounded tip.
[0362] Embodiment 40 is the ink applicator of any one of embodiments 11-38, wherein the nib includes a chisel-shaped tip.
[0363] Embodiment 41 is the ink applicator of any one of embodiments 11-38, wherein the nib includes a fine point tip.
[0364] Example 42 is the ink applicator of any one of Examples 11 to 41, further comprising a lid configured to cover the first end of the nib exterior to the upper body.
[0365] Embodiment 43 is the ink applicator of embodiment 42, wherein the lid provides a seal between the lid and the upper body.
[0366] Embodiment 44 is the ink applicator of any one of embodiments 16-41, wherein the reservoir comprises a void.
[0367] Embodiment 45 is the ink applicator of embodiment 44, wherein the void is configured to contain a volume of semi-permanent ink.
[0368] Embodiment 46 is the ink applicator of embodiment 45, having a volume of about 0.5 mL to about 1.5 mL.
[0369] Embodiment 47 is the ink applicator of embodiment 45 or embodiment 46, wherein the volume is about 1.0 mL.
[0370] Embodiment 48 is the ink applicator of any one of embodiments 11 to 47, wherein the ink applicator is a pen.
[0371] Embodiment 49 is the ink applicator of any one of embodiments 11 to 48, wherein the ink applicator is a marker.
[0372] Embodiment 50 is an ink applicator system, comprising: a reservoir containing a semi-permanent ink; and a plurality of nibs configured to contact the semi-permanent ink in the reservoir.
[0373] Embodiment 51 is the ink applicator system of embodiment 19, wherein a first nib of the plurality of nibs includes a solid rounded tip.
[0374] Embodiment 52 is an ink applicator system described in any one of embodiments 50-51, wherein a second nib of the plurality of nibs includes a chisel-shaped tip.
[0375] Embodiment 53 is an ink applicator system described in any one of embodiments 50-52, wherein a third nib of the plurality of nibs includes a fine point tip.
[0376] Embodiment 54 is an ink applicator system according to any one of embodiments 50 to 53, wherein a fourth nib of the plurality of nibs comprises nylon brush fibers.
[0377] Embodiment 55 is an ink applicator system described in any one of embodiments 50 to 54, wherein a fifth nib of the plurality of nibs includes a flexible, porous tip.
[0378] Embodiment 56 is the ink applicator system of any one of embodiments 50 to 55, further comprising a pouch of semi-permanent ink.
[0379] Embodiment 57 is the ink applicator system of embodiment 56, wherein the pouch contains a volume of about 0.5 mL to about 1.5 mL of the semi-permanent ink.
[0380] Embodiment 58 is the ink applicator system of embodiment 56 or embodiment 57, wherein the pouch contains a volume of about 1.0 mL of the semi-permanent tattoo composition.
[0381] Embodiment 59 is an ink applicator system according to any one of embodiments 50 to 58, wherein the reservoir further comprises polyethylene terephthalate.
[0382] Embodiment 60 is the ink applicator system of embodiment 59, wherein the polyethylene terephthalate is saturated with the semi-permanent ink.
[0383] Embodiment 61 is an ink applicator system according to any one of embodiments 50-60, wherein each of the plurality of nibs corresponds to a color of a semi-permanent ink.
[0384] Embodiment 62 is the ink applicator system according to any one of embodiments 50 to 61, further comprising the ink applicator according to any one of embodiments 1 to 49.
[0385] Embodiment 63 is a method for applying ink onto skin, the method comprising: bonding the nib to an upper body of an ink applicator containing an ink composition; applying the ink composition of the ink applicator to a portion of the skin.
[0386] Embodiment 64 is the method of embodiment 63, in which the ink applicator is a marker.
[0387] Embodiment 65 is the method of any one of embodiments 63-64, further comprising agitating the ink applicator to initiate flow of the ink composition from a reservoir of the ink applicator to the nib.
[0388] Embodiment 66 is Separating an upper ink applicator body from a lower ink applicator body; Removing the reservoir from the lower body; 66. The method of embodiment 65, further comprising replacing the reservoir with a different reservoir.
[0389] Embodiment 67 is Separating an upper ink applicator body from a lower ink applicator body; Removing the reservoir from the lower body; 67. The method of embodiment 66, further comprising filling the reservoir with an additional ink composition.
[0390] Embodiment 68 is Separating the nib from the ink applicator; coupling different nibs to an ink applicator; 68. The method of any one of embodiments 63-67, further comprising applying the ink to the portion of the skin via a nib distinct from the ink applicator.
[0391] In an embodiment 69, the semi-permanent ink comprises: a semi-permanent coloring agent, the semi-permanent coloring agent being selected from the group consisting of genipin, a genipin derivative, lawsone, a lawsone derivative, or a combination thereof; A solvent; 50. The ink applicator of any one of embodiments 1-49, comprising:
[0392] Embodiment 70 is a compound of formula I,
[0393] [ka] During the ceremony: R 1 is -C(=O)OR 6 , C 1~6 Alkyl or C 6~10 aryl, 1~6 Alkyl and C 6~10 Aryl is 1 to 5 R 7 are optionally replaced by R 6 , H, C 1~6 Alkyl or C 6~10 aryl, 1~6 Alkyl and C 6~10 Aryl is 1 to 5 R 7 are optionally replaced by Each R 7 is independently an electron withdrawing group or an electron donating group; R 2 H, -OR 9 , or OC(=O)R 9A and R 9 , H, C 1~6 Alkyl, C 6~10 selected from the group consisting of aryl and hydroxy protecting groups; R 9A is C 1~6 Alkyl and C 6~10 aryl; The dotted line indicates the optional presence of a double bond; If no double bond is present, R 4 and R 5 forms a 3- to 4-membered heterocyclic ring together with the carbon atom to which it is attached, and R 3 is -OH or -CHOH, or If a double bond is present, R 4 and R 5 does not exist, and R 3 -NR 7 R 8 , -CH2NR 7 R 8 , -C(=O)OR 10 , -C(=O)NR 10 R10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH2OR 10 and 1 to 5 R 7 phenyl substituted with R 10 , H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 phenyl substituted with R 8 is H or R 7 70. An ink applicator as described in embodiment 69, wherein
[0394] Embodiment 71 is R 1 is -C(=O)OR 6 Or 1 to 5 R 7 is a phenyl substituted with R 6 , H, C 1~6 Alkyl or 1 to 5 R 7 is a phenyl substituted with R 2 H, -OR 9 , or OC(=O)R 9 and R 9 is H or C 1~6 is alkyl, If a double bond is present, R 4 and R 5 does not exist, R 3 -NR 7 R 8 , -CH2NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 , diethyl malonate and 1 to 5 R7 phenyl substituted with R 10 , H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O) and 1 to 5 R 7 61. The ink applicator of embodiment 60, wherein R is phenyl substituted with
[0395] Embodiment 72 is an embodiment in which the hydroxy protecting group is tri(C 1~6 71. The compound according to embodiment 70, wherein R is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30,
[0396] Embodiment 73 is a compound according to embodiment 70, wherein the hydroxy protecting group is tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), or triethylsilyl (TES).
[0397] Embodiment 74 is R 6 74. The ink applicator of any one of embodiments 70-73, wherein is methyl.
[0398] Embodiment 75 is a method for producing 1 -C(=O)OR 6 and R 6 75. The ink applicator of any one of embodiments 70-74, wherein is methyl.
[0399] Embodiment 76 is directed to R 1 -C(=O)OR 6 and R 6 However, 1 to 5 R 7 75. The ink applicator of any one of embodiments 70-74, wherein N is phenyl substituted with .
[0400] Embodiment 77 is R 2 77. The ink applicator of any one of embodiments 70-76, wherein is -OC(=O)CH3.
[0401] Embodiment 78 is R 277. The ink applicator of any one of embodiments 70-76, wherein is --OH.
[0402] Embodiment 79 is R 2 -OR 9 and R 9 But, H, C 1~6 Alkyl, tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), triethylsilyl (TES), and C 6~10 77. The ink applicator of any one of embodiments 70-76, wherein the aromatic hydrocarbon group is selected from the group consisting of aryl.
[0403] Embodiment 80 is a method for producing a compound comprising the steps of: 9 80. The ink applicator of any one of embodiments 70 to 76 and 79, wherein
[0404] Embodiment 81 is R 9 80. The ink applicator of any one of embodiments 70 to 76 and 79, wherein is tert-butyldimethylsilyl (TBS).
[0405] Embodiment 82 is R 9 80. The ink applicator of any one of embodiments 70 to 76 and 79, wherein is --OH.
[0406] Embodiment 83 is the ink applicator of any one of embodiments 70-82, wherein the double bond is absent.
[0407] Embodiment 84 is a method for producing 4 and R 5 together with the carbon atom to which it is attached form a three-membered heterocyclic ring; R 3 84. The ink applicator of embodiment 83, wherein
[0408] Embodiment 85 is an embodiment in which the three-membered heterocycle is
[0409] [ka] 85. The ink applicator of embodiment 84, wherein
[0410] Embodiment 86 is a method for producing a compound according to the present invention 4 and R 5 together with the carbon atom to which it is attached form a four-membered heterocyclic ring; R 3 84. The ink applicator of embodiment 83, wherein:
[0411] Embodiment 87 is an embodiment in which the four-membered ring is
[0412] [ka] 87. The ink applicator of embodiment 86, wherein
[0413] Embodiment 88 is the ink applicator of any one of embodiments 70-82, wherein a double bond is present.
[0414] Embodiment 89 is a method for producing 1 But 1 to 3 R 7 89. The ink applicator of embodiment 88, wherein N is phenyl substituted with
[0415] Embodiment 90 is a method for producing 1 -C(=O)OR 6 and R 6 1 to 3 R 7 89. The ink applicator of embodiment 88, wherein N is phenyl substituted with
[0416] Embodiment 91 is R 2 is -OH and R 3 91. The ink applicator of any one of embodiments 88-90, wherein is CH2OH.
[0417] Embodiment 92 is R 3 but, -NR 7 R 8 , -CH2NR 7 R 8 , -C(=O)OR10 , -C(=O)NR 10 R 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH2OR 10 and 1 to 5 R 7 phenyl substituted with R 1 is -C(=O)OH, R 2 is -OH, R 10 , H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 89. The ink applicator of embodiment 88, wherein the phenyl is selected from phenyl substituted with
[0418] Embodiment 93 is R 3 but, -NR 7 R 8 , -CH2-NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -C(=O)NR 10 R 10 , -CH2OR 10 and 1 to 5 R 7 phenyl substituted with R 1 is -C(=O)OH, R 2 -OR 9 and R 9 , H, C 1~6 Alkyl, tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), triethylsilyl (TES) and C 6~1089. The ink applicator of embodiment 88, wherein the alkyl group is selected from the group consisting of aryl.
[0419] Embodiment 94 is a method for producing 3 but, -NR 7 R 8 , -CH2-NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH2OR 10 , diethyl malonate and 1 to 5 R 7 phenyl substituted with R 1 is -C(=O)OH, R 2 89. The ink applicator of embodiment 88, wherein
[0420] Embodiment 95 is the ink applicator of any one of embodiments 69-70, wherein the genipin derivative is a compound selected from the group consisting of the compounds shown in Table 1.
[0421] Embodiment 96 is a method for producing 7 but, -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -NHC(=O)R 8 , -OC(=O)R 8 , -SR 8 , -CO2 - , -SO2CF3, -NO, -NO2, -SO2R 8 , -CN, -CR 11 , -COR 11 , -CHO, -COR 8 , -C(=O)NR 8 R 8 and halides; R 8 is H, -(C1~9 alkyl), -(C 2~9 alkenyl), R 11 95. The ink applicator of any one of embodiments 70 to 94, wherein the ink is a halide.
[0422] Embodiment 97 is the ink applicator of any one of embodiments 69-96, wherein the lawsone derivative is a compound shown in Table 4.
[0423] Embodiment 98 is an embodiment in which the lawsone derivative is a compound of formula III,
[0424] [ka] In the formula, R 12 is -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -NHC(=O)R 8 , -OC(=O)R 8 , -SR 8 , -CO2 - , -SO2CF3, -NO, -NO2, -SO2R 8 , -CN, -CR 11 3. -COR 11 , -CHO, -COR 8 , -C(=O)NR 8 R 8 and halides; R 8 is H, -(C 1~9 alkyl), -(C 2~9 alkenyl), R 11 98. The ink applicator of any one of embodiments 69 to 97, wherein the ink is a halide.
[0425] Embodiment 99 is the ink applicator of any one of embodiments 69-98, wherein the semi-permanent colorant is a combination of two or more of genipin, genipin derivatives, lawsone, and lawsone derivatives.
[0426] Embodiment 100 is the ink applicator of any one of embodiments 69-99, wherein the semi-permanent colorant comprises a combination of two or more genipin derivatives.
[0427] Embodiment 101 is the ink applicator of any one of embodiments 69-99, wherein the semi-permanent colorant comprises a combination of two or more compounds shown in Table 1.
[0428] Embodiment 102 is the ink applicator of any one of embodiments 69-99 and 101, wherein the semi-permanent colorant comprises a combination of Compound 1 and Compound 12.
[0429] Embodiment 103 is the ink applicator of embodiment 102, wherein the ratio of compound 1 to compound 12 is from about 4:1 to about 1:4, compound 1:compound 12.
[0430] Embodiment 104 is the ink applicator of any one of embodiments 69 to 99, wherein the semi-permanent colorant comprises a combination of genipin and Compound 1.
[0431] Embodiment 105 is the ink applicator of embodiment 104, wherein the ratio of genipin to compound 1 is from about 4:1 to about 1:4 genipin:compound 1.
[0432] Embodiment 106 is an ink applicator according to embodiment 105, wherein the ratio of genipin to compound 1 is about 1:1 genipin:compound 1.
[0433] Embodiment 107 is the ink applicator of any one of embodiments 69-99 and 101, wherein the semi-permanent colorant is a combination of Compound 1 and Compound 14.
[0434] Embodiment 108 is the ink applicator of embodiment 107, wherein the ratio of compound 1 to compound 14 is from about 4:1 to about 1:4, compound 1:compound 14.
[0435] Embodiment 109 is the ink applicator of embodiment 108, wherein the ratio of compound 1 to compound 14 is about 1:1 compound 1:compound 14.
[0436] Embodiment 110 is the ink applicator of any one of embodiments 69-99, wherein the semi-permanent colorant is a combination of genipin and compound 14.
[0437] Embodiment 111 is the ink applicator of embodiment 110, wherein the ratio of genipin to compound 14 is from about 4:1 to about 1:4 genipin:compound 14.
[0438] Embodiment 112 is the ink applicator of embodiment 111, wherein the ratio of genipin to compound 14 is about 1:1 genipin:compound 14.
[0439] Embodiment 113 is the ink applicator of any one of embodiments 69-99, wherein the semi-permanent colorant is a combination of genipin, compound 1, and compound 14.
[0440] Embodiment 114 is the ink applicator of embodiment 113, wherein the ratio of genipin to Compound 1 to Compound 14 is from about 4:1:1 to about 1:1:4 genipin:Compound 1:Compound 14.
[0441] Embodiment 115 is an ink applicator according to embodiment 114, wherein the ratio of genipin to Compound 1 to Compound 14 is about 1:1:1 genipin:Compound 1:Compound 14.
[0442] Embodiment 116 is the ink applicator of any one of embodiments 69 to 115, wherein the semi-permanent colorant is present in an amount of about 5 w / w% to about 15 w / w% of the composition.
[0443] Embodiment 117 is the ink applicator of any one of embodiments 69 to 116, wherein the semi-permanent colorant is present in an amount of about 9 w / w% to about 11 w / w% of the composition.
[0444] Embodiment 118 is the ink applicator of any one of embodiments 69 to 117, wherein the semi-permanent colorant is present in an amount of about 10 w / w% of the composition.
[0445] Embodiment 119 is the ink applicator of any one of embodiments 69 to 118, wherein the solvent is present in an amount from about 65 w / w% to about 85 w / w% of the composition.
[0446] Embodiment 120 is the ink applicator of any one of embodiments 69 to 119, wherein the solvent is present in an amount of about 75 w / w% to about 80 w / w% of the composition.
[0447] Embodiment 121 is the ink applicator of any one of embodiments 69 to 120, wherein the solvent is present in an amount of about 77 w / w% of the composition.
[0448] Embodiment 122 is the ink applicator of any one of embodiments 69 to 121, wherein the solvent comprises water, methanol, ethanol, isopropanol, diethylene glycol monoethyl ether, or a combination thereof.
[0449] Embodiment 123 is the ink applicator of any one of embodiments 69 to 122, wherein the solvent is a combination of water and ethanol.
[0450] Embodiment 124 is the ink applicator of any one of embodiments 122-123, wherein the water is present in an amount of about 25 w / w% to about 35 w / w% of the composition.
[0451] Embodiment 125 is the ink applicator of any one of embodiments 122-124, wherein the water is present in an amount of about 30 w / w% of the composition.
[0452] Embodiment 126 is the ink applicator of any one of embodiments 122 to 125, wherein ethanol is present in an amount from about 40 w / w% to about 55 w / w% of the composition.
[0453] Embodiment 127 is the ink applicator of any one of embodiments 122 to 126, wherein ethanol is present in an amount from about 45 w / w% to about 50 w / w% of the composition.
[0454] Embodiment 128 is the ink applicator of any one of embodiments 122 to 127, wherein ethanol is present in an amount of about 48 w / w% of the composition.
[0455] Embodiment 129 is the ink applicator of any one of embodiments 69 to 128, wherein the film forming agent is present in an amount of about 5 w / w% to about 10 w / w% of the composition.
[0456] Embodiment 130 is the ink applicator of any one of embodiments 69 to 129, wherein the film forming agent is present in an amount from about 6 w / w% to about 9 w / w% of the composition.
[0457] Embodiment 131 is the ink applicator of any one of embodiments 69 to 130, wherein the film forming agent is present in an amount of about 7.5 w / w% of the composition.
[0458] Embodiment 132 is the ink applicator of any one of embodiments 69 to 131, wherein the film-forming agent comprises a volatile silicone resin, a polyvinylpyrrolidone, an acrylate, an acrylamide, a copolymer, an isododecane resin, or a combination thereof.
[0459] Embodiment 133 is an embodiment in which the film former is selected from the group consisting of polymethylsilsesquioxane, trimethylsiloxysilicate, polypropylsilsesquioxane, dimethicone, cyclopentasiloxane, dimethiconol crosspolymer, polysilicone-6, polysilicone-8, polysilicone-11, polysilicone-14, acrylates copolymer, styrene / acrylates copolymer, polyvinylpyrrolidone, acrylates / C12-22 alkyl methacrylate copolymer, acrylates / polytrimethylsiloxymethacrylate copolymer, polyvinylpyrrolidone / vinyl acetate (VP / VA) copolymer, VP / dimethiconyl acrylate / polycarbamyl. 133. The ink applicator of any one of embodiments 69-132, comprising a VP / polyglycol ester, VP / dimethylaminoethyl methacrylate copolymer, VP / dimethylaminoethyl methacrylate / polycarbamyl polyglycol ester, VP / eicosene copolymer, VP / hexadecene copolymer, VP / methacrylamide / vinylimidazole copolymer, VP / polycarbamyl polyglycol ester, VP / VA copolymer, polyester-1, polyester-2, polyester-3, polyester-4, polyester-5, polyester-7, polyester-8, polyester-10, or a combination thereof.
[0460] Embodiment 134 is the ink applicator of any one of embodiments 69 to 133, wherein the film former is a combination of an acrylate copolymer, polyvinylpyrrolidone, and a styrene / acrylate copolymer.
[0461] Embodiment 135 is the ink applicator of any one of embodiments 133 or 134, wherein the acrylate copolymer is present in an amount from about 0.1 w / w% to about 10 w / w% of the composition.
[0462] Embodiment 136 is an ink applicator described in any one of embodiments 133 to 135, wherein the acrylate copolymer is present in an amount of about 0.1 w / w% to about 1 w / w% of the composition.
[0463] Embodiment 137 is the ink applicator of any one of embodiments 133 to 136, wherein the acrylate copolymer is present in an amount of about 0.25 w / w% of the composition.
[0464] Embodiment 138 is an ink applicator described in any one of embodiments 133 to 137, wherein polyvinylpyrrolidone is present in an amount from about 0.1 w / w% to about 10 w / w% of the composition.
[0465] Embodiment 139 is an ink applicator described in any one of embodiments 133 to 138, wherein the polyvinylpyrrolidone is present in an amount from about 0.5 w / w% to about 1.5 w / w% of the composition.
[0466] Embodiment 140 is the ink applicator of any one of embodiments 133 to 139, wherein the polyvinylpyrrolidone is present in an amount of about 1 w / w% of the composition.
[0467] Embodiment 141 is an ink applicator described in any one of embodiments 133 to 140, wherein the styrene / acrylate copolymer is present in an amount of about 0.1 w / w% to about 10 w / w% of the composition.
[0468] Embodiment 142 is an ink applicator described in any one of embodiments 133 to 141, wherein the styrene / acrylate copolymer is present in an amount of about 5 w / w% to about 7 w / w% of the composition.
[0469] Embodiment 143 is the ink applicator of any one of embodiments 133-142, wherein the styrene / acrylate copolymer is present in an amount of about 6 w / w% of the composition.
[0470] Embodiment 144 is the ink applicator of any one of embodiments 69 to 143, wherein the composition further comprises a humectant.
[0471] Embodiment 145 is the ink applicator of embodiment 144, wherein the humectant is present in an amount from about 0.1 w / w% to about 10 w / w% of the composition.
[0472] Embodiment 146 is an ink applicator according to any one of embodiments 144 to 145, wherein the humectant is present in an amount of about 0.5 w / w% to about 1.5 w / w% of the composition.
[0473] Embodiment 147 is the ink applicator of any one of embodiments 144 to 146, wherein the humectant is present in an amount of about 1 w / w% of the composition.
[0474] Embodiment 148 is an ink applicator described in any one of embodiments 144 to 147, wherein the moisturizer comprises aloe vera gel, lithium chloride, allantoin, urea, dicyanamidoglycerol, lactic acid, propylene glycol, polyethylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol, propanediol, hexylene glycol, 1,3-butylene glycol, 1,2,6-hexanetriol, glycerol ethoxylate, glycerol propoxylate, glyceryl triacetate, sorbitol, hydroxypropyl sorbitol, xylitol, maltitol, hyaluronic acid, tremella extract, sodium lactate, sodium L-pyroglutamate urea, and pyrrolidone carboxylic acid, or a combination thereof.
[0475] Embodiment 149 is the ink applicator of any one of embodiments 144-148, wherein the humectant is propanediol.
[0476] Embodiment 150 is the ink applicator of any one of embodiments 69 to 149, wherein the composition further comprises a preservative.
[0477] Embodiment 151 is the ink applicator of embodiment 150, wherein the preservative is present in an amount from about 0.1 w / w% to about 5 w / w% of the composition.
[0478] Embodiment 152 is the ink applicator of embodiment 150 or 151, wherein the preservative is present in an amount from about 0.5 w / w% to about 1.5 w / w% of the composition.
[0479] Embodiment 153 is the ink applicator of any one of embodiments 150 to 152, wherein the preservative is present in an amount of about 1 w / w% of the composition.
[0480] Embodiment 154 is a method for preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: preparing a pharmaceutical composition comprising the steps of: 5-methyl-5-pyrimidine, 5-bromo-5-nitro-1,3-dioxane, bronopol, 2,4-dichlorobenzyl alcohol, 1-(4-chlorophenyl)-3-(3,4-dichlorophenyl)urea, chlorocresol, chloroxylenol, 5-chloro-2-(2,4-dichlorophenoxy)phenol, N,N''-methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea], polyaminopropyl biguanide, methenamine, quaternium-15, climbazole, DMDM hydantoin, benzyl alcohol, 1-hydroxy-4-methyl-6-(2,4,4-Trimethylpentyl)-2-pyridone, piroctone olamine, bromochlorophene, o-cymen-5-ol, chlorophene, chloroacetamine, methylchloroisothiazolinone, methylisothiazolinone, phenoxyisopropanol, chlorhexidine, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dihydrochloride, dimethyloxazolidine, behentrimonium chloride, cetrimonium bromide, cetrimonium chloride, lautrimonium bromide, lautrimonium chloride, steartrimonium bromide, steartrimonium chloride, diazolidinyl urea, hexamidine, hexamidine diisethionate, hexamidine paraben, glutaral, 7-ethylbicyclooxazolidine, chlorphenesin, sodium hydroxymethylglycine, silver chloride, benzethonium chloride, benzalkonium chloride 154. The ink applicator of any one of embodiments 150 to 153, comprising an isocyanate, benzalkonium bromide, benzalkonium saccharinate, benzyl hemiformal, iodopropynyl butylcarbamate, biphenyl-2-ol and its salts, zinc pyrithione, erythorbate, nitrous acid, ethylenediaminetetraacetic acid (EDTA), butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), caprylic acid, dilauryl thiodipropionic acid, erythorbic acid, guaiac acid, methylparaben, sulfite, bisulfite, metabisulfite, propyl galactose, propylparaben, stannous chloride, sulfur dioxide, thiodipropionic acid, isothiazolin, paraben, phenoxyethanol, ethylhexylglycerin, glycol, tocopherol, 1,2-hexanediol, or combinations thereof.
[0481] Embodiment 155 is the ink applicator of any one of embodiments 150 to 154, wherein the preservative comprises a combination of phenoxyethanol and ethylhexylglycerin.
[0482] Embodiment 156 is the ink applicator of embodiment 155, wherein the combination of phenoxyethanol and ethylhexylglycerin is present in the composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin.
[0483] Embodiment 157 is the ink applicator of embodiment 155 or 156, wherein the combination of phenoxyethanol and ethylhexylglycerin is present in an amount from about 0.1 w / w% to about 2 w / w% of the composition.
[0484] Embodiment 158 is an ink applicator described in any one of embodiments 155 to 157, wherein the combination of phenoxyethanol and ethylhexylglycerin is present in an amount of about 1 w / w% of the composition.
[0485] Embodiment 159 is the ink applicator of any one of embodiments 150 to 158, wherein the preservative comprises EDTA.
[0486] Embodiment 160 is the ink applicator of embodiment 159, wherein the EDTA is present in an amount from about 0.01 w / w% to about 2 w / w% of the composition.
[0487] Embodiment 161 is the ink applicator of any one of embodiments 159-160, wherein the EDTA is present in an amount of about 0.05 w / w% of the composition.
[0488] Embodiment 162 is an ink applicator that includes a lower body coupled to an upper body, the upper body including a nib including a first end exterior to the upper body and a second end interior to the upper body, the nib configured to dispense a semi-permanent ink, the semi-permanent ink being: a semi-permanent coloring agent, the semi-permanent coloring agent being selected from the group consisting of genipin, a genipin derivative, lawsone, a lawsone derivative, or a combination thereof; A solvent; and a film-forming agent.
[0489] Embodiment 163 is an ink applicator described in any one of embodiments 1 to 161, wherein the ink applicator comprises an upper body, in particular, the lower body is connected or connectable to the upper body, and / or the upper body includes a nib having a first end outside the upper body and a second end inside the upper body, and the nib is configured to dispense semi-permanent ink.
[0490] Although the present invention has been described in conjunction with a detailed description thereof, it should be understood that the foregoing description is illustrative and is not intended to limit the scope of the invention as defined by the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.
Claims
1. 1. An ink applicator comprising: A lower body, a reservoir contained within a cavity in the lower body; a semi-permanent ink contained within the reservoir, the semi-permanent ink comprising: a semi-permanent coloring agent, the semi-permanent coloring agent being selected from the group consisting of genipin, genipin derivatives, lawsone, lawsone derivatives, and combinations thereof; A solvent; and a film former.
2. The ink applicator of claim 1 , wherein the reservoir comprises polyethylene terephthalate.
3. The ink applicator of claim 2 , wherein said polyethylene terephthalate is saturated with said semi-permanent ink.
4. The ink applicator of any one of claims 1 to 3, further comprising an agitator contained within the reservoir.
5. The ink applicator of claim 4 , wherein the agitator is made of metal.
6. The ink applicator of any one of claims 1 to 5, wherein the lower body further comprises external threads connectable to the upper body.
7. 7. The ink composition of claim 6, wherein the upper body includes a nib having a first end exterior to the upper body and a second end interior to the upper body, the nib configured to dispense the semi-permanent ink.
8. 8. The ink applicator of claim 1, further comprising an upper body coupled to the lower body, the upper body including a nib having a first end exterior to the upper body and a second end interior to the upper body.
9. 9. The ink applicator of claim 8, further comprising a transfer nib contacting said second end of said nib and said semi-permanent ink contained in said reservoir.
10. The ink applicator of claim 9 , wherein the nib comprises nylon brush fibers and is configured to bond to the transfer nib.
11. The ink applicator of claim 9 , wherein the nib includes a porous, flexible tip and is configured to couple to the transfer nib.
12. 12. The ink applicator of claim 9, wherein the semi-permanent ink is absorbed by the transfer nib, and the semi-permanent ink absorbed by the nib is transferred to the second end of the nib.
13. The ink applicator of any one of claims 9 to 12, further comprising a transfer casing adjacent said first end of said nib.
14. The ink applicator of claim 13 , wherein the transfer casing couples the transfer nib to the nib.
15. The ink applicator of claim 13 or 14, wherein the transfer casing secures the transfer nib to the upper body.
16. The ink applicator of any one of claims 13 to 15, wherein the transfer casing is configured to absorb excess semi-permanent ink from the reservoir.
17. The ink applicator of any one of claims 8 to 16, wherein the second end of the nib contacts the semi-permanent ink contained in the reservoir.
18. The ink applicator of any one of claims 8 to 16, wherein the first end of the nib is configured to deposit the semi-permanent ink composition onto a substrate.
19. 20. The ink applicator of claim 18, wherein the substrate is selected from paper or animal skin.
20. The ink applicator of any one of claims 8 to 19, wherein the reservoir is selectively removable.
21. The ink applicator of any one of claims 8 to 20, wherein the lower body further comprises a transparent window.
22. 22. The ink applicator of claim 21, wherein the reservoir is visible through the transparent window.
23. a male thread integral with the lower body; and a female thread integral with the upper body; The ink applicator of any one of claims 8 to 22, wherein the male and female threads are complementary and couple the lower body to the upper body.
24. 24. The ink applicator of claim 23, wherein the female threads and the male threads join the upper body to the lower body such that a cavity in the lower body is sealed.
25. The ink applicator of any one of claims 8 to 24, wherein the nib comprises a stiff rounded tip, or a chisel tip, or a fine point tip.
26. The ink applicator of any one of claims 8 to 25, further comprising a lid configured to cover the first end of the nib exterior to the upper body.
27. 27. The ink applicator of claim 26, wherein the lid provides a seal between the lid and the upper body.
28. The ink applicator of any one of claims 8 to 27, wherein the reservoir comprises a void.
29. 30. The ink applicator of claim 28, wherein the cavity is configured to contain a volume of semi-permanent ink.
30. The ink applicator of claim 29, wherein the volume is from about 0.5 mL to about 1.5 mL, and more specifically, the volume is about 1.0 mL.
31. The ink applicator of any one of claims 8 to 30, wherein the ink applicator is selected from a pen or a marker.
32. 1. An ink applicator system comprising: a reservoir containing a semi-permanent ink; a plurality of nibs configured to contact the semi-permanent ink in the reservoir, the semi-permanent ink comprising: a semi-permanent coloring agent, the semi-permanent coloring agent being selected from the group consisting of genipin, genipin derivatives, lawsone, lawsone derivatives, and combinations thereof; A solvent; and a film former.
33. 33. The ink applicator system of claim 32, wherein a first nib of the plurality of nibs includes a solid rounded tip.
34. The ink applicator system of any one of claims 32-33, wherein a second nib of the plurality of nibs includes a chisel-type tip.
35. The ink applicator system of any one of claims 32 to 34, wherein a third nib of the plurality of nibs includes a fine point tip.
36. The ink applicator system of any one of claims 32 to 35, wherein a fourth nib of the plurality of nibs comprises nylon brush fibers.
37. The ink applicator system of any one of claims 32 to 36, wherein a fifth nib of the plurality of nibs includes a flexible porous tip.
38. The ink applicator system of any one of claims 32 to 37, further comprising a pouch of semi-permanent ink.
39. 40. The ink applicator system of claim 38, wherein the pouch contains a volume of from about 0.5 mL to about 1.5 mL of the semi-permanent ink.
40. 40. The ink applicator system of claim 38 or 39, wherein the pouch contains a volume of about 1.0 mL of the semi-permanent tattoo composition.
41. The ink applicator system of any one of claims 32 to 40, wherein the reservoir further comprises polyethylene terephthalate.
42. 42. The ink applicator system of claim 41, wherein the polyethylene terephthalate is saturated with the semi-permanent ink.
43. The ink applicator system of any one of claims 32 to 42, wherein each of the plurality of nibs corresponds to a color of the semi-permanent ink.
44. The ink applicator system of any one of claims 32 to 43, further comprising an ink applicator according to any one of claims 1 to 31.
45. 1. A method for applying ink onto skin, the method comprising: bonding the nib to an upper body of an ink applicator containing an ink composition; applying the ink composition from the ink applicator to a portion of the skin, the ink comprising: a semi-permanent coloring agent, the semi-permanent coloring agent being selected from the group consisting of genipin, genipin derivatives, lawsone, lawsone derivatives, and combinations thereof; A solvent; a film forming agent.
46. 46. The method of claim 45, wherein the ink applicator is a marker.
47. The method of any one of claims 45-46, further comprising agitating the ink applicator to initiate flow of ink composition from a reservoir of the ink applicator to the nib.
48. Separating the upper body of the ink applicator from the lower body of the ink applicator; removing the reservoir from the lower body; 48. The method of claim 47, further comprising replacing the reservoir with a different reservoir.
49. Separating the upper body of the ink applicator from the lower body of the ink applicator; removing the reservoir from the lower body; 49. The method of claim 48, further comprising filling the reservoir with an additional ink composition.
50. Separating the nib from the ink applicator; and coupling a different nib to the ink applicator; 50. The method of any one of claims 45 to 49, further comprising applying the ink to the portion of the skin via a nib distinct from the ink applicator.
51. The genipin derivative is a compound of formula I, 【Chemistry 1】 During the ceremony: R 1 is -C(=O)OR 6 , C 1~6 Alkyl, or C 6~10 aryl, 1~6 Alkyl and C 6~10 Aryl is 1 to 5 R 7 are optionally replaced by R 6 But, H, C 1~6 Alkyl or C 6~10 aryl, 1~6 Alkyl and C 6~10 Aryl is 1 to 5 R 7 are optionally replaced by Each R 7 is independently an electron withdrawing group or an electron donating group; R 2 H, -OR 9 or OC(=O)R 9A and R 9 But, H, C 1~6 Alkyl, C 6~10 selected from the group consisting of aryl and hydroxy protecting groups; R 9A But, C 1~6 Alkyl and C 6~10 aryl; The dotted line indicates the optional presence of a double bond; When no double bond is present, R 4 and R 5 together with the carbon atom to which it is attached form a 3- to 4-membered heterocyclic ring; R 3 is -OH or -CH 2 OH, or When a double bond is present, R 4 and R 5 does not exist, and R 3 But -NR 7 R 8 , -CH 2 N.R. 7 R 8 , -C(=O)OR 10 , -C(=O)NR 10 R 10 , —CH(═O), phenyl, —CHR 10 R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH 2 OR 10 and 1 to 5 R 7 phenyl substituted with R 10 But, H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 phenyl substituted with R 8 is H or R 7 32. The ink applicator of claim 1, wherein
52. R 1 is -C(=O)OR 6 Or 1 to 5 R 7 is a phenyl substituted with R 6 But, H, C 1~6 Alkyl, or 1 to 5 R 7 is a phenyl substituted with R 2 H, -OR 9 or OC(=O)R 9 and R 9 is H or C 1~6 is alkyl, When a double bond is present, R 4 and R 5 But it doesn't exist, R 3 But -NR 7 R 8 , -CH 2 N.R. 7 R 8 , -C(=O)OR 10 , —CH(═O), phenyl, —CHR 10 R 10 , -CH=CHR 10 , -CH 2 OR 10 , diethyl malonate and 1 to 5 R 7 phenyl substituted with R 10 But, H, C 1~6 Alkyl, alkoxy, oxo, —OH, —CH(═O) and 1 to 5 R 7 52. The ink applicator of claim 51, wherein the aryl group is phenyl substituted with aryl.
53. The hydroxy protecting group is tri(C 1~6 52. The compound of claim 51, wherein the silyl group is aryl)alkyl.
54. 52. The compound of claim 51, wherein the hydroxy protecting group is tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS) or triethylsilyl (TES).
55. R 6 The ink applicator of any one of claims 70 to 73, wherein is methyl.
56. R 1 is -C(=O)OR 6 and R 6 The ink applicator of any one of claims 51 to 55, wherein is methyl.
57. R 1 is -C(=O)OR 6 and R 6 But 1 to 5 R 7 The ink applicator of any one of claims 51 to 55, wherein the aryl group is phenyl substituted with aryl.
58. R 2 -OC(=O)CH 3 The ink applicator of any one of claims 51 to 57, wherein the radical is selected from -OH and -OH.
59. R 2 Ga-OR 9 and R 9 But, H, C 1~6 Alkyl, tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), triethylsilyl (TES), and C 6~10 The ink applicator of any one of claims 51 to 57, wherein the alkyl group is selected from the group consisting of aryls.
60. R 9 The ink applicator of any one of claims 51 to 57 or 59, wherein is selected from H, tert-butyldimethylsilyl (TBS), and -OH.
61. The ink applicator of any one of claims 51 to 60, wherein the double bonds are absent.
62. R 4 and R 5 together with the carbon atom to which it is attached form a three-membered heterocyclic ring; R 3 But -CH 2 62. The ink applicator of claim 61, wherein the ink is OH.
63. The three-membered heterocycle is 【Chemistry 2】 63. The ink applicator of claim 62, wherein:
64. R 4 and R 5 together with the carbon atom to which it is attached form a four-membered heterocyclic ring; R 3 The ink applicator of claim 61, wherein: is --OH.
65. The four-membered ring is 【Chemistry 3】 65. The ink applicator of claim 64,
66. The ink applicator of any one of claims 51 to 60, wherein the double bond is present.
67. R 1 But 1 to 3 R 7 67. The ink applicator of claim 66, wherein the aryl group is phenyl substituted with
68. R 1 is -C(=O)OR 6 and R 6 But 1 to 3 R 7 67. The ink applicator of claim 66, wherein the aryl group is phenyl substituted with
69. R 2 is —OH, and R 3 But, CH 2 The ink applicator of any one of claims 66 to 68, wherein the polymer is OH.
70. R 3 but, -NR 7 R 8 , -CH 2 N.R. 7 R 8 , -C(=O)OR 10 , -C(=O)NR 10 R 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH=CR 10 R 10 , -CH 2 OR 10 and 1 to 5 R 7 phenyl substituted with R 1 is -C(=O)OH, R 2 is —OH, R 10 But, H, C 1~6 Alkyl, alkoxy, oxo, -OH, -CH(=O), -C(=O)OR 6 , phenyl and 1 to 5 R 7 70. The ink applicator of claim 69, wherein the aryl group is selected from phenyl substituted with .
71. R 3 but, -NR 7 R 8 , -CH 2 -NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -C(=O)NR 10 R 10 , -CH 2 OR 10 , and 1 to 5 R 7 phenyl substituted with R 1 is -C(=O)OH, R 2 But, -OR 9 and R 9 is H, C 1~6 Alkyl, tert-butyldimethylsilyl (TBS), trimethylsilyl (TMS), triethylsilyl (TES) and C 6~10 67. The ink applicator of claim 66, wherein the alkyl group is selected from the group consisting of aryls.
72. R 3 but, -NR 7 R 8 , -CH 2 -NR 7 R 8 , -C(=O)OR 10 , -CH(=O), phenyl, -CHR 10 R 10 , -CH=CHR 10 , -CH 2 OR 10 , diethyl malonate and 1 to 5 R 7 phenyl substituted with R 1 is -C(=O)OH, R 2 The ink applicator of claim 66, wherein: is --OH.
73. 2. The ink applicator of claim 1, wherein the genipin derivative is a compound selected from the group consisting of the compounds shown in Table 1.
74. R 7 but, - (C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -NHC(=O)R 8 , -OC(=O)R 8 , -SR 8 , -CO 2 - , -SO 2 CF 3 , -NO, -NO 2 , -SO 2 R 8 , -CN, -CR 11 , -COR 11 , -CHO, -CO 2 R 8 , -C(=O)NR 8 R 8 and halides; R 8 H, -(C 1~9 alkyl), -(C 2~9 alkenyl); R 11 The ink applicator of any one of claims 51 to 72, wherein is a halide.
75. The ink applicator of any one of claims 51 to 74, wherein the Lawesone derivative is a compound shown in Table 4.
76. The Lawesone derivative is a compound of formula III, 【Chemistry 4】 In the formula, R 12 But -(C 1~9 alkyl), -(C 2~9 alkenyl), phenyl, -NR 8 R 8 , -OR 8 , -NHC(=O)R 8 , -OC(=O)R 8 , -SR 8 , -CO 2 - , -SO 2 CF 3 , -NO, -NO 2 , -SO 2 R 8 , -CN, -CR 11 3 , -COR 11 , -CHO, -CO 2 R 8 , -C(=O)NR 8 R 8 and halides; R 8 H, -(C 1~9 alkyl) and -(C 2~9 alkenyl); R 11 The ink applicator of any one of claims 51 to 75, wherein is a halide.
77. The ink applicator of any one of claims 51 to 76, wherein the semi-permanent colorant is a combination of two or more of genipin, a genipin derivative, lawsone, and lawsone derivatives.
78. The ink applicator of any one of claims 51 to 77, wherein the semi-permanent colorant comprises a combination of two or more genipin derivatives.
79. The ink applicator of any one of claims 51 to 77, wherein the semi-permanent colorant comprises a combination of two or more compounds set forth in Table 1.
80. 80. The ink applicator of any one of claims 51 to 77 and 79, wherein the semi-permanent colorant more specifically comprises a combination of Compound 1 and Compound 12 in a ratio of Compound 1:Compound 12 of about 4:1 to about 1:
4.
81. 78. The ink applicator of any one of claims 51 to 77, wherein the semi-permanent colorant is a combination of genipin and Compound 1, more specifically, the ratio of genipin to Compound 1 is from about 4:1 to about 1:4 genipin to Compound 1, and even more specifically, the ratio of genipin to Compound 1 is about 1:1 genipin:Compound 1.
82. 80. The ink applicator of any one of claims 51 to 77 and 79, wherein the semi-permanent colorant is a combination of compound 1 and compound 14, more specifically, the ratio of compound 1 to compound 14 is from about 4:1 to about 1:4, and even more specifically, the ratio of compound 1 to compound 14 is about 1:1 compound 1:compound 14.
83. 78. The ink applicator of any one of claims 51 to 77, wherein the semi-permanent colorant is a combination of genipin and compound 14, more specifically, the ratio of genipin to compound 14 is from about 4:1 to about 1:4 genipin:compound 14, and even more specifically, the ratio of genipin to compound 14 is about 1:1 genipin:compound 14.
84. 78. The ink applicator of any one of claims 51 to 77, wherein the semi-permanent colorant is a combination of genipin, Compound 1, and Compound 14, more specifically, the ratio of genipin to Compound 1 to Compound 14 is from about 4:1:1 to about 1:1:4 genipin:Compound 1:Compound 14, and even more specifically, the ratio of genipin to Compound 1 to Compound 14 is about 1:1:1 genipin:Compound 1:Compound 14.
85. 86. An ink applicator as described in any one of claims 52 to 85, wherein the semi-permanent colorant is present in an amount of from about 5 w / w% to about 15 w / w% of the composition, more specifically, in an amount of from about 9 w / w% to about 11 w / w% of the composition, and even more specifically, in an amount of about 10 w / w% of the composition.
86. An ink applicator as described in any one of claims 51 to 85, wherein the solvent is present in an amount of from about 65 w / w% to about 85 w / w% of the composition, more specifically, in an amount of from about 75 w / w% to about 80 w / w% of the composition, and even more specifically, in an amount of about 77 w / w% of the composition.
87. The ink applicator of any one of claims 51 to 86, wherein the solvent comprises water, methanol, ethanol, isopropanol, diethylene glycol monoethyl ether, or combinations thereof.
88. The ink applicator of any one of claims 51 to 88, wherein the solvent is a combination of water and ethanol.
89. An ink applicator according to any one of claims 87 to 88, wherein the water is present in an amount from about 25% to about 35% w / w of the composition, more specifically, in an amount of about 30% w / w of the composition.
90. 90. An ink applicator as described in any one of claims 87 to 89, wherein the ethanol is present in an amount of from about 40% to about 55% w / w of the composition, more specifically, in an amount of from about 45% to about 50% w / w of the composition, and even more specifically, in an amount of about 48% w / w of the composition.
91. 91. An ink applicator as described in any one of claims 51 to 90, wherein the film forming agent is present in an amount of from about 5 w / w% to about 10 w / w% of the composition, more specifically, in an amount of from about 6 w / w% to about 9 w / w% of the composition, and even more specifically, in an amount of about 7.5 w / w% of the composition.
92. The ink applicator of any one of claims 51 to 91, wherein the film-forming agent comprises a volatile silicone resin, a polyvinylpyrrolidone, an acrylate, an acrylamide, a copolymer, an isododecane resin, or a combination thereof.
93. The film former is selected from the group consisting of polymethylsilsesquioxane, trimethylsiloxysilicate, polypropylsilsesquioxane, dimethicone, cyclopentasiloxane, dimethiconol crosspolymer, polysilicone-6, polysilicone-8, polysilicone-11, polysilicone-14, acrylates copolymer, styrene / acrylates copolymer, polyvinylpyrrolidone, acrylates / C12-22 alkyl methacrylate copolymer, acrylates / polytrimethylsiloxymethacrylate copolymer, polyvinylpyrrolidone / vinyl acetate (VP / VA) copolymer, VP / dimethiconyl acrylate / polycarbamyl / 93. The ink applicator of any one of claims 51 to 92, comprising a polyglycol ester, VP / dimethylaminoethyl methacrylate copolymer, VP / dimethylaminoethyl methacrylate / polycarbamyl polyglycol ester, VP / eicosene copolymer, VP / hexadecene copolymer, VP / methacrylamide / vinylimidazole copolymer, VP / polycarbamyl polyglycol ester, VP / VA copolymer, polyester-1, polyester-2, polyester-3, polyester-4, polyester-5, polyester-7, polyester-8, polyester-10, or combinations thereof.
94. The ink applicator of any one of claims 51 to 93, wherein the film-forming agent is a combination of an acrylate copolymer, polyvinylpyrrolidone, and a styrene / acrylate copolymer.
95. An ink applicator as described in any one of claims 93 or 94, wherein the acrylate copolymer is present in an amount of from about 0.1 w / w% to about 10 w / w% of the composition, more specifically, in an amount of from about 0.1 w / w% to about 1 w / w% of the composition, and even more specifically, in an amount of about 0.25 w / w% of the composition.
96. An ink applicator as described in any one of claims 93 to 95, wherein the polyvinylpyrrolidone is present in an amount of from about 0.1 w / w% to about 10 w / w% of the composition, more specifically, in an amount of from about 0.5 w / w% to about 1.5 w / w% of the composition, and even more specifically, in an amount of about 1 w / w% of the composition.
97. An ink applicator as described in any one of claims 95 to 96, wherein the styrene / acrylate copolymer is present in an amount of from about 0.1 w / w% to about 10 w / w% of the composition, more specifically, in an amount of from about 5 w / w% to about 7 w / w% of the composition, and even more specifically, in an amount of about 6 w / w% of the composition.
98. The ink applicator of any one of claims 51 to 97, wherein the composition further comprises a humectant.
99. 99. The ink applicator of claim 98, wherein the humectant is present in an amount of from about 0.1 w / w% to about 10 w / w% of the composition, more specifically, in an amount of from about 0.5 w / w% to about 1.5 w / w% of the composition, and even more specifically, in an amount of about 1 w / w% of the composition.
100. 100. The ink applicator of any one of claims 98 to 99, wherein the humectant comprises aloe vera gel, lithium chloride, allantoin, urea, dicyanamidoglycerol, lactic acid, propylene glycol, polyethylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol, propanediol, hexylene glycol, 1,3-butylene glycol, 1,2,6-hexanetriol, glycerol ethoxylate, glycerol propoxylate, glyceryl triacetate, sorbitol, hydroxypropyl sorbitol, xylitol, maltitol, hyaluronic acid, tremella extract, sodium lactate, sodium urea-pyroglutamate, pyrrolidone carboxylic acid, or combinations thereof.
101. The ink applicator of any one of claims 98 to 100, wherein the humectant is propanediol.
102. The ink applicator of any one of claims 51 to 101, wherein the composition further comprises a preservative.
103. The ink applicator of claim 102, wherein the preservative is present in an amount of from about 0.1 w / w% to about 5 w / w% of the composition, more specifically, in an amount of from about 0.5 w / w% to about 1.5 w / w% of the composition, and even more specifically, in an amount of about 1 w / w% of the composition.
104. The preservative is selected from the group consisting of ascorbic acid, ascorbate, palmitate, citric acid, benzoate, benzoic acid, propionate, propionic acid, sorbate, sorbic acid, salicylic acid, salicylates, hexa-2,4-dienoic acid, hexa-2,4-dienoate, formaldehyde, formaldehyde-releasing agents, formic acid and its salts, 3-acetyl-6-methylpyran-2,4-(3H)-dione and its salts, 3,3'-dibromo-4,4'-hexamethylenedioxydibenzamidine and its salts, thiomersal, phenylmercury salts, undec-10-enoic acid and its salts, 1,3-bis(2-ethylhexyl)hexahydro-5 -methyl-5-pyrimidine, 5-bromo-5-nitro-1,3-dioxane, bronopol, 2,4-dichlorobenzyl alcohol, 1-(4-chlorophenyl)-3-(3,4-dichlorophenyl)urea, chlorocresol, chloroxylenol, 5-chloro-2-(2,4-dichlorophenoxy)phenol, N,N''-methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea], polyaminopropyl biguanide, methenamine, quaternium-15, climbazole, DMDM hydantoin, benzyl alcohol, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-pyridone, piroctone olamine, bromochlorophene, o-cymen-5-ol, chlorophene, chloroacetamine, methylchloroisothiazolinone, methylisothiazolinone, phenoxyisopropanol, chlorhexidine, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dihydrochloride, dimethyloxazolidine, behentrimonium chloride, cetrimonium bromide, cetrimonium chloride, lauttrimonium bromide, lauttrimonium chloride, steartrimonium bromide, steartrimonium chloride, diazolidinyl urea, hexamidine, hexamidine diisethionate, hexamidine paraben, glutaral, 7-ethylbicyclooxazolidine, chlorphenesin, sodium hydroxymethylglycine, silver chloride, benzethonium chloride, benzalkonium chloride 104. The ink applicator of claim 102, further comprising an alkyl group selected from the group consisting of butyl ether, butyl ether, isopropyl ...
105. The ink applicator of any one of claims 102 to 104, wherein the preservative comprises a combination of phenoxyethanol and ethylhexylglycerin.
106. 106. The ink applicator of claim 105, wherein said combination of phenoxyethanol and ethylhexylglycerin is present in said composition in a ratio of about 9:1 phenoxyethanol:ethylhexylglycerin.
107. 107. An ink applicator as described in claim 105 or 106, wherein the combination of phenoxyethanol and ethylhexylglycerin is present in an amount of about 0.1 w / w% to about 2 w / w% of the composition, more specifically, in an amount of about 1 w / w% of the composition.
108. The ink applicator of any one of claims 102 to 107, wherein the preservative comprises EDTA.
109. The ink applicator of claim 108, wherein the EDTA is present in an amount from about 0.01 w / w% to about 2 w / w% of the composition, more specifically, in an amount of about 0.05 w / w% of the composition.
Citation Information
Patent Citations
Long-acting skin marking pen based on genipin coloring principle
CN110226975A
Applicator
JP2011206926A
